INGERSOLL RAND INC.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-K
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended
December 31, 2019
or
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from
to_________
Commission File Number:
001-38095
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification No.)
|
(Address of Principal Executive Offices) (Zip Code)
(
414
)
212-4700
(Registrant’s Telephone Number, Including Area Code)
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
|
|
|
|
Securities Registered Pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes
☒
No
☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
☐
No
☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
☒
|
Accelerated filer
|
☐
|
||
|
Non-accelerated filer
|
☐
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
|
||
|
Emerging growth company
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant on June 28, 2019 was approximately $
4,560.2
million based on the closing price of such common equity on the New York Stock Exchange on such date.
The registrant had outstanding
205,211,761
shares of Common Stock, par value $0.01 per share, as of
February 19, 2020.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Proxy Statement for the registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.
|
|
Page
No.
|
|
PART I
|
|
|
3
|
|
|
11
|
|
|
21
|
|
|
22
|
|
|
22
|
|
|
22
|
|
|
|
|
|
PART II
|
|
|
23
|
|
|
23
|
|
|
27
|
|
|
45
|
|
|
47
|
|
|
47
|
|
|
48
|
|
|
49
|
|
|
50
|
|
|
51
|
|
|
52
|
|
|
101
|
|
|
101
|
|
|
102
|
|
|
|
|
|
PART III
|
|
|
102
|
|
|
102
|
|
|
102
|
|
|
103
|
|
|
103
|
|
|
|
|
|
PART IV
|
|
|
103
|
|
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
PART I
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
In addition to historical information, this Annual Report on Form 10-K (this “Form 10-K”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the “safe harbor” created by those sections. All statements, other than statements of historical facts included in this Form 10-K, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, business trends and other information, may be forward-looking statements. Words such as “estimates,” “expects,” “contemplates,” “will,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” “may,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. The forward-looking statements are not historical facts, and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates, and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.
There are a number of risks, uncertainties, and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this Form 10-K. Such risks, uncertainties and other important factors include, among others, the risks, uncertainties and factors set forth under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Form 10-K. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. See “Item 1A. Risk Factors” for more information.
Gardner Denver Holdings, Inc. is a holding company whose operating subsidiaries are Gardner Denver, Inc. (“GDI”) and certain of GDI’s subsidiaries. The holding company and its consolidated subsidiaries are collectively referred to in this Annual Report as “we,” “us,” “our,” “ourselves,” “Company,” or “Gardner Denver.”
Service marks, trademarks and trade names, and related designs or logotypes owned by Gardner Denver or its subsidiaries are shown in
italics.
Transaction with Ingersoll Rand
In April 2019, the Board of Directors of Gardner Denver approved a merger that will combine Gardner Denver with the industrial segment of Ingersoll-Rand plc (“Ingersoll Rand”) (the “Merger”). To facilitate this Merger, Ingersoll Rand will cause specific assets and liabilities of its industrial segment to be transferred to Ingersoll-Rand U.S. HoldCo, Inc. (“Ingersoll Rand Industrial”), a newly formed wholly-owned subsidiary of Ingersoll Rand, and distribute the shares of common stock of Ingersoll Rand Industrial to Ingersoll Rand’s shareholders. Charm Merger Sub Inc., (“Merger Sub”), which is a newly formed wholly-owned subsidiary of Gardner Denver, will be merged with and into Ingersoll Rand Industrial, with Ingersoll Rand Industrial surviving such merger as a wholly-owned subsidiary of Gardner Denver.
Pursuant to the definitive agreement Gardner Denver entered into with Ingersoll Rand, Ingersoll Rand Industrial and Merger Sub with respect to the Merger (the “Merger Agreement”), Gardner Denver will issue an aggregate number of shares of its common stock to Ingersoll Rand Industrial stockholders which will result in Ingersoll Rand Industrial stockholders owning approximately, but not less than, 50.1% of the shares of Gardner Denver common stock outstanding on a fully-diluted basis upon the closing of the Merger. The number of shares to be issued to Ingersoll Rand Industrial stockholders is based on the exchange ratio set forth in the Merger Agreement. In addition, Ingersoll Rand will receive approximately $1.9 billion in cash from Ingersoll Rand Industrial that will be funded by newly-issued debt that is expected to be deemed issued under the existing Senior Secured Credit Facilities of Gardner Denver upon consummation of the merger. The merger is expected to close on February 29, 2020.
The Merger will result in Gardner Denver acquiring Ingersoll Rand Industrial, which includes compressed air and gas systems and services, power tools, material handling systems, fluid management systems as well as Club Car golf, utility and consumer low-speed vehicles. Following the Merger, the combined company is expected to be renamed and operate under the Ingersoll Rand name and its common stock is expected to be listed on the New York Stock Exchange under Ingersoll Rand’s existing ticker symbol “IR.”
See Note 3 “Business Combinations” to our audited consolidated financial statements included elsewhere in this Form 10-K for additional information related to the transaction with Ingersoll Rand.
Our Company
We are a leading global provider of mission-critical flow control and compression equipment and associated aftermarket parts, consumables and services, which we sell across multiple attractive end-markets within the industrial, energy and medical industries. We manufacture one of the broadest and most complete ranges of compressor, pump, vacuum and blower products in our markets, which, combined with our global geographic footprint and application expertise, allows us to provide differentiated product and service offerings to our customers. Our products are sold under a collection of premier, market-leading brands, including Gardner Denver, CompAir, Nash, Emco Wheaton, Robuschi, Elmo Rietschle and Thomas, which we believe are globally recognized in their respective end-markets and known for product quality, reliability, efficiency and superior customer service.
These attributes, along with over 155 years of engineering heritage, generate strong brand loyalty for our products and foster long-standing customer relationships, which we believe have resulted in leading market positions within each of our operating segments. We have sales in more than 175 countries and our diverse customer base utilizes our products across a wide array of end-markets, including industrial manufacturing, energy (with particular exposure to the North American upstream land-based market), transportation, medical and laboratory sciences, food and beverage packaging and chemical processing.
Our products and services are critical to the processes and systems in which they are utilized, which are often complex and function in harsh conditions where the cost of failure or downtime is high. However, our products typically represent only a small portion of the costs of the overall systems or functions that they support. As a result, our customers place a high value on our application expertise, product reliability and the responsiveness of our service. To support our customers and market presence, we maintain significant global scale with 38 key manufacturing facilities, more than 30 complementary service and repair centers across six continents and approximately 6,600 employees worldwide as of December 31, 2019.
The process-critical nature of our product applications, coupled with the standard wear and tear replacement cycles associated with the usage of our products, generates opportunities to support customers with our broad portfolio of aftermarket parts, consumables and services. Customers place a high value on minimizing any time their operations are offline. As a result, the availability of replacement parts, consumables and our repair and support services are key components of our value proposition. Our large installed base of products provides a recurring revenue stream through our aftermarket parts, consumables and services offerings. As a result, our aftermarket revenue is significant, representing 38% of total Company revenue and approximately 42% of our combined Industrials and Energy segments’ revenue in 2019.
Our Segments
Our business is comprised of three strategic segments.
Industrials
We design, manufacture, market and service a broad range of air compression, vacuum and blower products, including associated aftermarket parts, consumables and services, across a wide array of technologies and applications for use in diverse end-markets. Compressors are used to increase the pressure of air or gas, vacuum products are used to remove air or gas in order to reduce the pressure below atmospheric levels, and blower products are used to produce a high volume of air or gas at low pressure. Almost every manufacturing and industrial facility, and many service and process industry applications, use air compression, vacuum and blower products in a variety of process-critical applications such as the operation of industrial air tools, vacuum packaging of food products and aeration of waste water, among others.
We offer one of the broadest portfolios of compression, vacuum and blower technology in our markets which we believe, alongside our geographic footprint, allows us to provide differentiated service to our customers globally and maintain leading positions in many of our end-markets. Our compression products cover the full range of technologies, including rotary screw, reciprocating piston, scroll, rotary vane and centrifugal compressors. Our vacuum products and blowers also cover the full technology spectrum; vacuum technologies include side channel, liquid ring, claw vacuum, screw, turbo and rotary vane vacuum pumps among others, while blower technologies include rotary lobe blowers, screw, claw and vane, side channel and radial blowers. The breadth and depth of our product offering creates incremental business opportunities by allowing us to cross-sell our full product portfolio and uniquely address customers’ needs in one complete solution.
We sell our industrial products through an integrated network of direct sales representatives and independent distributors, which is strategically tailored to meet the dynamics of each target geography or end-market. Our large installed base also provides for a significant stream of recurring aftermarket revenue. For example, on average, the useful life of a compressor is between 10 and 12 years. However, a customer typically services the compressor at regular intervals, starting within the first two years of purchase and continuing throughout the life of the product. The cumulative aftermarket revenue generated by a compressor over the product’s life cycle will typically exceed its original cost.
Industrial air compressors represent the largest market in which we compete in our Industrials segment and is a product category for which we believe there is significant potential to drive increased sales of our aftermarket parts, consumables and services. We use our direct salesforce and strong distributor relationships, the majority of which are exclusive to our business for the products that we sell through them, to sell our broad portfolio of aftermarket parts, consumables and services. Within our Industrials segment, we primarily sell through the Gardner Denver, CompAir, Elmo Rietschle and Robuschi brands, as well as other leading brand names.
Energy
We design, manufacture, market and service a diverse range of positive displacement pumps, liquid ring vacuum pumps, compressors and integrated systems, engineered fluid loading and transfer equipment and associated aftermarket parts, consumables and services. The highly engineered products offered by our Energy segment serve customers across upstream, midstream and downstream energy markets, as well as petrochemical processing, transportation and general industrial sectors. We are one of the largest suppliers of equipment and associated aftermarket parts, consumables and services for the energy market applications that we serve.
Our positive displacement pumps are fit-for-purpose to meet the demands and challenges of modern unconventional drilling and hydraulic fracturing activity, particularly in the major basins and shale plays in the North American land market. Our positive displacement pump offering includes mission-critical oil and gas drilling pumps, frac pumps and well servicing pumps, in addition to sales of associated consumables used in the operation of our pumps and aftermarket parts, consumables and services. The products we sell into upstream energy applications are highly aftermarket-intensive, and so we support these products in the field with one of the industry’s most comprehensive service networks, which encompasses locations across all major basins and shale plays in the North American land market. This service network is critical to serving our customers and, by supporting them in the field, to generating demand for new original equipment sales and aftermarket parts, consumables, service and repair sales which in aggregate are often multiples of the cost of the original equipment.
Our liquid ring vacuum pumps and compressors are highly engineered products specifically designed for continuous duty in harsh environments to serve a wide range of applications, including oil and gas refining and processing, mining, chemical processing, petrochemical and industrial applications. Our liquid ring technology utilizes a service liquid to evacuate or compress gas by forming a rotating ring of liquid that acts like a piston to deliver an uninterrupted flow of gas without pulsation. In addition, our engineered fluid loading and transfer equipment and systems ensure the safe and efficient transportation and transfer of petroleum products as well as certain other liquid commodity products to serve a wide range of industries. Similar to our positive displacement pumps business, we complement these products with a broad array of aftermarket parts, service and repair capabilities by leveraging our global network of manufacturing and service locations to meet the diverse needs of our customers. Within our Energy segment, we primarily sell through the Gardner Denver, Nash and Emco Wheaton brands, as well as other leading brand names.
Medical
We design, manufacture and market a broad range of highly specialized gas, liquid and precision syringe pumps and compressors that are specified by medical and laboratory equipment suppliers and integrated into their final equipment for use in applications, such as oxygen therapy, blood dialysis, patient monitoring, laboratory sterilization and wound treatment, among others. We offer a comprehensive product portfolio across a breadth of technologies to address the medical and laboratory sciences pump and fluid handling industry, as well as a range of end-use vacuum products for laboratory science applications. Our product performance, quality and long-term reliability are often mission-critical in healthcare applications. We are one of the largest product suppliers in the medical markets we serve and have long-standing customer relationships with industry-leading medical and laboratory equipment providers. Additionally, many of our Medical segment gas and liquid pumps are also used in other technology applications beyond the medical and laboratory sciences. Within our Medical segment, we primarily sell through the Thomas brand, as well as other leading brand names.
Our Industries and Products
We operate in the global markets for flow control and air compression products for the industrial, energy and medical industries. Our highly engineered products and proprietary technologies are focused on serving specialized applications within these attractive and growing industries.
Industrials
Our Industrials segment designs, manufactures, markets and services a broad range of air compression, vacuum and blower products across a wide array of technologies. Compression, vacuum and blower products are used in a wide spectrum of applications in nearly all manufacturing and industrial facilities and many service and process industries in a variety of end-markets, including infrastructure, construction, transportation, food and beverage packaging and chemical processing.
Compression Products
Sales to industrial end-markets include industrial air compression products, as well as associated aftermarket parts, consumables and services. Industrial air compressors compress air to create pressure to power machinery, industrial tools, material handling systems and automated equipment. Compressed air is also used in applications as diversified as snow making and fish farming, on high-speed trains and in hospitals. Compressors can be either stationary or portable, depending on the requirements of the application or customer.
We focus on five basic types of air compression technologies: rotary screw, reciprocating piston, scroll, rotary vane and centrifugal compressors. Rotary screw compressors are a newer technology than reciprocating compressors and exhibit better suitability for continuous processes due to a more compact size, less maintenance and better noise profile. We believe our reciprocating piston compressors provide one of the broadest ranges of pressures in the market and are supported by increasing demand across wide-ranging attractive end-markets. Scroll compressors are most commonly seen where less oil-free air is needed, and is most commonly used in medical and food applications where the need for pure, clean and precise air is of great importance. Rotary vane compressors feature high efficiency, compact compression technology and can be found throughout all sectors of industry, including automotive, food and beverage, energy and manufacturing with specialist solutions within transit, gas and snow making. Centrifugal compressors are most effective when in applications that demand larger quantities of oil-free air and are utilized across a wide range of industries.
Vacuum Products
Industrial vacuum products are integral to manufacturing processes in applications for packaging, pneumatic conveying, drying, holding / lifting, distillation, evacuation, forming / pressing, removal and coating. Within each of these processes are a multitude of sub-applications. As an example of one such end-process, within packaging, a vacuum will be used on blister packaging, foil handling, labeling, carton erection, stacking and palletizing (placing, stacking or transporting goods on pallets), as well as central vacuum supply for entire packaging departments. Management believes that we hold a leading position in our addressable portion of the global vacuum products market.
We focus on five basic types of vacuum technologies: side channel, liquid ring, claw vacuum, screw and rotary vane vacuum pumps. Side channel vacuum pumps are used for conveying gases and gas-air mixtures in a variety of applications, including laser printers, packaging, soil treatment, textiles and food and beverage products. Liquid ring vacuum pumps are used for extreme conditions, which prevail in humid and wet processes across ceramics, environmental, medical and plastics applications. Claw vacuum pumps efficiently and economically generate contact-free vacuum for chemical, environmental and packaging applications. Screw
vacuum pumps are a dry running technology used to reduce the carbon footprint and life cycle costs in drying and packaging applications. Rotary vane vacuum pumps are used for vacuum and combined pressure and vacuum applications in the environmental, woodworking, packaging and food and beverage end-markets.
Blower Products
Blower products are used for conveying high volumes of air and gas at various flow rates and at low pressures, and are utilized in a broad range of industrial and environmental applications, including waste water aeration, biogas upgrading and conveying, pneumatic transport and dehydrating applications for food and beverage, cement, pharmaceutical, petrochemical and mobile industrial applications. We also design, manufacture, market and service frac sand blowers within our Industrials segment. In many cases, blowers are a core component for the operation of the entire end-users’ systems. Management believes that we hold a leading position in our addressable portion of the global blower products market.
We focus on several key technologies within blower products: rotary lobe, screw, claw and vane, turbo, side channel and radial blowers. Rotary lobe blowers, screw blowers and claw and vane blowers are positive displacement technologies that have the ability to consistently move the same volume of gas or air and vary the volume flow according to the speed of the machine itself enabling it to adapt the flow condition in a flexible manner despite pressure in the system. Turbo blowers and side channel and radial blowers are dynamic technologies that have the ability to accelerate gas or air through an impeller and transform their kinetic energy at the discharge with some limitation on flexibility.
Energy
Our Energy segment designs, manufactures, markets and services a diverse range of positive displacement pumps, liquid ring vacuum pumps, compressors and integrated systems, engineered fluid loading and transfer equipment and associated aftermarket parts, consumables and services for a number of attractive, growing market
sectors with energy exposure, spanning upstream, midstream, downstream and petrochemical applications. The high cost of failure in these applications makes quality and reliability key purchase criteria for end-users and drives demand for our highly engineered and differentiated products.
Upstream
Through the manufacture and aftermarket service of pumps and manufacture of associated aftermarket parts and consumables used in drilling, hydraulic fracturing and well servicing applications, our Energy segment is well-positioned to capitalize on an upstream recovery, particularly in the North American land-based market, where our customers include market-leading hydraulic fracturing (also known as pressure pumping) and contract drilling service companies, as well as certain other types of well service companies. Sales to upstream energy end-markets consist of positive displacement pumps and associated aftermarket parts, most notably fluid ends, as well as consumables and services.
| ● |
Positive displacement pumps in the upstream energy end-market primarily move fluid to assist in drilling, hydraulic fracturing and well servicing applications. The majority of positive displacement pumps we sell are frac pumps, which experience significant service intensity during use in the field and, as such, typically have useful life spans of approximately four to six years before needing to be replaced. During that useful life, such pumps will need to receive intermittent repairs as well as major overhauls. In addition, we also sell positive displacement pumps that are used in drilling and well servicing applications.
|
| ● |
Fluid ends are a key component of positive displacement pumps that generate the pumping action, along with other parts, such as plungers, and consumables, such as valves, seats and packing, which pressurizes the fluid, in the case of drilling or well servicing applications, or fluid and proppant mixture, in the case of hydraulic fracturing, and propels such fluid or mixture out of the pump and into a series of flow lines that distribute the fluid or mixture into the well. Fluid ends are incorporated in original equipment pumps, and due to the highly corrosive nature of the fluids and the abrasive nature of the proppants used in hydraulic fracturing operations, need to be frequently replaced.
|
The level of profitability at which new wells can be drilled is a primary driver of drilling and completions activities, including hydraulic fracturing. Thus, demand for our Energy and Industrials products exposed to the upstream energy industry is driven by the prices of crude oil and natural gas, and the intensity and activity levels of drilling and hydraulic fracturing.
Midstream and Downstream
Sales to midstream and downstream energy end-markets consist of liquid ring vacuum pumps and compressors and integrated systems, engineered fluid loading and transfer equipment and associated aftermarket parts and services. Our downstream energy business contributes a larger share of revenue and profitability than our midstream energy business.
We focus on two basic types of midstream and downstream energy equipment: fluid transfer equipment and liquid ring vacuum pumps and compressors, which are employed in the midstream and downstream markets, respectively.
| ● |
Fluid transfer equipment, including fluid loading systems, tank truck and fleet fueling products and couplers: Fluid loading systems are used in the transfer and loading of hydrocarbons and certain other liquid commodity products in marine and land applications. Tank truck and fleet fueling products allow for safe transfer of liquid products without spillage or contamination while safeguarding the operator and the environment. Operators use Dry-Break® technology couplers and adapters to provide a secure connection for the transfer of liquid products without spillage or contamination while safeguarding the operator and the environment.
|
| ● |
Liquid ring vacuum pumps and compressors: Liquid ring vacuum pumps and compressors are designed for continuous duty in harsh environments, including vapor and flare gas recovery equipment (which recovers and compresses certain polluting gases to transmit them for further processing), primarily in downstream applications. The liquid ring technology utilizes a service liquid, typically water, oil or fuel, to evacuate or compress gas by forming a rotating ring of liquid that follows the contour of the body of the pump or compressor and acts like a piston to deliver an uninterrupted flow of gas without pulsation.
|
Petrochemical
Our Energy segment is positioned to capitalize on the large and growing petrochemical industry. Sales to petrochemical end-markets consist of vacuum and compression process systems, both of which are used in harsh, continuous-duty applications. Demand for our petrochemical industry products correlates with growth in the development of new petrochemical plants as well as activity levels therein, which drive demand for aftermarket parts and services on our market-leading installed base of equipment.
Medical
The Medical segment designs, manufactures and markets a broad range of flow control products for the durable medical equipment, laboratory vacuum and automated liquid handling end-markets. Key technologies include gas, liquid and precision syringe pumps and automated liquid handling systems.
Our gas pumps are used for a wide range of applications, such as aspirators, blood analyzers, blood pressure monitors, compression therapy, dental carts, dialysis machines, gas monitors and ventilators. Gas pumps transfer and compress gases and generate vacuum to enable precise flow conditions. Our liquid pump products are primarily used to meter and transfer both neutral and chemically aggressive fluids and our automated liquid handling products, which includes syringe pumps, systems and accessories that are integrated into large scale automated liquid handling systems primarily for clinical, pharmaceutical and environmental analyses.
Our products are also used in the laboratory vacuum equipment space which includes end-use chemically resistant devices used in research and commercial laboratories.
Customers in the durable medical pump end-market and the automated liquid handling end-market develop and manufacture equipment used in a highly regulated environment requiring highly specialized technologies. As a result, relationships with customers are built based on a supplier’s long-term reputation and expertise and deep involvement throughout a product’s evolution, from concept to long-term commercialization. Customers value suppliers that can provide global research and development, regulatory and manufacturing support, as well as sales footprint and expertise to foster close relationships with key decision makers at their company. Combined with the long product life cycle in the regulated medical device space, these factors create a strong, recurring base of business. As a leading pump manufacturer in these markets, we have established a history of innovation that enables us to work closely with our customers to create highly customized flow control solutions for their unique applications. These products are mission-critical in the ultimate device in which they are deployed and remain a key component over the entire life cycle of the end products. The regulated market structure and nature of long-tenured customer relationships enables pump manufacturers to have a highly visible, recurring revenue stream from key customers.
Competition
Industrials
The industrial end-markets we serve are competitive, with an increasing focus on product quality, performance, energy efficiency, customer service and local presence. Although there are several large manufacturers of compression, vacuum and blower products, the marketplace for these products remains highly fragmented due to the wide variety of product technologies, applications and selling channels. Our principal competitors in sales of compression, vacuum and blower products in our Industrials segment include Atlas Copco AB, Ingersoll-Rand plc, Colfax Corp., Flowserve Corporation, IDEX Corporation and Kaeser Compressors, Inc.
Energy
Across our product lines exposed to the energy industry, the competitive landscape is specific to the end-markets served. Our principal competitor for drilling pumps is National Oilwell Varco Inc., and for frac pumps is The Weir Group plc. Within upstream energy, we additionally compete with certain smaller, regional manufacturers of pumps and aftermarket parts, although these are not direct competitors for most of our products. Our principal competitors in sales of fluid transfer equipment include Dover Corporation, SVT GmbH and TechnipFMC plc. Our principal competitors in the sale of liquid ring pumps and compressors are Flowserve Corporation and Busch-Holding GmbH.
Medical
Competition in the medical pump market is primarily based on product quality and performance, as most products must be qualified by the customer for a particular use. Further, there is an increasing demand for more efficient healthcare solutions, which is driving the adoption of premium and high performance systems. Our primary competitors in medical pumps include IDEX Corporation, Watson-Marlow, Inc., KNF Neuberger, Inc. and Thermo Fisher Scientific, as well as other regional and local manufacturers.
Customers and Customer Service
We consider superior customer service to be one of our primary pillars of future success and view it as being built upon a foundation of critical application expertise, an industry leading range of compressor, pump, vacuum and blower products, a global manufacturing and sales presence and a long-standing reputation for quality and reliability. Intense customer focus is at the center of our vision of becoming the industry’s first choice for innovative and application-critical flow control and compression equipment, services and solutions. We strive to collaborate with our customers and become an essential part of their engineering process by drawing on our deep industry and application engineering experience to develop best-in-class products that are critical to the processes and systems in which they operate.
We have established strong and long-standing customer relationships with numerous industry leaders. We sell our products directly to end-use customers and to certain OEMs, and indirectly through independent distributors and sales representatives. Our Energy and Medical products are primarily sold directly to end-use customers and OEMs, while approximately 50% of our Industrials sales in 2019 were fulfilled through independent distributors and sales representatives.
We use a direct sales force to serve end-use customers and OEMs because these customers typically require higher levels of technical assistance, more coordinated shipment scheduling and more complex product service than customers that purchase through distributors. We have distribution centers and warehouses that stock parts, accessories and certain products to provide adequate and timely availability.
In addition to our direct sales force, we are also committed to developing and supporting our global network of over 1,000 distributors and representatives who we believe provide us with a competitive advantage in the markets and industries we serve. These distributors maintain an inventory of complete units and parts and provide aftermarket services to end-users. While most distributors provide a broad range of products from different suppliers, we view our distributors as exclusive at the product category level (e.g. compressor, vacuum and blower). For example, a distributor may exclusively carry our compressor technologies, and also source additional components of the broader industrial system in which those products operate from other suppliers. Our service personnel and product engineers provide the distributors’ service representatives with technical assistance and field training, particularly with respect to installation and repair of equipment. We also provide our distributors with sales and product literature, advertising and sales promotions, order-entry and tracking systems and an annual restocking program. Furthermore, we participate in major trade shows and directly market our offerings to generate sales leads and support the distributors’ sales personnel.
Our customer base is diverse, and we did not have any customers that individually provided more than 3% of 2019 consolidated revenues.
Patents, Trademarks, and Other Intellectual Property
We rely on a combination of intellectual property rights, including patents, trademarks, copyrights, trade secrets and contractual provisions to protect our intellectual property. While in the aggregate our more than 600 patents and our trademarks are of considerable importance to the manufacture and marketing of many of our products, we believe that the success of our business depends more on the technical competence, creativity and marketing abilities of our employees than on any individual patent or trademark, and therefore we do not consider any single patent or trademark, group of patents or trademarks, copyright or trade secret to be material to our business as a whole, except for the
Gardner Denver
trademark. We have registered our trademarks in the countries we deem necessary or in our best interest. We also rely upon trade secret protection for our confidential and proprietary information and techniques, and we routinely enter into confidentiality agreements with our employees as well as our suppliers and other third parties receiving such information.
Pursuant to trademark license agreements, Cooper Industries has exclusive rights to use the
Gardner Denver
trademark for certain power tools and their components, meaning that we are prevented from using our mark in connection with those products.
Raw Materials and Suppliers
We purchase a wide variety of raw materials to manufacture our products. Our most significant commodity exposures are to cast iron, aluminum and steel. Additionally, we purchase a large number of motors and, therefore, are also exposed to changes in the price of copper, which is a primary component of motors. Most of our raw materials are generally available from a number of suppliers. We have a limited number of long-term contracts with some suppliers of key components, but we believe that our sources of raw materials and components are reliable and adequate for our needs. We use single sources of supply for certain castings, motors and other select engineered components. A disruption in deliveries from a given supplier could therefore have an adverse effect on our ability to meet commitments to our customers. Nevertheless, we believe that we have appropriately balanced this risk against the cost of maintaining a greater number of suppliers. Moreover, we have sought, and will continue to seek, cost reductions in purchases of materials and supplies by consolidating purchases and pursuing alternate sources of supply.
Employees
As of December 31, 2019, we had approximately 6,600 employees of which approximately 1,900 are located in the United States. Of those employees located outside of the United States, a significant portion are represented by works councils and labor unions, and of those employees located in the United States, approximately 200 are represented by labor unions. We believe that our current relations with employees are satisfactory.
Environmental Matters
We are subject to numerous federal, state, local and foreign laws and regulations relating to the storage, handling, emission and disposal of materials and discharge of materials into the environment. We believe that our existing environmental control procedures are adequate and we have no current plans for substantial capital expenditures in this area. We have an environmental policy that confirms our commitment to a clean environment and compliance with environmental laws. We have an active environmental management program aimed at complying with existing environmental regulations and reducing the generation of pollutants in the manufacturing processes. We are also subject to laws concerning the cleanup of hazardous substances and wastes, such as the U.S. federal “Superfund” and similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. We have been identified as a potentially responsible party with respect to several sites designated for cleanup under the “Superfund” or similar state laws. See “Item 3. Legal Proceedings.”
Corporate History
Gardner Denver Holdings, Inc. was incorporated in Delaware on March 1, 2013. Through our predecessors, Gardner Denver was founded in Quincy, Illinois in 1859. From August 1943 until we were acquired by an affiliate of Kohlberg, Kravis and Roberts & Co. L.P. (“KKR”) on July 30, 2013 (the “KKR Transaction”), we operated as a public company. We returned to being a public company when we completed our initial public offering in May 2017. Our common stock is listed on the New York Stock Exchange under the symbol “GDI” and our principal executive offices are located at 222 East Erie Street, Suite 500, Milwaukee, Wisconsin 53202.
Where You Can Find More Information
We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission (“SEC”). Our SEC filings are available to the public over the internet at the SEC’s website at
http://www.sec.gov
. Our SEC filings are also available on our website at
http://www.gardnerdenver.com
as soon as reasonably practicable after they are filed with or furnished to the SEC.
We maintain an internet site at
http://www.gardnerdenver.com
. From time to time, we may use our website as a distribution channel of material company information. Financial and other important information regarding us is routinely accessible through and posted on our website at
www.investors.gardnerdenver.com
. In addition, you may automatically receive email alerts and other information about us when you enroll your email address by visiting the Email Alerts section at
www.investors.gardnerdenver.com
. Our website and the information contained on or connected to that site are not incorporated into this Annual Report on Form 10-K.
The following risk factors as well as the other information included in this Form 10-K, including “Selected Historical Consolidated Financial Data,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements and related notes thereto should be carefully considered. Any of the following risks could materially and adversely affect our business, financial condition or results of operations. The selected risks described below, however, are not the only risks facing us. Additional risks and uncertainties not currently known to us or those we currently view to be immaterial may also materially and adversely affect our business, financial condition or results of operations.
Risks Related to Our Pending Merger with Ingersoll Rand Industrial
The pending Merger may have a material adverse effect on us whether or not it is completed.
On April 30, 2019, we entered into the Merger Agreement, pursuant to which, on the terms and subject to the conditions set forth in the Merger Agreement, Ingersoll Rand will separate Ingersoll Rand Industrial and then combine it with the Company. Under the terms of the Merger Agreement, which has been unanimously approved by the Boards of Directors of Ingersoll Rand and the Company, at the time of close, Ingersoll Rand will receive $1.9 billion in cash from Ingersoll Rand Industrial that will be funded by newly-issued debt assumed by the Company in the Merger. Upon close of the transaction, existing Ingersoll Rand shareholders will receive 50.1% of the shares of the Company on a fully diluted basis.
The Merger and the preparation for the integration of our business with Ingersoll Rand Industrial has placed a significant burden on management and internal resources. In addition, if the proposed Merger is completed, the anticipated benefits of the Merger may not be realized fully or at all and may take longer to realize than expected. The integration process will be complex, costly and time-consuming, which could adversely affect our businesses, financial results and financial condition. Even if we are able to integrate Ingersoll Rand Industrial successfully, the Merger may not result in the realization of the full benefits of anticipated cost synergies, innovation, operational efficiencies and incremental revenue growth opportunities that we expect to realize or these benefits may not be achieved within a reasonable period of time. Moreover, the combined company may be unable to implement its business strategy or retain and hire key personnel.
We currently anticipate that we will close the Merger on February 29, 2020, but we cannot be certain that the customary closing conditions will be satisfied or waived on or prior to that date. We may be required to pay to Ingersoll Rand a termination fee of approximately $176 million if the Merger Agreement is terminated under certain circumstances. See also “Risks Related to Our Business—Acquisitions and integrating such acquisitions create certain risks and may affect our operating results.”
Risks Related to Our Business
We have exposure to the risks associated with instability in the global economy and financial markets, which may negatively impact our revenues, liquidity, suppliers and customers.
Our financial performance depends, in large part, on conditions in the markets we serve and on the general condition of the global economy, which impacts these markets. Any sustained weakness in demand for our products and services resulting from a contraction or uncertainty in the global economy could adversely impact our revenues and profitability.
In addition, we believe that many of our suppliers and customers access global credit markets to provide liquidity, and in some cases, utilize external financing to purchase products or finance operations. If our customers are unable to access credit markets or lack liquidity, it may impact customer demand for our products and services.
Furthermore, our products are sold in many industries, some of which are cyclical and may experience periodic contractions. Cyclical weakness in the industries that we serve could adversely affect demand for our products and affect our profitability and financial performance.
More than half of our sales and operations are in non-U.S. jurisdictions and we are subject to the economic, political, regulatory and other risks of international operations.
For the year ended December 31, 2019, approximately 59% of our revenues were from customers in countries outside of the United States. We have manufacturing facilities in Germany, the United Kingdom, China, Finland, Italy, India and other countries. We intend to continue to expand our international operations to the extent that suitable opportunities become available. Non-U.S. operations and United States export sales could be adversely affected as a result of: political or economic instability in certain countries; differences in foreign laws, including increased difficulties in protecting intellectual property and uncertainty in enforcement of contract rights; credit risks; currency fluctuations, in particular, changes in currency exchange rates between the U.S. dollar, Euro, British Pound and the Chinese Renminbi; exchange controls; changes in and uncertainties with respect to tariffs and import/export trade restrictions (including changes in United States trade policy toward other countries, such as the imposition of tariffs and the resulting consequences), as well as other changes in political policy in the United States, China, the U.K. and certain European countries (including the impacts of the U.K.’s national referendum resulting in the
U.K.’s
withdrawal from the European Union); royalty and tax increases; nationalization of private enterprises; civil unrest and protests, strikes, acts of terrorism, war or other armed conflict; shipping products during times of crisis or war; and other factors inherent in foreign operations.
In addition, our expansion into new countries may require significant resources and the efforts and attention of our management and other personnel, which will divert resources from our existing business operations. As we expand our business globally, our success will depend, in large part, on our ability to anticipate and effectively manage these risks associated with our international operations.
Our revenues and operating results, especially in the Energy segment, depend on the level of activity in the energy industry, which is significantly affected by volatile oil and gas prices.
Demand for certain products of our Energy segment, particularly in the upstream energy market, depends on the level of activity in oil and gas exploration, development and production, and is primarily tied to the number of working and available drilling rigs, number of wells those rigs drill annually, the amount of hydraulic fracturing horsepower required on average to fracture each well and, ultimately, oil and natural gas prices overall. The energy market is volatile as the worldwide demand for oil and natural gas fluctuates.
Generally, when worldwide demand or our customers’ expectations of future prices for these commodities are depressed, the demand for our products used in drilling and recovery applications is reduced. Other factors, including availability of quality drilling prospects, exploration success, relative production costs and political and regulatory environments are also expected to affect the demand for our products. Worldwide military, political and economic events have in the past contributed to oil and gas price volatility and are likely to do so in the future. A change in economic conditions also puts pressure on our receivables and collections.
Accordingly, our operating results for any particular period are not necessarily indicative of the operating results for any future period as the markets for our products have historically experienced volatility. In particular, orders in the Energy segment have historically corresponded to demand for oil and gas and petrochemical products and have been influenced by prices and inventory levels for oil and natural gas, rig count, number of wells those rigs drill annually, the amount of hydraulic fracturing horsepower required on average to fracture each well and other economic factors which we cannot reasonably predict. The Energy segment generated approximately 35% of our consolidated revenues for the year ended December 31, 2019.
Our results of operations are subject to exchange rate and other currency risks. A significant movement in exchange rates could adversely impact our results of operations and cash flows.
We conduct our business in many different currencies. A significant portion of our revenue, approximately 56% for the year ended December 31, 2019, is denominated in currencies other than the U.S. dollar. Accordingly, currency exchange rates, and in particular unfavorable movement in the exchange rates between U.S. dollars and Euros, British Pounds and Chinese Renminbi, affect our operating results. The effects of exchange rate fluctuations on our future operating results are unpredictable because of the number of currencies in which we do business and the potential volatility of exchange rates. We are also subject to the risks of currency controls and devaluations. Although historically not significant, if currency controls were enacted in countries where the Company generates significant cash balances, these controls may limit our ability to convert currencies into U.S. dollars or other currencies, as needed, or to pay dividends or make other payments from funds held by subsidiaries in the countries imposing such controls, which could adversely affect our liquidity. Currency devaluations could also negatively affect our operating margins and cash flows.
Potential governmental regulations restricting the use, and increased public attention to and litigation regarding the impacts, of hydraulic fracturing or other processes on which it relies could reduce demand for our products.
Oil and natural gas extracted from unconventional sources, such as shale, tight sands and coal bed methane, frequently requires hydraulic fracturing. Recent initiatives to study, regulate or otherwise restrict hydraulic fracturing and processes on which it relies, such as water disposal, as well as litigation over hydraulic fracturing impacts, could adversely affect some of our customers and their demand for our products, which could have a material adverse effect on our business, results of operations and financial condition.
For example, although hydraulic fracturing currently is generally exempt from regulation under the U.S. Safe Drinking Water Act’s (“SDWA”) Underground Injection Control program and is typically regulated by state oil and natural gas commissions or similar agencies, several federal agencies have asserted regulatory authority over certain aspects of the process. These include, among others, a number of regulations issued and other steps taken by the U.S. Environmental Protection Agency (“EPA”) over the last five years, including its New Source Performance Standards issued in 2012, its June 2016 rules establishing new emissions standards for methane and additional standards for volatile organic compounds from certain new, modified and reconstructed equipment and processes in the oil and natural gas source category and its June 2016 rule prohibiting the discharge of wastewater from onshore unconventional oil and natural gas extraction facilities to publicly owned wastewater treatment plants; and the federal Bureau of Land Management (“BLM”) rule in March 2015 that established new or more stringent standards relating to hydraulic fracturing on federal and American Indian lands (which was the subject of litigation and which the BLM rescinded in December 2017). While the EPA in the Trump administration and the Trump administration more generally have indicated their interest in scaling back or rescinding regulations that inhibit the development of the U.S. oil and gas industry and have taken steps to do so, it is difficult to predict the extent to which such policies will be implemented or the outcome of litigation challenging such implementation, such as the suit the State of California’s attorney general filed in January 2018 challenging the BLM’s rescission of its March 2015 rule referred to above; in July 2018, the federal district judge in the Northern District of California, where the suit was filed, denied motions by the BLM and several petroleum industry groups to transfer the challenge to Wyoming.
Moreover, some states and local governments have adopted, and other governmental entities are considering adopting, regulations that could impose more stringent requirements on hydraulic fracturing operations. For example, Texas, Colorado and North Dakota among others have adopted regulations that impose new or more stringent permitting, disclosure, disposal and well construction requirements on hydraulic fracturing operations. States could also elect to prohibit high volume hydraulic fracturing altogether, following the approach taken by the State of New York in 2015. Local land use restrictions, such as city ordinances, may restrict drilling in general and hydraulic fracturing in particular. Some state and federal regulatory agencies have also recently focused on a connection between the operation of injection wells used for oil and natural gas waste disposal and seismic activity. Similar concerns have been raised that hydraulic fracturing may also contribute to seismic activity. In March 2016, the United States Geological Survey identified six states with the most significant hazards from induced seismicity, including Oklahoma, Kansas, Texas, Colorado, New Mexico and Arkansas. In light of these concerns, some state regulatory agencies have modified their regulations or issued orders to address induced seismicity. For example, in December 2016, the Oklahoma Corporation Commission’s Oil and Gas Conservation Division (the “OCC Division”) and the Oklahoma Geologic Survey released well completion seismicity guidance, which requires operators to take certain prescriptive actions, including mitigation, following anomalous seismic activity within 1.25 miles of hydraulic fracturing operations. In February 2017, the OCC Division issued an order limiting future increases in the volume of oil and natural gas wastewater injected into the ground in an effort to reduce earthquakes in the state, and it announced further requirements (involving seismic monitoring) in February 2018. Ongoing lawsuits have also alleged that disposal well operations have caused damage to neighboring properties or otherwise violated state and federal rules regulating waste disposal. Increased regulation and attention given to induced seismicity could lead to greater opposition to, and litigation concerning, oil and natural gas activities utilizing hydraulic fracturing or injection wells for waste disposal. The adoption of more stringent regulations regarding hydraulic fracturing and the outcome of litigation over hydraulic fracturing could adversely affect some of our customers and their demand for our products, which could have a material adverse effect on our business, results of operations and financial condition.
We face competition in the markets we serve, which could materially and adversely affect our operating results.
We actively compete with many companies producing similar products. Depending on the particular product and application, we experience competition based on a number of factors, including price, quality, performance and availability. We compete against many companies, including divisions of larger companies with greater financial resources than we possess. As a result, these competitors may be both domestically and internationally better able to withstand a change in conditions within the markets in which we compete and throughout the global economy as a whole.
In addition, our ability to compete effectively depends on how successfully we anticipate and respond to various competitive factors, including new competitors entering our markets, new products and services that may be introduced by competitors, changes in customer preferences, pricing pressures and new government regulations. If we are unable to anticipate our competitors’ development of new products and services, identify customer needs and preferences on a timely basis, or successfully introduce new products and services or modify existing products and service offerings in response to such competitive factors, we could lose customers to competitors. If we cannot compete successfully, our sales and operating results could be materially and adversely affected.
Large or rapid increases in the cost of raw materials and component parts, substantial decreases in their availability or our dependence on particular suppliers of raw materials and component parts could materially and adversely affect our operating results.
Our primary raw materials, directly and indirectly, are cast iron, aluminum and steel. We also purchase a large number of motors and, therefore, also have exposure to changes in the price of copper, which is a primary component of motors. We have long-term contracts with only a few suppliers of key components. Consequently, we are vulnerable to fluctuations in prices and availability of such raw materials. Factors such as supply and demand, freight costs and transportation availability, inventory levels of brokers and dealers, the level of imports and general economic conditions may affect the price and availability of raw materials. In addition, we use single sources of supply for certain iron castings, motors and other select engineered components that are critical in the manufacturing of our products. From time to time in recent years, we have experienced disruptions to our supply deliveries for raw materials and component parts and may experience further supply disruptions. Any such disruption could have a material adverse effect on our ability to timely meet our commitments to customers and, therefore, our operating results.
Our operating results could be adversely affected by a loss or reduction of business with key customers or consolidation or the vertical integration of our customer base.
We derive revenue from certain key customers, in particular with respect to our oilfield service products and services. The loss or reduction of significant contracts with any of these key customers could result in a material decrease of our future profitability and cash flows. In addition, the consolidation or vertical integration of key customers may result in the loss of certain customer contracts or impact demand or competition for our products. Any changes in such customers’ purchasing practices, or decline in such customers’ financial condition, may have a material adverse impact on our business, results of operations and financial condition. Some of our customers are significantly larger than we are, have greater financial and other resources and also have the ability to purchase products from our competitors. As a result of their size and position in the marketplace, some of our customers have significant purchasing leverage and could cause us to materially reduce the price of our products, which could have a material adverse effect on our revenue and profitability. In addition, in the petroleum product market, lost sales may be difficult to replace due to the relative concentration of the customer base. We are unable to predict what effect consolidation in our customers’ industries may have on prices, capital spending by customers, selling strategies, competitive position, our ability to retain customers or our ability to negotiate favorable agreements with customers.
Credit and counterparty risks could harm our business.
The financial condition of our customers could affect our ability to market our products or collect receivables. In addition, financial difficulties faced by our customers as a result of an adverse economic event or other market factors may lead to cancellation or delay of orders. Our customers may suffer financial difficulties that make them unable to pay for a product or solution when payments become due, or they may decide not to pay us, either as a matter of corporate decision-making or in response to changes in local laws and regulations. Although historically not material, we cannot be certain that, in the future, expenses or losses for uncollectible amounts will not have a material adverse effect on our revenues, earnings and cash flows.
Acquisitions and integrating such acquisitions create certain risks and may affect our operating results.
We have acquired businesses in the past and may continue to acquire businesses or assets in the future. The acquisition and integration of businesses or assets involves a number of risks. The core risks are valuation (negotiating a fair price for the business), integration (managing the process of integrating the acquired company’s people, products, technology and other assets to extract the value and synergies projected to be realized in connection with the acquisition), regulation (obtaining necessary regulatory or other government approvals that may be necessary to complete acquisitions) and diligence (identifying undisclosed or unknown liabilities or restrictions that will be assumed in the acquisition).
In addition, acquisitions outside of the United States often involve additional or increased risks including, for example:
| ● |
managing geographically separated organizations, systems and facilities;
|
| ● |
integrating personnel with diverse business backgrounds and organizational cultures;
|
| ● |
complying with non-U.S. regulatory requirements;
|
| ● |
fluctuations in currency exchange rates;
|
| ● |
enforcement of intellectual property rights in some non-U.S. countries;
|
| ● |
difficulty entering new non-U.S. markets due to, among other things, consumer acceptance and business knowledge of these new markets; and
|
| ● |
general economic and political conditions.
|
The process of integrating operations could cause an interruption of, or loss of momentum in, the activities of one or more of our combined businesses and the possible loss of key personnel. The diversion of management’s attention and any delays or difficulties encountered in connection with acquisitions and the integration of an acquired company’s operations could have an adverse effect on our business, results of operations, financial condition or prospects.
The loss of, or disruption in, our distribution network could have a negative impact on our abilities to ship products, meet customer demand and otherwise operate our business.
We sell a significant portion of our products through independent distributors and sales representatives. We rely in large part on the orderly operation of this distribution network, which depends on adherence to shipping schedules and effective management. We conduct all of our shipping through independent third parties. Although we believe that our receiving, shipping and distribution process is efficient and well-positioned to support our operations and strategic plans, we cannot provide assurance that we have anticipated all issues or that events beyond our control, such as natural disasters or other catastrophic events, labor disagreements, acquisition of distributors by a competitor, consolidation within our distributor network or shipping problems, will not disrupt our distribution network. If complications arise within a segment of our distribution network, the remaining network may not be able to support the resulting additional distribution demands. Any of these disruptions or complications could negatively impact our revenues and costs.
Our ongoing and expected restructuring plans and other cost savings initiatives may not be as effective as we anticipate, and we may fail to realize the cost savings and increased efficiencies that we expect to result from these actions. Our operating results could be negatively affected by our inability to effectively implement such restructuring plans and other cost savings initiatives.
We continually seek ways to simplify or improve processes, eliminate excess capacity and reduce costs in all areas of our operations, which from time to time includes restructuring activities. We have implemented significant restructuring activities across our global manufacturing, sales and distribution footprint, which include workforce reductions and facility consolidations. From 2015 to 2018, we incurred restructuring charges of approximately $60.7 million across our segments. In 2019, we incurred restructuring charges of $17.1 million. Costs of future initiatives may be material and the savings associated with them are subject to a variety of risks, including our inability to effectively eliminate duplicative back office overhead and overlapping sales personnel, rationalize manufacturing capacity, synchronize information technology systems, consolidate warehousing and distribution facilities and shift production to more economical facilities. As a result, the contemplated costs to effect these initiatives may materially exceed estimates. The initiatives we are contemplating may require consultation with various employees, labor representatives or regulators, and such consultations may influence the timing, costs and extent of expected savings and may result in the loss of skilled employees in connection with the initiatives.
Although we have considered the impact of local regulations, negotiations with employee representatives and the related costs associated with our restructuring activities, factors beyond the control of management may affect the timing of these projects and therefore affect when savings will be achieved under the plans. There can be no assurance that we will be able to successfully implement these cost savings initiatives in the time frames contemplated (or at all) or that we will realize the projected benefits of these and other restructuring and cost savings initiatives. If we are unable to implement our cost savings initiatives, our business may be adversely affected. Moreover, our continued implementation of cost savings initiatives may have a material adverse effect on our business, results of operations and financial condition.
In addition, as we consolidate facilities and relocate manufacturing processes to lower-cost regions, our success will depend on our ability to continue to meet customer demand and maintain a high level of quality throughout the transition. Failure to adequately meet customer demand or maintain a high level or quality could have a material adverse effect on our business, results of operations and financial condition.
Our success depends on our executive management and other key personnel and our ability to attract and retain top talent throughout the Company.
Our future success depends to a significant degree on the skills, experience and efforts of our executive management and other key personnel and their ability to provide us with uninterrupted leadership and direction. The failure to retain our executive officers and other key personnel or a failure to provide adequate succession plans could have an adverse impact. Our future success also depends on our ability to attract, retain and develop qualified personnel at all levels of the organization. The availability of highly qualified talent is limited in a number of the jurisdictions in which we operate, and the competition for talent is robust. A failure to attract, retain and develop new qualified personnel throughout the organization could have an adverse effect on our operations and implementation of our strategic plan.
If we are unable to develop new products and technologies, our competitive position may be impaired, which could materially and adversely affect our sales and market share.
The markets in which we operate are characterized by changing technologies and introductions of new products and services. Our ability to develop new products based on technological innovation can affect our competitive position and often requires the investment of significant resources. Difficulties or delays in research, development or production of new products and technologies, or failure to gain market acceptance of new products and technologies, may significantly reduce future revenues and materially and adversely affect our competitive position. We cannot assure you that we will have sufficient resources to continue to make the investment required to maintain or increase our market share or that our investments will be successful. If we do not compete successfully, our business, financial condition, results of operations and cash flows could be materially adversely affected.
Cost overruns, delays, penalties or liquidated damages could negatively impact our results, particularly with respect to fixed-price contracts for custom engineered products.
A portion of our revenues and earnings is generated through fixed-price contracts for custom engineered products. Certain of these contracts provide for penalties or liquidated damages for failure to timely perform our obligations under the contract, or require that we, at our expense, correct and remedy to the satisfaction of the other party certain defects. Because substantially all of our custom engineered product contracts are at a fixed price, we face the risk that cost overruns, delays, penalties or liquidated damages may exceed, erode or eliminate our expected profit margin, or cause us to record a loss on our projects.
The risk of non-compliance with U.S. and foreign laws and regulations applicable to our international operations could have a significant impact on our results of operations, financial condition or strategic objectives.
Our global operations subject us to regulation by U.S. federal and state laws and multiple foreign laws, regulations and policies, which could result in conflicting legal requirements. These laws and regulations are complex, change frequently, have become more stringent over time and increase our cost of doing business. These laws and regulations include import and export control, environmental, health and safety regulations, data privacy requirements, international labor laws and work councils and anti-corruption and bribery laws such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, the U.N. Convention Against Bribery and local laws prohibiting corrupt payments to government officials.
We are subject to the risk that we, our employees, our affiliated entities, contractors, agents or their respective officers, directors, employees and agents may take actions determined to be in violation of any of these laws, for which we might be held responsible, particularly as we expand our operations geographically through organic growth and acquisitions. An actual or alleged violation could result in substantial fines, sanctions, civil or criminal penalties, debarment from government contracts, curtailment of operations in certain jurisdictions, competitive or reputational harm, litigation or regulatory action and other consequences that might adversely affect our results of operations, financial condition or strategic objectives.
Changes in tax or other laws, regulations, or adverse determinations by taxing or other governmental authorities could increase our effective tax rate and cash taxes paid or otherwise affect our financial condition or operating results.
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (“Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code that affected 2017 and 2018, including, but not limited to (1) requiring a one-time transition tax on certain unrepatriated earnings of foreign subsidiaries that is payable over eight years and (2) bonus depreciation that will allow for full expensing of qualified property. The Tax Act also established new tax laws that significantly affected 2019, 2018 and 2017.
While we monitor proposals and other developments that would materially impact our tax burden and/or effective tax rate and investigate our options, we could still be subject to increased taxation on a going forward basis no matter what action we undertake if certain legislative proposals or regulatory changes are enacted, certain tax treaties are amended and/or our interpretation of applicable tax or other laws is challenged and determined to be incorrect. The inability to realize any anticipated tax benefits related to our operations and corporate structure could have a material adverse impact on our results of operations, financial condition and cash flows. See Note 1 “Summary of Significant Accounting Policies” and Note 15 “Income Taxes” to our audited consolidated financial statements included elsewhere in this Form 10-K for additional information related to our accounting for income tax matters.
The inability to realize any anticipated tax benefits related to our operations and corporate structure could have a material adverse impact on our results of operations, financial condition and cash flows.
Further, the specific future impacts of the Tax Act on holders of our common shares are uncertain and could in certain instances be adverse. We urge our stockholders to consult with their legal and tax advisors with respect to any such legislation and the potential tax consequences of investing in our common stock.
A significant portion of our assets consists of goodwill and other intangible assets, the value of which may be reduced if we determine that those assets are impaired.
As a result of the KKR Transaction, we applied the acquisition method of accounting and established a new basis of accounting on July 30, 2013. Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the tangible and identifiable intangible assets acquired, liabilities assumed and any non-controlling interest. Intangible assets, including goodwill, are assigned to our reporting units based upon their fair value at the time of acquisition. In accordance with GAAP, goodwill and indefinite-lived intangible assets are evaluated for impairment annually, or more frequently if circumstances indicate impairment may have occurred. In 2017, we recorded an impairment charge related to other intangible assets of $1.6 million primarily within the Industrials segment. As of December 31, 2019, the net carrying value of goodwill and other intangible assets, net represented $2,542.7 million, or 55%, of our total assets. A future impairment, if any, could have a material adverse effect to our consolidated financial position or results of operations. See Note 8 “Goodwill and Other Intangible Assets” to our audited consolidated financial statements included elsewhere in this Form 10-K for additional information related to impairment testing for goodwill and other intangible assets and the associated charges taken.
Our business could suffer if we experience employee work stoppages, union and work council campaigns or other labor difficulties.
As of December 31, 2019, we had approximately 6,600 employees of which approximately 1,900 were located in the United States. Of those employees located outside of the United States, a significant portion are represented by works councils and labor unions, and of those employees located in the United States, approximately 200 are represented by labor unions. Although we believe that our relations with employees are satisfactory and have not experienced any material work stoppages, work stoppages have occurred, and may in the future occur, and we may not be successful in negotiating new collective bargaining agreements. In addition, negotiations with our union employees may (1) result in significant increases in our cost of labor, (2) divert management’s attention away from operating our business or (3) break down and result in the disruption of our operations. The occurrence of any of the preceding conditions could impair our ability to manufacture our products and result in increased costs and/or decreased operating results.
We are a defendant in certain asbestos and silica-related personal injury lawsuits, which could adversely affect our financial condition.
We have been named as a defendant in many asbestos and silica-related personal injury lawsuits. The plaintiffs in these suits allege exposure to asbestos or silica from multiple sources, and typically we are one of approximately 25 or more named defendants. We believe that, given our financial reserves and anticipated insurance recoveries, the pending and potential future lawsuits are not likely to have a material adverse effect on our consolidated financial position, results of operations or liquidity. However, future developments, including, without limitation, potential insolvencies of insurance companies or other defendants, an adverse determination in the Adams County Case (discussed below), or other inability to collect from our historical insurers or indemnitors, could cause a different outcome. In addition, even if any damages payable by us in any individual lawsuit are not material, the aggregate damages and related defense costs could be material and could materially adversely affect our financial condition if we were to receive an adverse judgment in a number of these lawsuits. Accordingly, the resolution of pending or future lawsuits may have a material adverse effect on our consolidated financial position, results of operations or liquidity. See Note 20 “Contingencies” to our audited consolidated financial statements included elsewhere in this Form 10-K.
A natural disaster, catastrophe, pandemic or other event could adversely affect our operations.
Some of our operations involve risks of, among other things, property damage, which could curtail our operations. For example, if one or more of our manufacturing facilities are damaged by severe weather or any other disaster, accident, catastrophe or event, our operations could be significantly interrupted impacting our ability to produce products and sell products to customers. These interruptions might involve significant damage to, among other things, property, and repairs might take from a week or less for a minor incident to many months for a major interruption. In addition, disruptions in our supply chain due to natural disasters, catastrophes, pandemic or other events could reduce our ability to produce products and satisfy customer demand. Similar interruptions could result from damage to production or other facilities that provide supplies or other raw materials to our plants. Interruptions to our operations and supply chain could also result from pandemic which could adversely impact our workforce or that of our suppliers, causing disruption to the manufacturing process or our supply chain, and last a week or months depending on the severity of the disruption.
Information systems failure may disrupt our business and result in financial loss and liability to our customers.
Our business is highly dependent on financial, accounting and other data-processing systems and other communications and information systems, including our enterprise resource planning tools. We process a large number of transactions on a daily basis and rely upon the proper functioning of computer systems. If any of these systems fail, whether caused by fire, other natural disaster, power or telecommunications failure, acts of cyber terrorism or war or otherwise, or they do not function correctly, we could suffer financial loss, business disruption, liability to our customers, regulatory intervention or damage to our reputation. If our systems are unable to accommodate an increasing volume of transactions, our ability to grow could be limited. Although we have backup systems, procedures and capabilities in place, they may also fail or be inadequate. Further, to the extent that we may have customer information in our databases, any unauthorized disclosure of, or access to, such information could result in claims under data protection laws and regulations. If any of these risks materialize, our reputation and our ability to conduct our business may be materially adversely affected.
The nature of our products creates the possibility of significant product liability and warranty claims, which could harm our business.
Customers use some of our products in potentially hazardous applications that can cause injury or loss of life and damage to property, equipment or the environment. In addition, our products are integral to the production process for some end-users and any failure of our products could result in a suspension of operations. Although we maintain quality controls and procedures, we cannot be certain that our products will be completely free from defects. We maintain amounts and types of insurance coverage that we believe are currently adequate and consistent with normal industry practice for a company of our relative size, and we limit our liability by contract wherever possible. However, we cannot guarantee that insurance will be available or adequate to cover all liabilities incurred. We also may not be able to maintain insurance in the future at levels we believe are necessary and at rates we consider reasonable. We may be named as a defendant in product liability or other lawsuits asserting potentially large claims if an accident occurs at a location where our equipment and services have been or are being used.
Environmental compliance costs and liabilities could adversely affect our financial condition.
Our operations and properties are subject to increasingly stringent domestic and foreign laws and regulations relating to environmental protection, including laws and regulations governing air emissions, water discharges, waste management and workplace safety. Under such laws and regulations, we can be subject to substantial fines and sanctions for violations and be required to install costly pollution control equipment or put into effect operational changes to limit pollution emissions or decrease the likelihood of accidental hazardous substance releases.
We use and generate hazardous substances and waste in our manufacturing operations. In addition, many of our current and former properties are, or have been, used for industrial purposes. We have been identified as a potentially responsible party with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that may impose joint and several liability for cleanup of certain waste sites and for related natural resource damages. An accrued liability on our balance sheet reflects costs that are probable and estimable for our projected financial obligations relating to these matters. If we have underestimated our remaining financial obligations, we may face greater exposure that could have an adverse effect on our financial condition, results of operations or liquidity.
We have experienced, and expect to continue to experience, operating costs to comply with environmental laws and regulations. In addition, new laws and regulations, stricter enforcement of existing laws and regulations, the discovery of previously unknown contamination or the imposition of new cleanup requirements could require us to incur costs or become the basis for new or increased liabilities that could have a material adverse effect on our business, financial condition, results of operations or liquidity.
Third parties may infringe upon our intellectual property or may claim we have infringed their intellectual property, and we may expend significant resources enforcing or defending our rights or suffer competitive injury.
Our success depends in part on the creation, maintenance and protection of our proprietary technology and intellectual property rights. We rely on a combination of patents, trademarks, trade secrets, copyrights, confidentiality provisions, contractual restrictions and licensing arrangements to establish and protect our proprietary rights. Our nondisclosure agreements and confidentiality agreements may not effectively prevent disclosure of our proprietary information, technologies and processes, and may not provide an adequate remedy in the event of breach of such agreements or unauthorized disclosure of such information, and if a competitor lawfully obtains or independently develops our trade secrets, we would have no right to prevent such competitor from using such technology or information to compete with us, either of which could harm our competitive position. Our applications for patent and trademark protection may not be granted, or the claims or scope of such issued patents or registered trademarks may not be sufficiently broad to protect our products. In addition, effective patent, copyright, trademark and trade secret protection may be unavailable or limited for some of our trademarks and patents in some foreign countries. We may be required to spend significant resources to monitor and police our intellectual property rights, and we cannot guarantee that such efforts will be successful in preventing infringement or misappropriation. If we fail to successfully enforce these intellectual property rights, our competitive position could suffer, which could harm our operating results.
Although we make a significant effort to avoid infringing known proprietary rights of third parties, the steps we take to prevent misappropriation, infringement or other violation of the intellectual property of others may not be successful and from time to time we may receive notice that a third party believes that our products may be infringing certain patents, trademarks or other proprietary rights of such third party. Responding to and defending such claims, regardless of their merit, can be costly and time-consuming, can divert management’s attention and other resources, and we may not prevail. Depending on the resolution of such claims, we may be barred from using a specific technology or other rights, may be required to redesign or re-engineer a product which may require significant resources, may be required to enter into licensing arrangements from the third party claiming infringement (which may not be available on commercially reasonable terms, or at all), or may become liable for significant damages.
If any of the foregoing occurs, our ability to compete could be affected or our business, financial condition and results of operations may be materially adversely affected.
We face risks associated with our pension and other postretirement benefit obligations.
We have both funded and unfunded pension and other postretirement benefit plans worldwide. As of December 31, 2019, our projected benefit obligations under our pension and other postretirement benefit plans exceeded the fair value of plan assets by an aggregate of approximately $101.9 million (“unfunded status”), compared to $96.9 million as of December 31, 2018. Estimates for the amount and timing of the future funding obligations of these benefit plans are based on various assumptions. These assumptions include discount rates, rates of compensation increases, expected long-term rates of return on plan assets and expected healthcare cost trend rates. If our assumptions prove incorrect, our funding obligations may increase, which may have a material adverse effect on our financial results.
We have invested the plan assets of our funded benefit plans in various equity and debt securities. A deterioration in the value of plan assets could cause the unfunded status of these benefit plans to increase, thereby increasing our obligation to make additional contributions to these plans. An obligation to make contributions to our benefit plans could reduce the cash available for working capital and other corporate uses, and may have an adverse impact on our operations, financial condition and liquidity.
Risks Related to Our Indebtedness
Our substantial indebtedness could have important adverse consequences and adversely affect our financial condition.
We have a significant amount of indebtedness. As of December 31, 2019, we had total indebtedness of $1,611.4 million, and we had availability under the Revolving Credit Facility and the Receivables Financing Agreement of $445.6 million and $62.4 million, respectively. Our high level of debt could have important consequences, including: making it more difficult for us to satisfy our obligations with respect to our debt; limiting our ability to obtain additional financing to fund future working capital, capital expenditures, investments or acquisitions, or other general corporate requirements; requiring a substantial portion of our cash flows to be dedicated to debt service payments instead of other purposes, thereby reducing the amount of cash flows available for working capital, capital expenditures, investments or acquisitions and other general corporate purposes; increasing our vulnerability to adverse changes in general economic, industry and competitive conditions; exposing us to the risk of increased interest rates as certain of our borrowings, including borrowings under the Senior Secured Credit Facilities, are at variable rates of interest; limiting our flexibility in planning for and reacting to changes in the industries in which we compete; placing us at a disadvantage compared to other, less leveraged competitors; increasing our cost of borrowing; and hampering our ability to execute on our growth strategy. For a complete description of the Company’s credit facilities and definitions of capitalized terms used in this section, see Note 10 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K.
We may not be able to generate sufficient cash to service all of our indebtedness, and may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.
Our ability to make scheduled payments on, or refinance, our debt obligations depends on our financial condition and operating performance, which are subject to prevailing economic, industry and competitive conditions and to certain financial, business, legislative, regulatory and other factors beyond our control (as well as and including those factors discussed under “Risks Related to Our Business” above). We may be unable to maintain a level of cash flow from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness.
If our cash flow and capital resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional debt or equity capital, or restructure or refinance our indebtedness. We may not be able to implement any such alternative measures on commercially reasonable terms or at all and, even if successful, those alternative actions may not allow us to meet our scheduled debt service obligations.
If we cannot make scheduled payments on our debt, we will be in default and the lenders under the Revolving Credit Facility could terminate their commitments to loan money, and our secured lenders (including the lenders under the Senior Secured Credit Facilities) could foreclose against the assets securing their borrowings and we could be forced into bankruptcy or liquidation.
Despite our level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt, including off-balance sheet financing, contractual obligations and general and commercial liabilities. This could further exacerbate the risks to our financial condition described above.
We and our subsidiaries may be able to incur significant additional indebtedness in the future, including off-balance sheet financings, contractual obligations and general and commercial liabilities. Although the credit agreement governing the Senior Secured Credit Facilities contains restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of qualifications and exceptions, and the additional indebtedness incurred in compliance with these restrictions could be substantial. In addition, we can increase the borrowing availability under the Senior Secured Credit Facilities by up to $450.0 million in the form of additional commitments under the Revolving Credit Facility and/or incremental term loans plus an additional amount so long as we do not exceed a specified senior secured leverage ratio. We also can incur additional secured indebtedness under the Term Loan Facilities if certain specified conditions are met under the credit agreement governing the Term Loan Facilities. If new debt is added to our current debt levels, the related risks that we now face could intensify. For a complete description of the Company’s credit facilities and definitions of capitalized terms used in this section, see Note 10 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K.
The terms of the credit agreement governing the Senior Secured Credit Facilities may restrict our current and future operations, particularly our ability to respond to changes or to take certain actions.
The credit agreement governing the Senior Secured Credit Facilities contains a number of restrictive covenants that impose significant operating and financial restrictions on us and may limit our ability to engage in acts that may be in our best interest, including restrictions on our ability to: incur additional indebtedness and guarantee indebtedness; pay dividends, make other distributions in respect of, or repurchase or redeem capital stock; prepay, redeem or repurchase certain debt; make loans, investments and other restricted payments; sell or otherwise dispose of assets; incur liens; enter into transactions with affiliates; enter into agreements restricting our subsidiaries’ ability to pay dividends; consolidate, merge or sell all or substantially all of our assets; make needed capital expenditures; make strategic acquisitions, investments or enter into joint ventures; plan for or react to market conditions or otherwise execute our business strategies; and engage in business activities, including future opportunities, that may be in our interest.
A breach of the covenants under the credit agreement governing the Senior Secured Credit Facilities could result in an event of default under the applicable indebtedness. Such a default may allow the creditors to accelerate the related debt principal and/or related interest payments and may result in the acceleration of any other debt to which a cross-acceleration or cross-default provision applies. In addition, an event of default under the credit agreement governing our Senior Secured Credit Facilities would permit the lenders under our Revolving Credit Facility to terminate all commitments to extend further credit under that facility. Furthermore, if we were unable to repay the amounts due and payable under our Senior Secured Credit Facilities, those lenders could proceed against the collateral granted to them to secure that indebtedness. In the event our lenders or noteholders accelerate the repayment of our borrowings and/or interest, we and our subsidiaries may not have sufficient assets to repay that indebtedness.
Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
Borrowings under our Senior Secured Credit Facilities and our Receivables Financing Agreement are at variable rates of interest and expose us to interest rate risk. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed will remain the same, and our net income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease.
We utilize derivative financial instruments to reduce our exposure to market risks from changes in interest rates on our variable rate indebtedness and we will be exposed to risks related to counterparty credit worthiness or non-performance of these instruments.
We have entered into pay-fixed interest rate swap instruments to limit our exposure to changes in variable interest rates. Such instruments will result in economic losses should interest rates not rise above the pay-fixed interest rate in the derivative contracts. We will be exposed to credit-related losses which could impact the results of operations in the event of fluctuations in the fair value of the interest rate swaps due to a change in the credit worthiness or non-performance by the counterparties to the interest rate swaps. See Note 18 “Hedging Activities, Derivative Instruments and Credit Risk” to our audited consolidated financial statements included elsewhere in this Form 10-K.
If the financial institutions that are part of the syndicate of our Revolving Credit Facility fail to extend credit under our facility or reduce the borrowing base under our Revolving Credit Facility, our liquidity and results of operations may be adversely affected.
We have access to capital through our Revolving Credit Facility, which is part of our Senior Secured Credit Facilities. Each financial institution which is part of the syndicate for our Revolving Credit Facility is responsible on a several, but not joint, basis for providing a portion of the loans to be made under our facility. If any participant or group of participants with a significant portion of the commitments in our Revolving Credit Facility fails to satisfy its or their respective obligations to extend credit under the facility and we are unable to find a replacement for such participant or participants on a timely basis (if at all), our liquidity may be adversely affected.
T
he Company may face risk associated with the discontinuation of and transition from currently used financial reference rates.
LIBOR and certain other floating rate benchmark indices to which our floating rate debt is tied, including, without limitation, the Euro Interbank Offered Rate (collectively, “IBORs”) are the subject of recent national, international and regulatory guidance and proposals for reform. In a speech on July 27, 2017, Andrew Bailey, the Chief Executive of the Financial Conduct Authority of the U.K., or the FCA, announced the FCA’s intention to cease sustaining LIBOR after 2021. The FCA has statutory powers to require panel banks to contribute to LIBOR where necessary. The FCA has decided not to ask, or to require, that panel banks continue to submit contributions to LIBOR beyond the end of 2021. The FCA has indicated that it expects that the current panel banks will voluntarily sustain LIBOR until the end of 2021. It is possible that the ICE Benchmark Administration Limited (formerly NYSE Euronext Rate Administration Limited), or the IBA, and the panel banks could continue to produce LIBOR on the current basis after 2021, if they are willing and able to do so, but we do not currently anticipate that LIBOR will survive in its current form, or at all. Other jurisdictions have also indicated they will implement reforms or phase-outs, which are currently scheduled to take effect at the end of calendar year 2021. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, has identified the Secured Overnight Financing Rate, or SOFR, a new index calculated by short-term repurchase agreements, backed by Treasury securities, as its preferred alternative rate for LIBOR. At this time, it is not possible to predict how markets will respond to SOFR or other alternative reference rates as the transition away from the IBOR benchmarks is anticipated in coming years.
As of December 31, 2019, we had $1.6 billion of floated rate debt with maximum maturities extending past 2021 tied to IBOR benchmarks and $825.0 million of interest rate swaps with maximum maturities extending past 2021 tied to IBOR benchmarks. There is currently no definitive information regarding the future utilization of any IBOR benchmark or of any particular replacement rate. In addition, any IBOR benchmark may perform differently during any phase-out period than in the past. As such, the potential effect of any such event on our cost of capital cannot yet be determined and any changes to benchmark interest rates could increase our financing costs, which could impact our results of operations and cash flows. In addition, we may need to renegotiate certain of our debt agreements that extend past 2021 with lenders, which could require us to incur significant expense and may subject us to disputes or litigation over the appropriateness or comparability to the relevant IBOR benchmark of the replacement reference rates. We are assessing the impact of a potential transition from IBOR; however, we cannot reasonably estimate the impact of the transition at this time.
None.
Our corporate headquarters is a leased facility located at 222 East Erie Street, Milwaukee, Wisconsin 53202. The number of significant properties used by each of our segments is summarized by segment, type and geographic location in the tables below.
|
|
Type of Significant Property
|
|||||||||||||||
|
Manufacturing
|
Warehouse
|
Other
(4)
|
Total
|
|||||||||||||
|
Industrials
|
||||||||||||||||
|
Americas
|
6
|
1
|
0
|
7
|
||||||||||||
|
EMEA
(1)
|
10
|
1
|
15
|
26
|
||||||||||||
|
APAC
(2)
|
0
|
1
|
8
|
9
|
||||||||||||
|
Industrials Total
|
16
|
3
|
23
|
42
|
||||||||||||
|
Energy
|
||||||||||||||||
|
Americas
|
7
|
1
|
7
|
15
|
||||||||||||
|
EMEA
|
5
|
0
|
1
|
6
|
||||||||||||
|
APAC
|
2
|
0
|
1
|
3
|
||||||||||||
|
Energy Total
|
14
|
1
|
9
|
24
|
||||||||||||
|
Medical
|
||||||||||||||||
|
Americas
|
3
|
0
|
0
|
3
|
||||||||||||
|
EMEA
|
4
|
0
|
1
|
5
|
||||||||||||
|
APAC
|
1
|
0
|
0
|
1
|
||||||||||||
|
Medical Total
|
8
|
0
|
1
|
9
|
||||||||||||
|
Total (All Segments)
|
||||||||||||||||
|
Americas
|
16
|
2
|
7
|
25
|
||||||||||||
|
EMEA
|
19
|
1
|
17
|
37
|
||||||||||||
|
APAC
|
3
|
1
|
9
|
13
|
||||||||||||
|
Company Total
(3)
|
38
|
4
|
33
|
75
|
||||||||||||
| (1) |
Europe, Middle East and Africa (“EMEA”)
|
| (2) |
Asia Pacific (“APAC”)
|
| (3) |
Two facilities are shared between our segments and each is counted once, in the Industrials segment, to avoid double counting.
|
| (4) |
Other facilities includes service centers and sales offices.
|
Of the 75 significant properties included in the above table, 44 of the properties are leased and 31 of the properties are owned. We believe that our properties, taken as a whole, are in good operating condition and are suitable for our business operations.
We are a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of our size and sector. We believe that such proceedings, lawsuits and administrative actions will not materially adversely affect our operations, financial condition, liquidity or competitive position. For a detailed discussion of certain of these proceedings, lawsuits and administrative actions, see Note 20, “Contingencies” to our audited consolidated financial statements included elsewhere in this form 10-K.
Not Applicable.
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our Common Stock, $0.01 par value per share, trades on the New York Stock Exchange (“NYSE”) under the symbol “GDI.” As of January 31, 2020, there were 106 holders of record of our common stock. This stockholder figure does not include a substantially greater number of holders whose shares are held of record by banks, brokers, and other financial institutions.
Dividend Policy
We did not declare or pay dividends to the holders of our common stock in the years ended December 31, 2019 and 2018. We do not intend to pay cash dividends on our common stock in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions contained in current or future financing instruments and other factors that our board of directors deem relevant.
Company Purchases
The following table contains detail related to the repurchase of our common stock based on the date of trade during the quarter ended December 31, 2019.
|
2019 Fourth Quarter Months
|
Total Number of
Shares Purchased
(1)
|
Average Price Paid
Per Share
(2)
|
Total Number of
Shares Purchased
as Part of
Publicly Announced
Plans or Programs
(3)
|
Maximum Approximate
Dollar Value
of Shares that May Yet
Be Purchased Under the
Plans or Programs
(3)
|
||||||||||||
|
October 1, 2019 - October 31, 2019
|
-
|
$
|
-
|
-
|
220,756,556
|
|||||||||||
|
November 1, 2019 - November 30, 2019
|
38,285
|
$
|
33.71
|
-
|
220,756,556
|
|||||||||||
|
December 1, 2019 - December 31, 2019
|
1,571
|
$
|
35.02
|
-
|
220,756,556
|
|||||||||||
| (1) |
All of the shares purchased during the quarter ended December 31, 2019 were in connection with net exercises of stock options.
|
| (2) |
The average price paid per share includes brokerage commissions.
|
| (3) |
On August 1, 2018, we announced that our Board of Directors had approved a share repurchase program which authorized the repurchase of up to $250.0 million of our outstanding common stock over the next two years, effective August 1, 2018 until and including July 31, 2020. For a further description of the share repurchase program, see Note 25 “Share Repurchase Program” to our audited consolidated financial statements included elsewhere in this Form 10-K.
|
Set forth below is our selected consolidated financial data as of the dates and for the periods indicated. The selected consolidated financial data as of December 31, 2019 and 2018 and for the fiscal years ended December 31, 2019, 2018 and 2017 have been derived from our audited consolidated financial statements and related notes to our audited consolidated financial statements included elsewhere in this Form 10-K. The selected consolidated financial data as of December 31, 2017, 2016 and 2015, and for the fiscal years ended December 31, 2016 and 2015, have been derived from our audited consolidated financial statements and related notes to our audited consolidated financial statements not included in this Form 10-K.
The selected historical consolidated financial data set forth below should be read in conjunction with, and are qualified by reference to, “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our audited consolidated financial statements and related notes to our audited consolidated financial statements included elsewhere in this Form 10-K.
|
(in millions, except per share amounts)
|
Year Ended
December 31,
2019
|
Year Ended
December 31,
2018
|
Year Ended
December 31,
2017
|
Year Ended
December 31,
2016
|
Year Ended
December 31,
2015
|
|||||||||||||||
|
Consolidated Statements of Operations:
|
||||||||||||||||||||
|
Revenues
|
$
|
2,451.9
|
$
|
2,689.8
|
$
|
2,375.4
|
$
|
1,939.4
|
$
|
2,126.9
|
||||||||||
|
Cost of sales
|
1,540.2
|
1,677.3
|
1,477.5
|
1,222.7
|
1,347.8
|
|||||||||||||||
|
Gross profit
|
911.7
|
1,012.5
|
897.9
|
716.7
|
779.1
|
|||||||||||||||
|
Selling and administrative expenses
|
436.4
|
434.6
|
446.2
|
415.1
|
431.0
|
|||||||||||||||
|
Amortization of intangible assets
|
124.3
|
125.8
|
118.9
|
124.2
|
115.4
|
|||||||||||||||
|
Impairment of goodwill
|
-
|
-
|
-
|
-
|
343.3
|
|||||||||||||||
|
Impairment of other intangible assets
|
-
|
-
|
1.6
|
25.3
|
78.1
|
|||||||||||||||
|
Other operating expense, net
|
75.7
|
9.1
|
222.1
|
48.6
|
20.7
|
|||||||||||||||
|
Operating income (loss)
|
275.3
|
443.0
|
109.1
|
103.5
|
(209.4
|
)
|
||||||||||||||
|
Interest expense
|
88.9
|
99.6
|
140.7
|
170.3
|
162.9
|
|||||||||||||||
|
Loss on extinguishment of debt
|
0.2
|
1.1
|
84.5
|
-
|
-
|
|||||||||||||||
|
Other income, net
|
(4.7
|
)
|
(7.2
|
)
|
(3.4
|
)
|
(3.6
|
)
|
(5.6
|
)
|
||||||||||
|
Income (loss) before income taxes
|
190.9
|
349.5
|
(112.7
|
)
|
(63.2
|
)
|
(366.7
|
)
|
||||||||||||
|
Provision (benefit) for income taxes
|
31.8
|
80.1
|
(131.2
|
)
|
(31.9
|
)
|
(14.7
|
)
|
||||||||||||
|
Net income (loss)
|
159.1
|
269.4
|
18.5
|
(31.3
|
)
|
(352.0
|
)
|
|||||||||||||
|
Less: Net income (loss) attributable to noncontrolling interest
|
-
|
-
|
0.1
|
5.3
|
(0.8
|
)
|
||||||||||||||
|
Net income (loss) attributable to Gardner Denver Holdings, Inc.
|
$
|
159.1
|
$
|
269.4
|
$
|
18.4
|
$
|
(36.6
|
)
|
$
|
(351.2
|
)
|
||||||||
|
Earnings (loss) per share, basic
|
$
|
0.78
|
$
|
1.34
|
$
|
0.10
|
$
|
(0.25
|
)
|
$
|
(2.35
|
)
|
||||||||
|
Earnings (loss) per share, diluted
|
$
|
0.76
|
$
|
1.29
|
$
|
0.10
|
$
|
(0.25
|
)
|
$
|
(2.35
|
)
|
||||||||
|
Weighted average shares, basic
|
203.5
|
201.6
|
182.2
|
149.2
|
149.6
|
|||||||||||||||
|
Weighted average shares, diluted
|
208.9
|
209.1
|
188.4
|
149.2
|
149.6
|
|||||||||||||||
|
Statement of Cash Flow Data:
|
||||||||||||||||||||
|
Cash flows - operating activities
|
$
|
343.3
|
$
|
444.5
|
$
|
200.5
|
$
|
165.6
|
$
|
172.1
|
||||||||||
|
Cash flows - investing activities
|
(54.3
|
)
|
(235.0
|
)
|
(60.8
|
)
|
(82.1
|
)
|
(84.0
|
)
|
||||||||||
|
Cash flows - financing activities
|
(11.5
|
)
|
(373.0
|
)
|
(17.4
|
)
|
(43.0
|
)
|
(35.0
|
)
|
||||||||||
|
Balance Sheet Data (at period end):
|
||||||||||||||||||||
|
Cash and cash equivalents
|
$
|
505.5
|
$
|
221.2
|
$
|
393.3
|
$
|
255.8
|
$
|
228.3
|
||||||||||
|
Total assets
|
4,628.4
|
4,487.1
|
4,621.2
|
4,316.0
|
4,462.0
|
|||||||||||||||
|
Total liabilities
|
2,758.5
|
2,811.1
|
3,144.4
|
4,044.2
|
4,056.5
|
|||||||||||||||
|
Total stockholders’ equity
|
1,869.9
|
1,676.0
|
1,476.8
|
271.8
|
405.5
|
|||||||||||||||
|
Other Financial Data (unaudited):
|
||||||||||||||||||||
|
Adjusted EBITDA
(1)
|
$
|
564.8
|
$
|
681.8
|
$
|
561.5
|
$
|
400.7
|
$
|
418.9
|
||||||||||
|
Adjusted net income
(1)
|
332.4
|
394.7
|
249.3
|
133.6
|
128.1
|
|||||||||||||||
|
Capital expenditures
|
43.2
|
52.2
|
56.8
|
74.4
|
71.0
|
|||||||||||||||
|
Free cash flow
(1)
|
300.1
|
392.3
|
143.7
|
91.2
|
101.1
|
|||||||||||||||
| (1) |
We report our financial results in accordance with GAAP. To supplement this information, we also use the following measures in this Form 10-K: “Adjusted EBITDA,” “Adjusted Net Income” and “Free Cash Flow.” Management believes that Adjusted EBITDA and Adjusted Net Income are helpful supplemental measures to assist us and investors in evaluating our operating results as they exclude certain items whose fluctuation from period to period do not necessarily correspond to changes in the operations of our business. Adjusted EBITDA represents net income (loss) before interest, taxes, depreciation and amortization, as further adjusted to exclude certain non-cash, non-recurring and other adjustment items. We believe that the adjustments applied in presenting Adjusted EBITDA are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that we do not expect to continue at the same level in the future. Adjusted Net Income is defined as net income (loss) including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions.
|
We use Free Cash Flow to review the liquidity of our operations. We measure Free Cash Flow as cash flows from operating activities less capital expenditures. We believe Free Cash Flow is a useful supplemental financial measure for us and investors in assessing our ability to pursue business opportunities and investments and to service our debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.
As a result, we and our board of directors regularly use these measures as tools in evaluating our operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to, and should not be considered to be a substitute for, or superior to, the comparable measure under GAAP. In addition, we believe that Adjusted EBITDA, Adjusted Net Income and Free Cash Flow are frequently used by investors, analysts and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted Net Income and Free Cash Flow when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity.
Adjusted EBITDA, Adjusted Net Income and Free Cash Flow should not be considered as alternatives to net income (loss) or other performance measures calculated in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Adjusted EBITDA, Adjusted Net Income and Free Cash Flow have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing our results as reported under GAAP.
Set forth below are the reconciliations of net income to Adjusted EBITDA and Adjusted Net Income and cash flows from operating activities to Free Cash Flow.
|
|
Year Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Net Income
|
$
|
159.1
|
$
|
269.4
|
$
|
18.5
|
||||||
|
Plus:
|
||||||||||||
|
Interest expense
|
88.9
|
99.6
|
140.7
|
|||||||||
|
Provision (benefit) for income taxes
|
31.8
|
80.1
|
(131.2
|
)
|
||||||||
|
Depreciation expense
|
53.8
|
54.6
|
54.9
|
|||||||||
|
Amortization expense
(a)
|
124.3
|
125.8
|
118.9
|
|||||||||
|
Impairment of other intangible assets
(b)
|
-
|
-
|
1.6
|
|||||||||
|
KKR fees and expenses
(c)
|
-
|
-
|
17.3
|
|||||||||
|
Restructuring and related business transformation costs
(d)
|
25.6
|
38.8
|
24.7
|
|||||||||
|
Acquisition related expenses and non-cash charges
(e)
|
54.6
|
16.7
|
4.1
|
|||||||||
|
Environmental remediation loss reserve
(f)
|
0.1
|
-
|
0.9
|
|||||||||
|
Expenses related to public stock offerings
(g)
|
-
|
2.9
|
4.1
|
|||||||||
|
Establish public company financial reporting compliance
(h)
|
0.6
|
4.3
|
8.1
|
|||||||||
|
Stock-based compensation
(i)
|
23.1
|
(2.3
|
)
|
194.2
|
||||||||
|
Loss on extinguishment of debt
(j)
|
0.2
|
1.1
|
84.5
|
|||||||||
|
Foreign currency transaction losses (gains), net
|
8.1
|
(1.9
|
)
|
9.3
|
||||||||
|
Shareholder litigation settlement recoveries
(k)
|
(6.0
|
)
|
(9.5
|
)
|
-
|
|||||||
|
Other adjustments
(l)
|
0.6
|
2.2
|
10.9
|
|||||||||
|
Adjusted EBITDA
|
$
|
564.8
|
$
|
681.8
|
$
|
561.5
|
||||||
|
Minus:
|
||||||||||||
|
Interest expense
|
$
|
88.9
|
$
|
99.6
|
$
|
140.7
|
||||||
|
Income tax provision, as adjusted
(m)
|
77.9
|
119.0
|
105.4
|
|||||||||
|
Depreciation expense
|
53.8
|
54.6
|
54.9
|
|||||||||
|
Amortization of non-acquisition related intangible assets
|
11.8
|
13.9
|
11.2
|
|||||||||
|
Adjusted Net Income
|
$
|
332.4
|
$
|
394.7
|
$
|
249.3
|
||||||
|
Free Cash Flow
|
||||||||||||
|
Cash flows - operating activities
|
$
|
343.3
|
$
|
444.5
|
$
|
200.5
|
||||||
|
Minus:
|
||||||||||||
|
Capital expenditures
|
43.2
|
52.2
|
56.8
|
|||||||||
|
Free Cash Flow
|
$
|
300.1
|
$
|
392.3
|
$
|
143.7
|
||||||
| (a) |
Represents $112.5 million, $111.9 million and $107.7 million of amortization of intangible assets arising from the KKR Transaction and other acquisitions (customer relationships and trademarks) and $11.8 million, $13.9 million and $11.2 million of amortization of non-acquisition related intangible assets, in each case for the years ended December 31, 2019, 2018 and 2017, respectively.
|
| (b) |
Represents non-cash charges for impairment of intangible assets other than goodwill.
|
| (c) |
Represents management fees and expenses paid to Kohlberg, Kravis & Roberts & Co., L.P. (“KKR” or “Former Sponsor”).
|
| (d) |
Restructuring and related business transformation costs consisted of the following.
|
|
Year Ended December 31,
|
||||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Restructuring charges
|
$
|
17.1
|
$
|
12.7
|
$
|
5.3
|
||||||
|
Severance, sign-on, relocation and executive search costs
|
2.5
|
4.1
|
3.5
|
|||||||||
|
Facility reorganization, relocation and other costs
|
2.4
|
3.1
|
5.3
|
|||||||||
|
Information technology infrastructure transformation
|
1.2
|
0.8
|
5.2
|
|||||||||
|
Losses (gains) on asset and business disposals
|
0.8
|
(1.1
|
)
|
0.8
|
||||||||
|
Consultant and other advisor fees
|
0.3
|
14.1
|
1.7
|
|||||||||
|
Other, net
|
1.3
|
5.1
|
2.9
|
|||||||||
|
Total restructuring and related business transformation costs
|
$
|
25.6
|
$
|
38.8
|
$
|
24.7
|
||||||
| (e) |
Represents costs associated with successful and/or abandoned acquisitions, including third-party expenses, post-closure integration costs (including certain incentive and non-incentive cash compensation costs), and non-cash charges and credits arising from fair value purchase accounting adjustments.
|
| (f) |
Represents estimated environmental remediation costs and losses relating to a former production facility.
|
| (g) |
Represents certain expenses related to our initial public offering and secondary offerings.
|
| (h) |
Represents third party expenses to comply with the requirements of Sarbanes-Oxley and the accelerated adoption of the new accounting standards (ASC 606 –
Revenue from Contracts with Customers
and ASC 842 –
Leases
) in the first quarter of 2018 and 2019, respectively, one year ahead of the required adoption dates for a private company.
|
| (i) |
Represents stock-based compensation expense recognized for stock options outstanding for the year ended December 31, 2019 of $19.2 million, increased by $3.9 million due to costs associated with employer taxes.
|
Represents stock-based compensation expense recognized for the year ended December 31, 2018 of $2.8 million, reduced by $5.1 million primarily due to a decrease in the estimated accrual for employer taxes related to deferred stock units (“DSU”) as a result of a lower per share stock price.
Represents stock-based compensation expense recognized for the year ended December 31, 2017 for stock options outstanding of $77.6 million and DSUs granted to employees at the date of the initial public offering of $97.4 million and employer taxes related to DSUs granted to employees at the date of the initial public offering of $19.2 million.
| (j) |
Represents losses on the extinguishment of the Company’s senior notes, extinguishment of a portion of the U.S. Term Loan, refinancing of the Original Dollar Term Loan Facility and the Original Euro Term Loan Facility and losses reclassified from AOCI into income related to the amendment of the interest rate swaps in conjunction with the debt repayment.
|
| (k) |
Represents insurance recoveries of our shareholder litigation settlement in 2014.
|
| (l) |
Includes (i) non-cash impact of net LIFO reserve adjustment, (ii) effects of amortization of prior service costs and amortization of losses in pension and other postretirement benefits (“OPEB”) expense, (iii) certain legal and compliance costs and (iv) other miscellaneous adjustments.
|
| (m) |
Represents our income tax provision adjusted for the tax effect of pre-tax items excluded from Adjusted Net Income and the removal of applicable discrete tax items. The tax effect of pre-tax items excluded from Adjusted Net Income is computed using the statutory tax rate related to the jurisdiction that was impacted by the adjustment after taking into account the impact of permanent differences and valuation allowances. Discrete tax items include changes in tax laws or rates, changes in uncertain tax positions relating to prior years and changes in valuation allowances. All impacts relating to the Tax Cuts and Jobs Act of 2017 have been included as an adjustment on the ‘Tax law change” line of the table below.
|
The income tax provision, as adjusted for each of the periods presented below consists of the following.
|
|
Year Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Provision (benefit) for income taxes
|
$
|
31.8
|
$
|
80.1
|
$
|
(131.2
|
)
|
|||||
|
Tax impact of pre-tax income adjustments
|
45.6
|
36.9
|
139.3
|
|||||||||
|
Tax law change
|
-
|
1.2
|
95.3
|
|||||||||
|
Discrete tax items
|
0.5
|
0.8
|
2.0
|
|||||||||
|
Income tax provision, as adjusted
|
$
|
77.9
|
$
|
119.0
|
$
|
105.4
|
||||||
The following discussion contains management’s discussion and analysis of our financial condition and results of operations and should be read together with “Item 6. Selected Financial Data” and our audited consolidated financial statements and related notes to our consolidated financial statements included elsewhere in this Form 10-K. This discussion contains forward-looking statements and involves numerous risks and uncertainties. Our actual results may differ materially from those anticipated in any forward-looking statements as a result of many factors, including those set forth under the “Special Note Regarding Forward-Looking Statements,” “Item 1A. Risk Factors” and elsewhere in this Form 10-K.
Transaction with Ingersoll Rand
In April 2019, our Board of Directors approved a merger that will combine Gardner Denver with the industrial segment of Ingersoll-Rand plc (“Ingersoll Rand”) (the “Merger”). To facilitate this Merger, Ingersoll Rand will cause specific assets and liabilities of its industrial segment to be transferred to Ingersoll-Rand U.S. HoldCo, Inc. (“Ingersoll Rand Industrial”), a newly formed wholly-owned subsidiary of Ingersoll Rand, and distribute the shares of common stock of Ingersoll Rand Industrial to Ingersoll Rand’s shareholders. Charm Merger Sub Inc. (“Merger Sub”), which is a newly formed wholly-owned subsidiary of Gardner Denver, will be merged with and into Ingersoll Rand Industrial, with Ingersoll Rand Industrial surviving such merger as a wholly-owned subsidiary of Gardner Denver.
Pursuant to the definitive agreement Gardner Denver entered into with Ingersoll Rand, Ingersoll Rand Industrial and Merger Sub with respect to the Merger (the “Merger Agreement”), Gardner Denver will issue an aggregate number of shares of its common stock to Ingersoll Rand Industrial stockholders which will result in Ingersoll Rand Industrial stockholders owning approximately, but not less than, 50.1% of the shares of Gardner Denver common stock outstanding on a fully-diluted basis upon the closing of the Merger. The number of shares to be issued to Ingersoll Rand Industrial stockholders is based on the exchange ratio set forth in the Merger Agreement. In addition, Ingersoll Rand will receive approximately $1.9 billion in cash from Ingersoll Rand Industrial that will be funded by newly-issued debt that is expected to be deemed issued under the existing Senior Secured Credit Facilities of Gardner Denver upon consummation of the merger. The Merger is expected to close on February 29, 2020.
The Merger will result in Gardner Denver acquiring Ingersoll Rand Industrial, which includes compressed air and gas systems and services, power tools, material handling systems, fluid management systems as well as Club Car golf, utility and consumer low-speed vehicles. Following the Merger, the combined company is expected to be renamed and operate under the Ingersoll Rand name and its common stock is expected to be listed on the New York Stock Exchange under Ingersoll Rand’s existing ticker symbol “IR.”
See Note 3 “Business Combinations” to our audited consolidated financial statements included elsewhere in this Form 10-K for additional information related to the transaction with Ingersoll Rand.
Executive Overview
Our Company
We are a leading global provider of mission-critical flow control and compression equipment and associated aftermarket parts, consumables and services, which we sell across multiple attractive end-markets within the industrial, energy and medical industries. We manufacture one of the broadest and most complete ranges of compressor, pump, vacuum and blower products in our markets, which, combined with our global geographic footprint and application expertise, allows us to provide differentiated product and service offerings to our customers. Our products are sold under a collection of premier, market-leading brands, including Gardner Denver, CompAir, Nash, Emco Wheaton, Robuschi, Elmo Rietschle and Thomas, which we believe are globally recognized in their respective end-markets and known for product quality, reliability, efficiency and superior customer service. These attributes, along with over 155 years of engineering heritage, generate strong brand loyalty for our products and foster long-standing customer relationships, which we believe have resulted in leading market positions within each of our operating segments. We have sales in more than 175 countries and our diverse customer base utilizes our products across a wide array of end-markets that have favorable near- and long-term growth prospects, including industrial manufacturing, energy (with particular exposure to the North American upstream land-based market), transportation, medical and laboratory sciences, food and beverage packaging and chemical processing.
Our products and services are critical to the processes and systems in which they are utilized, which are often complex and function in harsh conditions where the cost of failure or downtime is high. However, our products and services typically represent only a small portion of the costs of the overall systems or functions that they support. As a result, our customers place a high value on our application expertise, product reliability and the responsiveness of our service. To support our customers and market presence, we maintain significant global scale with 38 key manufacturing facilities, more than 30 complementary service and repair centers across six continents and approximately 6,600 employees worldwide as of December 31, 2019.
The process-critical nature of our product applications, coupled with the standard wear and tear replacement cycles associated with the usage of our products, generates opportunities to support customers with our broad portfolio of aftermarket parts, consumables and services. Customers place a high value on minimizing any time their operations are offline. As a result, the availability of replacement parts, consumables and our repair and support services are key components of our value proposition. Our large installed base of products provides a recurring revenue stream through our aftermarket parts, consumables and services offerings. As a result, our aftermarket revenue is significant, representing 38% of total Company revenue and approximately 42% of our combined Industrials and Energy segments’ revenue in 2019.
Our Segments
We report our results of operations through three reportable segments: Industrials, Energy and Medical.
Industrials
In the Industrials segment, we design, manufacture, market and service a broad range of air compression, vacuum and blower products across a wide array of technologies and applications. Almost every manufacturing and industrial facility, and many service and process industries, use air compression and vacuum products in a variety of applications such as operation of pneumatic air tools, vacuum packaging of food products and aeration of waste water. We maintain a leading position in our markets and serve customers globally. We offer comprehensive aftermarket parts and an experienced direct and distributor-based service network world-wide to complement all of our products. In 2019, the Industrials segment generated Segment Revenue of $1,301.3 million and Segment Adjusted EBITDA of $296.6 million, reflecting a Segment Adjusted EBITDA Margin of 22.8%.
Energy
In the Energy segment, we design, manufacture, market and service a diverse range of positive displacement pumps, liquid ring vacuum pumps and compressors, and engineered loading systems and fluid transfer equipment, consumables, and associated aftermarket parts and services. We serve customers in the upstream, midstream, and downstream oil and gas markets, and various other markets including petrochemical processing, power generation, transportation, and general industrial. We are one of the largest suppliers in these markets and have long-standing customer relationships. Our positive displacement pumps are used in the oilfield for drilling, hydraulic fracturing, completion and well servicing. Our liquid ring vacuum pumps and compressors are used in many power generation, mining, oil and gas refining and processing, chemical processing and general industrial applications including flare gas and vapor recovery, geothermal gas removal, vacuum de-aeration, enhanced oil recovery, water extraction in mining and paper and chlorine compression in petrochemical operations. Our engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials.
In 2019, the Energy segment generated Segment Revenue of $870.2 million and Segment Adjusted EBITDA of $225.1 million, reflecting a Segment Adjusted EBITDA Margin of 25.9%.
Medical
In the Medical segment, we design, manufacture and market a broad range of highly specialized gas, liquid and precision syringe pumps and compressors primarily for use in the medical, laboratory and biotechnology end markets. Our customers are mainly medium and large durable medical equipment suppliers that integrate our products into their final equipment for use in applications such as oxygen therapy, blood dialysis, patient monitoring, wound treatment, and others. Further, with recent acquisitions, we expanded into liquid handling components and systems used in biotechnology applications including clinical analysis instrumentation. We also have a broad range of end use deep vacuum products for laboratory science applications. In 2019, the Medical segment generated Segment Revenue of $280.4 million and Segment Adjusted EBITDA of $84.4 million, reflecting a Segment Adjusted EBITDA Margin of 30.1%.
Components of Our Revenue and Expenses
Revenues
We generate revenue from sales of our highly engineered, application-critical products and by providing associated aftermarket parts, consumables and services. We sell our products and deliver aftermarket services both directly to end-users and through independent distribution channels, depending on the product line and geography. Below is a description of our revenues by segment and factors impacting total revenues.
Industrials Revenue
Our Industrials Segment Revenues are generated primarily through sales of air compression, vacuum and blower products to customers in multiple industries and geographies. A significant portion of our sales in the Industrials segment are made to independent distributors. The majority of Industrials segment revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. Certain contracts may involve significant design engineering to customer specifications, and depending on the contractual terms, revenue is recognized either over the duration of the contract or at contract completion when equipment is delivered to the customer. Our large installed base of products in our Industrials segment drives demand for recurring aftermarket support services primarily composed of replacement part sales to our distribution partners and, to a lesser extent, by directly providing replacement parts and repair and maintenance services to end customers. Revenue for services is recognized when services are performed.
Energy Revenue
Our Energy Segment Revenues are generated primarily through sales of positive displacement pumps, liquid ring vacuum pumps, compressors and integrated systems and engineered fluid loading and transfer equipment and associated aftermarket parts, consumables and services for use primarily in upstream, midstream, downstream and petrochemical end-markets across multiple geographies. The majority of Energy segment revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. Certain contracts with customers in the mid- and downstream and petrochemical markets are higher sales value and often have longer lead times and involve more application specific engineering. Depending on the contractual terms, revenue is recognized either over the duration of the contract or at contract completion when equipment is delivered to the customer. Provisions for estimated losses on uncompleted contracts are recognized in the period in which such losses are determined to be probable. As a result, the timing of these contracts can result in significant variation in reported revenue from quarter to quarter. Our large installed base of products in our Energy segment drives demand for recurring aftermarket support services to customers, including replacement parts, consumables and repair and maintenance services. The mix of aftermarket to original equipment revenue within the Energy segment is impacted by trends in upstream energy activity in North America. Revenue for services is recognized when services are performed. In response to customer demand for faster access to aftermarket parts and repair services, we expanded our direct aftermarket service locations in our Energy segment, particularly in North American markets driven by upstream energy activity. Energy segment products and aftermarket parts, consumables and services are sold both directly to end customers and through independent distributors, depending on the product category and geography.
Medical Revenue
Our Medical Segment Revenues are generated primarily through sales of highly specialized gas, liquid and precision syringe pumps that are specified by medical and laboratory equipment suppliers for use in medical and laboratory applications. Our products are often subject to extensive collaborative design and specification requirements, as they are generally components specifically designed for, and integrated into, our customers’ products. Revenue is recognized when control is transferred to the customer, generally at shipment or when delivery has occurred. Our Medical segment also has limited aftermarket revenues related to certain products.
Expenses
Cost of Sales
Cost of sales includes the costs we incur, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing our most significant materials inputs. Stock-based compensation expense for employees associated with the manufacture of products or delivery of services to customers is included in cost of sales. We have instituted a global sourcing strategy to take advantage of coordinated purchasing opportunities of key materials across our manufacturing plant locations.
Cost of sales for services includes the direct costs we incur, including direct labor, parts and other overhead costs including depreciation of equipment and facilities, to deliver repair, maintenance and other field services to our customers.
Selling and Administrative Expenses
Selling and administrative expenses consist of (i) salaries and other employee-related expenses for our selling and administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) facility operating expenses for selling and administrative activities, including office rent, maintenance, depreciation and insurance; (iii) marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iv) research and development expenditures; (v) professional and consultant fees; (vi) KKR fees and expenses; (vii) expenses related to our public stock offerings and to establish public company reporting compliance; (viii) employee related stock-based compensation for our selling and administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; and (ix) other miscellaneous expenses. Certain corporate expenses, including those related to our shared service centers in the United States and Europe, that directly benefit our businesses are allocated to our business segments. Certain corporate administrative expenses, including corporate executive compensation, treasury, certain information technology, internal audit and tax compliance, are not allocated to the business segments.
Amortization of Intangible Assets
Amortization of intangible assets includes the periodic amortization of intangible assets recognized when an affiliate of KKR acquired us on July 30, 2013, intangible assets recognized in connection with businesses we acquired since July 30, 2013, including customer relationships and trademarks, and internally developed software.
Impairment of Other Intangible Assets
Impairment of other intangible assets includes non-cash charges we recognized for the impairment of intangible assets other than goodwill.
Other Operating Expense, Net
Other operating expense, net includes foreign currency gains and losses, restructuring charges, certain litigation and contract settlement losses, environmental remediation and other miscellaneous operating expenses.
Provision (Benefit) for Income Taxes
The provision or benefit for income taxes includes U.S. federal, state and local income taxes and all non-U.S. income taxes. We are subject to income tax in approximately 35 jurisdictions outside of the United States. Because we conduct operations on a global basis, our effective tax rate depends, and will continue to depend, on the geographic distribution of our pre-tax earnings among several different taxing jurisdictions. Our effective tax rate can also vary based on changes in the tax rates of the different jurisdictions, the availability of tax credits and non-deductible items.
Items Affecting our Reported Results
General Economic Conditions and Capital Spending in the Industries We Serve
Our financial results closely follow changes in the industries and end-markets we serve. Demand for most of our products depends on the level of new capital investment and planned and unplanned maintenance expenditures by our customers. The level of capital expenditures depends, in turn, on the general economic conditions as well as access to capital at reasonable cost. In particular, demand for our Industrials products generally correlates with the rate of total industrial capacity utilization and the rate of change of industrial production. Capacity utilization rates above 80% have historically indicated a strong demand environment for industrial equipment. In our Energy segment, demand for our products that serve upstream energy end-markets are influenced heavily by energy prices and the expectation as to future trends in those prices. Energy prices have historically been cyclical in nature and are affected by a wide range of factors. In addition to energy prices, demand for our upstream energy products are positively impacted by increasing global land rig count, drilled but uncompleted wells, the level of hydraulic fracturing intensity and activity measured by horsepower utilization and lateral lengths as well as drilling and completion capital expenditures. In the midstream and downstream portions of our Energy segment, overall economic growth and industrial production, as well as secular trends, impact demand for our products. In our Medical segment we expect demand for our products to be driven by favorable trends, including the growth in healthcare spend and expansion of healthcare systems due to an aging population requiring medical care and increased investment in health solutions and safety infrastructures in emerging economies. Over longer time periods, we believe that demand for all of our products also tends to follow economic growth patterns indicated by the rates of change in the GDP around the world, as augmented by secular trends in each segment. Our ability to grow and our financial performance will also be affected by our ability to address a variety of challenges and opportunities that are a consequence of our global operations, including efficiently utilizing our global sales, manufacturing and distribution capabilities and engineering innovative new product applications for end-users in a variety of geographic markets.
Foreign Currency Fluctuations
A significant portion of our revenues, approximately 56% for the year ended December 31, 2019, was denominated in currencies other than the U.S. dollar. Because much of our manufacturing facilities and labor force costs are outside of the United States, a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can therefore impact our results of operations and are quantified when significant to our discussion.
Factors Affecting the Comparability of our Results of Operations
As a result of a number of factors, our historical results of operations are not comparable from period to period and may not be comparable to our financial results of operations in future periods. Key factors affecting the comparability of our results of operations are summarized below.
Variability within Upstream Energy Markets
We sell products and services to customers in upstream energy markets, primarily in the United States. For the upstream energy end-market, in our Energy segment, we manufacture pumps and associated aftermarket products and services used in drilling, hydraulic fracturing and well service applications.
Demand for upstream energy products has historically corresponded to the supply and demand dynamics related to oil and natural gas products, and has been influenced by oil and natural gas prices, the level and intensity of hydraulic fracturing activity rig count, drilling activity and other economic factors. These factors have caused the level of demand for certain of our Energy products to change at times (both positively and negatively) and we expect these trends to continue in the future.
We believe it is helpful to consider the impact of our energy exposure to upstream energy in evaluating our 2018 and 2019 Segment Revenue and Segment Adjusted EBITDA, in order to better understand other drivers of our performance during those periods, including operational improvements. For the Energy segments, we assess the impact of our exposure to upstream energy as the portion of Energy Segment Adjusted EBITDA of the business unit serving the upstream energy market.
Restructuring and Other Business Transformation Initiatives
We continue to implement business transformation initiatives. A key element of those business transformation initiatives was restructuring programs within our Industrials, Energy and Medical segments as well as at the Corporate level. Restructuring charges, program related facility reorganization, relocation and other costs, and related capital expenditures were impacted most significantly.
We announced a restructuring program in the third quarter of 2018 that primarily involves workforce reductions and facility consolidations. For the years ended December 31, 2019 and 2018, $17.1 million and $12.7 million, respectively were charged to expense related to this restructuring program.
Acquisitions
Part of our strategy for growth is to acquire complementary flow control and compression equipment businesses, which provide access to new technologies or geographies or improve our aftermarket offerings.
In June 2017, within our Industrials segment, we acquired a leading North American manufacturer of gas compression equipment and solutions for vapor recovery, biogas and other process and industrial applications for approximately $20.4 million, net of cash acquired (inclusive of an indemnity holdback of $1.9 million).
In February 2018, we acquired a leading global manufacturer of turbo vacuum technology systems and optimization solutions for industrial applications in our Industrials segment for total consideration, net of cash acquired, of approximately $94.9 million. In May 2018, we acquired a leading manufacturer of plungers and other well service pump consumable products in our Energy segment for total consideration, net of cash acquired, of approximately $21.0 million (inclusive of cash payments of $18.8 million, a $2.0 million promissory note and a $0.2 million holdback). In November 2018, we acquired a leading manufacturer of rotary screws and piston compressors and associated aftermarket parts in our Industrials segment for total consideration, net of cash acquired, of $16.1 million (inclusive of cash payments of $14.8 million and a $1.3 million holdback). In December 2018, we acquired a leading manufacturer of specialty industrial pumps and associated aftermarket parts in our Industrials segment for total consideration of $58.5 million, net of cash acquired (inclusive of cash payments of $57.8 million and a $0.7 million holdback).
In July 2019, we acquired a company which specializes in customized pump solutions for liquid handling processes for use in medical, process and industrial applications, in our Medical segment for total consideration, net of cash acquired, of $10.0 million (inclusive of cash payments of $5.6 million, a $1.6 million holdback and up to $2.8 million in contingent earn-out provisions). In August 2019, we acquired a provider of vacuum pumps, blowers and compressors in our Industrials segment for total consideration, net of cash acquired, of $7.0 million (inclusive of cash payments of $5.9 million and a $1.1 million deferred payment).
The revenues for these acquisitions subsequent to the respective dates of acquisition included in our financial results were $137.6 million $96.2 million and $13.9 million for the years ended December 31, 2019, 2018 and 2017, respectively. The operating income for these acquisitions subsequent to their respective dates of acquisition, including organic growth since acquisition, included in our financial results was $19.1 million, $8.3 million and $1.4 million for the years ended December 31, 2019, 2018 and 2017, respectively.
See Note 3 “Business Combinations” to our audited consolidated financial statements included elsewhere in this Form 10-K for further discussion around the outstanding holdbacks for the years ended December 31, 2019, 2018 and 2017.
Stock-Based Compensation Expense
For the year ended December 31, 2018, we incurred stock-based compensation expense of approximately $2.8 million which was reduced by $5.1 million primarily due to a decrease in the estimated accrual for employer taxes related to deferred stock units (“DSU”) as a result of a lower per share stock price.
For the year ended December 31, 2019, we incurred stock-based compensation expense of approximately $19.2 million which was increased by $3.9 million due to costs associated with employer taxes. See Note 17 “Stock-Based Compensation” to our audited consolidated financial statements included elsewhere in this Form 10-K for further discussion around our stock-based compensation expense.
Income Taxes
On December 22, 2017, the 2017 Tax Cuts and Jobs Act (“Tax Act”) was enacted into law. The new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes, including the determination of the transition tax, the remeasurement of our U.S. deferred tax assets and liabilities as well as the reassessment of the net realizability of our deferred tax assets and liabilities, in the period of enactment. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which allowed us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. As a result, we previously provided a provisional estimate of the effect of the Tax Act in our financial statements for 2017 and through the first nine months of 2018. In the fourth quarter of 2018, we completed our accounting for all of the enactment-date income tax effects of the Tax Act by increasing the total benefit taken in 2017 of $95.3 million to $96.5 million. Due to the Tax Act, the total U.S. deferred changed from a tax benefit of $89.6 million in 2017 to $74.5 million in 2018, with a 2018 measurement-period adjustment of $15.1 million and the ASC 740-30 (formerly APB 23) liability, related to the permanent reinvestment of earnings in foreign subsidiaries assertion, changed from a tax benefit of $69.0 million in 2017 to $72.5 million in 2018, with a 2018 measurement-period adjustment of $3.5 million. The provisional one-time transition tax of $63.3 million in 2017 decreased to $50.5 million in 2018, with a 2018 measurement-period adjustment of $12.8 million. The total $1.2 million benefit had a (0.3)% impact to the overall rate in 2018.
The Tax Act creates a new requirement that certain income (i.e., GILTI) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, we are allowed to make an accounting policy election of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”).
The Company has determined that it will follow the period cost method (option 1 above) going forward. The tax provision for the twelve month period ended December 31, 2019 reflects this decision.
All of the additional calculations and rule changes found in the Tax Act have been considered in the tax provision for the year ended December 31, 2019
. The Company recorded a tax expense of $2.0 million in 2019 for the GILTI provisions of the Tax Act that were effective for the first time during 2018.
See Note 15 “Income Taxes” to our audited consolidated financial statements included elsewhere in this Form 10-K.
Outlook
Industrials Segment
The mission-critical nature of our Industrials products across manufacturing processes drives a demand environment and outlook that are correlated with global and regional industrial production, capacity utilization and long-term GDP growth. In the fourth quarter of 2019, we booked $307.6 million of orders in our Industrials segment, a decrease of 4.6% over the fourth quarter of 2018, or a 3.1% decrease on a constant currency basis
.
Energy Segment
Our Energy segment has a diverse range of equipment and associated aftermarket parts, consumables and services for a number of market sectors with both energy exposure, spanning upstream, midstream, downstream and petrochemical applications.
Our upstream products demand environment and outlook are influenced heavily by the supply and demand dynamics related to oil and natural gas products, and has been influenced by oil and natural gas prices, the level and intensity of hydraulic fracturing activity, global land rig count, drilled but uncompleted wells and other economic factors. These factors have caused the level of demand for certain of our upstream products to change at times (both positively and negatively) and we expect these trends to continue in the future. We believe we are well positioned to continue to benefit given our market position, diverse range of equipment, aftermarket parts and consumables and our service presence, despite the current demand environment.
Our midstream and downstream products demand environment and outlook are relatively stable with attractive, long-term growth trends influenced by long-term GDP growth and the continued increase in the production and transportation of hydrocarbon. Demand for our petrochemical industry products correlates with capital expenditures related to growth and maintenance of petrochemical plants as well as activity levels therein. Advancements in the development of unconventional natural gas resources in North America over the past decade have resulted in the abundant availability of locally-sourced natural gas as feedstock for petrochemical plants in North America, supporting long-term growth.
In the fourth quarter of 2019, we booked $171.8 million of orders in our Energy segment, a decrease of 36.3% over the fourth quarter of 2018, or a 35.4% decrease on an constant currency basis.
Medical Segment
In 2020, we believe that demand for products and services in the Medical space will continue to benefit from attractive secular growth trends in the aging population requiring medical care, emerging economies modernizing and expanding their healthcare systems and increased investment globally in health solutions. In addition, we expect growing demand for higher healthcare efficiency, requiring premium and high performance systems. In the fourth quarter of 2019 we booked $63.7 million of orders in our Medical segment, a decrease of 3.2% over 2018, or a 1.8% decrease on a constant currency basis
.
How We Assess the Performance of Our Business
We manage operations through the three business segments described above. In addition to our consolidated GAAP financial measures, we review various non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income and Free Cash Flow.
We believe Adjusted EBITDA and Adjusted Net Income are helpful supplemental measures to assist us and investors in evaluating our operating results as they exclude certain items whose fluctuation from period to period do not necessarily correspond to changes in the operations of our business. Adjusted EBITDA represents net income (loss) before interest, taxes, depreciation, amortization and certain non-cash, non-recurring and other adjustment items. We believe that the adjustments applied in presenting Adjusted EBITDA are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that we do not expect to continue at the same level in the future. Adjusted Net Income is defined as net income (loss) including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions.
We use Free Cash Flow to review the liquidity of our operations. We measure Free Cash Flow as cash flows from operating activities less capital expenditures. We believe Free Cash Flow is a useful supplemental financial measure for us and investors in assessing our ability to pursue business opportunities and investments and to service our debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities.
Management and our board of directors regularly use these measures as tools in evaluating our operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to, and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition, we believe that Adjusted EBITDA, Adjusted Net Income and Free Cash Flow are frequently used by investors and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted Net Income and Free Cash Flow when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity.
Adjusted EBITDA, Adjusted Net Income and Free Cash Flow should not be considered as alternatives to net income (loss) or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Adjusted EBITDA, Adjusted Net Income and Free Cash Flow have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing our results as reported under GAAP.
Included in our discussion of our consolidated and segment results below are changes in revenues and Adjusted EBITDA on a Constant Currency basis. Constant Currency information compares results between periods as if exchange rates had remained constant period over period. We define Constant Currency revenues and Adjusted EBITDA as total revenues and Adjusted EBITDA excluding the impact of foreign exchange rate movements and use it to determine the Constant Currency revenue and Adjusted EBITDA growth on a year-over-year basis. Constant Currency revenues and Adjusted EBITDA are calculated by translating current period revenues and Adjusted EBITDA using corresponding prior period exchange rates. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Results on a Constant Currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not a measure of performance presented in accordance with GAAP.
For further information regarding these measures, see “Item 6. Selected Financial Data.”
Results of Operations
Consolidated results should be read in conjunction with segment results and the Segment Information notes to our audited consolidated financial statements included elsewhere in this Form 10-K, which provide more detailed discussions concerning certain components of our consolidated statements of operations. All intercompany accounts and transactions have been eliminated within the consolidated results.
This section discusses our results of operations for the year ended December 31, 2019 as compared to the year ended December 31, 2018. For a discussion and analysis of the year ended December 31, 2018, compared to the same in 2017, please refer to the “Management’s Discussion and Analysis of Financial Condition” and “Results of Operations” included in Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on February 27, 2019.
Consolidated Results of Operations for the Years Ended December 31, 2019 and 2018
|
Year Ended December 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Consolidated Statements of Operations
|
||||||||
|
Revenues
|
$
|
2,451.9
|
$
|
2,689.8
|
||||
|
Cost of sales
|
1,540.2
|
1,677.3
|
||||||
|
Gross profit
|
911.7
|
1,012.5
|
||||||
|
Selling and administrative expenses
|
436.4
|
434.6
|
||||||
|
Amortization of intangible assets
|
124.3
|
125.8
|
||||||
|
Impairment of other intangible assets
|
-
|
-
|
||||||
|
Other operating expense, net
|
75.7
|
9.1
|
||||||
|
Operating income
|
275.3
|
443.0
|
||||||
|
Interest expense
|
88.9
|
99.6
|
||||||
|
Loss on extinguishment of debt
|
0.2
|
1.1
|
||||||
|
Other income, net
|
(4.7
|
)
|
(7.2
|
)
|
||||
|
Income before income taxes
|
190.9
|
349.5
|
||||||
|
Provision for income taxes
|
31.8
|
80.1
|
||||||
|
Net income
|
$
|
159.1
|
$
|
269.4
|
||||
|
Percentage of Revenues
|
||||||||
|
Gross profit
|
37.2
|
%
|
37.6
|
%
|
||||
|
Selling and administrative expenses
|
17.8
|
%
|
16.2
|
%
|
||||
|
Operating income
|
11.2
|
%
|
16.5
|
%
|
||||
|
Net income
|
6.5
|
%
|
10.0
|
%
|
||||
|
Adjusted EBITDA
(1)
|
23.0
|
%
|
25.3
|
%
|
||||
|
Other Financial Data
|
||||||||
|
Adjusted EBITDA
(1)
|
$
|
564.8
|
$
|
681.8
|
||||
|
Adjusted net income
(1)
|
332.4
|
394.7
|
||||||
|
Cash flows - operating activities
|
343.3
|
444.5
|
||||||
|
Cash flows - investing activities
|
(54.3
|
)
|
(235.0
|
)
|
||||
|
Cash flows - financing activities
|
(11.5
|
)
|
(373.0
|
)
|
||||
|
Free cash flow
(1)
|
300.1
|
392.3
|
||||||
| (1) |
See “Item 6. Selected Financial Data” for a reconciliation to the most directly comparable GAAP measure.
|
Revenues
Revenues for 2019 were $2,451.9 million, a decrease of $237.9 million, or 8.8%, compared to $2,689.8 million in 2018. The decrease in revenues was due primarily to lower revenues from upstream exposed markets (8.8% or $235.6 million) and the unfavorable impact of foreign currencies (2.4% or $65.2 million), partially offset by improved pricing (1.4% or $36.8 million) and higher volume in our Industrials and Medical segments including acquisitions (1.1% or $28.9 million). The percentage of consolidated revenues derived from aftermarket parts and services was 37.8% in 2019 compared to 39.2% in 2018.
Gross Profit
Gross profit in 2019 was $911.7 million, a decrease of $100.8 million, or 10.0%, compared to $1,012.5 million in 2018, and as a percentage of revenues was 37.2% in 2019 and 37.6% in 2018. The decrease in gross profit reflects primarily the lower revenues from upstream energy exposed markets, the unfavorable impact of foreign currencies and higher materials and other manufacturing costs, partially offset by improved pricing. The slight decrease in gross profit as a percentage of revenues primarily reflects the unfavorable impact of foreign currencies and higher materials and other manufacturing costs in our Industrials and Medical segments, partially offset by improved pricing.
Selling and Administrative Expenses
Selling and administrative expenses were $436.4 million in 2019, an increase of $1.8 million, or 0.4%, compared to $434.6 million in 2018. Selling and administrative expenses as a percentage of revenues increased to 17.8% in 2019 from 16.2% in 2018. This increase in selling and administrative expenses was primarily due to increased stock based compensation expense and other employee-related expenses, partially offset by lower professional and consultant fees.
Amortization of Intangible Assets
Amortization of intangible assets was $124.3 million in 2019, a decrease of $1.5 million compared to $125.8 million in 2018. The decrease was primarily due to intangibles that became fully amortized in 2019, partially offset by the amortization of intangibles acquired in 2018 and 2019.
Other Operating Expense, Net
Other operating expense, net was $75.7 million in 2019, an increase of $66.6 million compared to $9.1 million in 2018. The increase was primarily due to increased acquisition related expenses and non-cash charges of $44.0 million, foreign currency transaction losses of $8.1 million in 2019 compared to gains of $1.9 million in 2018, increased restructuring costs of $4.4 million and lower shareholder litigation settlement recoveries of $3.5 million.
Interest Expense
Interest expense was $88.9 million in 2019, a decrease of $10.7 million compared to $99.6 million in 2018. The decrease was primarily due to reduced debt as a result of prepayments in 2018 and 2019, partially offset by an increased weighted-average rate of 5.4% in 2019 compared to 5.2% in 2018.
Other Income, Net
Other income, net, was $4.7 million in 2019, a decrease of $2.5 million compared to $7.2 million in 2018. The decrease in other income, net was primarily due to an increase of $4.6 million in the other components of net periodic benefit cost and a decrease of $0.8 million in other financing income, partially offset by increased gains on postretirement plan investments of $2.9 million.
Provision for Income Taxes
The provision for income taxes was $31.8 million resulting in a 16.7% effective tax rate in 2019 compared to a provision of $80.1 million resulting in a 22.9% effective tax provision rate in 2018. The decrease in the tax provision and the decrease in the effective tax rate is primarily due to a decrease in pretax book income and an increase in a benefit related to equity compensation.
Net Income
Net income was $159.1 million in 2019 compared to net income of $269.4 million in 2018. The decrease in net income was primarily due to lower gross profit on lower revenues and higher other operating expense, net, partially offset by lower interest expense and a lower provision for income taxes.
Adjusted EBITDA
Adjusted EBITDA decreased $117.0 million to $564.8 million in 2019 compared to $681.8 million in 2018. Adjusted EBITDA as a percentage of revenues decreased 230 basis points to 23.0% in 2019 from 25.3% in 2018. The decrease in Adjusted EBITDA was primarily due to lower revenue in upstream energy exposed markets in our Energy segment of $110.4 million, higher selling and administrative expenses of $19.4 million, the unfavorable impact of foreign currencies of $15.6 million, higher materials and other manufacturing costs in our Industrials and Medical segments of $12.4 million and higher volume including acquisitions being offset by the dilutive impact of acquisitions in our Industrials segment of $7.4 million, partially offset by improved pricing of $36.8 million and higher volume in other markets in our Energy segment and in our Medical segment including acquisitions of $10.7 million.
Adjusted Net Income
Adjusted Net Income decreased $62.3 million to $332.4 million in 2019 compared to $394.7 million in 2018. The decrease was primarily due to lower Adjusted EBITDA, partially offset by a lower income tax provision, as adjusted and lower interest expense.
Segment Results
We classify our businesses into three segments: Industrials, Energy and Medical. Our Corporate operations (as described below) are not discussed separately as any results that had a significant impact on operating results are included in the consolidated results discussion above.
We evaluate the performance of our segments based on Segment Revenues and Segment Adjusted EBITDA. Segment Adjusted EBITDA is indicative of operational performance and ongoing profitability. Our management closely monitors Segment Adjusted EBITDA to evaluate past performance and identify actions required to improve profitability.
The segment measurements provided to, and evaluated by, the chief operating decision maker are described in Note 22 “Segment Information” to our audited consolidated financial statements included elsewhere in this Form 10-K.
Included in our discussion of our segment results below are changes in Segment Revenues and Segment Adjusted EBITDA on a Constant Currency basis. Constant Currency information compares results between periods as if exchange rates had remained constant period over period. We define Constant Currency as changes in Segment Revenues and Segment Adjusted EBITDA excluding the impact of foreign exchange rate movements. We use these measures to determine the Constant Currency Segment Revenues and Segment Adjusted EBITDA growth on a year-on-year basis. Constant Currency Segment Revenues and Segment Adjusted EBITDA are calculated by translating current period Segment Revenues and Segment Adjusted EBITDA using prior period exchange rates. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not a measure of performance presented in accordance with GAAP.
Segment Results for Years Ended December 31, 2019 and 2018
The following tables display Segment Revenues, Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin (Segment Adjusted EBITDA as a percentage of Segment Revenues) for each of our Segments and illustrates, on a percentage basis, the impact of foreign currency fluctuations on Segment Revenues and Segment Adjusted EBITDA growth.
Industrials Segment Result
s
|
|
Years Ended December 31,
|
Percent Change
|
Constant Currency
Percent Change
|
|||||||||||||
|
2019
|
2018
|
2019 vs. 2018
|
2019 vs. 2018
|
|||||||||||||
|
Segment Revenues
|
$
|
1,301.3
|
$
|
1,303.3
|
(0.2
|
)%
|
3.1
|
%
|
||||||||
|
Segment Adjusted EBITDA
|
$
|
296.6
|
$
|
288.2
|
2.9
|
%
|
6.2
|
%
|
||||||||
|
Segment Margin
|
22.8
|
%
|
22.1
|
%
|
70 bps
|
|||||||||||
2019 vs. 2018
Segment Revenues
for 2019
were $1,301.3 million, a decrease of $2.0 million, or 0.2%, compared to $1,303.3 million in 2018. The decrease in Segment Revenues was primarily due to unfavorable impact of foreign currencies (3.3% or $42.4 million), partially offset by improved pricing (2.3% or $29.8 million) and higher volume including acquisitions (0.8% or $10.6 million). The percentage of Segment Revenues derived from aftermarket parts and service was 31.4% in 2019 compared to 31.5% in 2018.
Segment Adjusted EBITDA in 2019 was $296.6 million, an increase of $8.4 million, or 2.9%, from $288.2 million in 2018. Segment Adjusted EBITDA Margin increased 70 bps to 22.8% from 22.1% in 2018. The increase in Segment Adjusted EBITDA was due primarily to improved pricing of $29.8 million and lower selling and administrative expenses of $5.1 million, partially offset by the unfavorable impact of foreign currencies of $9.6 million, higher material and other manufacturing costs of $9.5 million, and higher volume including acquisitions offset by the dilutive impact of acquisitions $7.4 million.
Energy Segment Results
|
Years Ended December 31,
|
Percent Change
|
Constant Currency
Percent Change
|
||||||||||||||
|
2019
|
2018
|
2019 vs. 2018
|
2019 vs. 2018
|
|||||||||||||
|
Segment Revenues
|
$
|
870.2
|
$
|
1,121.1
|
(22.4
|
)%
|
(20.8
|
)%
|
||||||||
|
Segment Adjusted EBITDA
|
$
|
225.1
|
$
|
337.8
|
(33.4
|
)%
|
(32.3
|
)%
|
||||||||
|
Segment Margin
|
25.9
|
%
|
30.1
|
%
|
(420) bps
|
|||||||||||
2019 vs. 2018
Segment Revenues
for 2019
were $870.2 million, a decrease of $250.9 million, or 22.4%, compared to $1,121.1 million in 2018. The decrease in Segment Revenues was primarily due to lower revenues from upstream energy exposed markets (21.0% or $235.6 million), the unfavorable impact of foreign currencies (1.3% or $14.9 million) and lower volume in other markets in our Energy segment (0.3% or $2.8 million), partially offset by improved pricing in other markets in our Energy segment (0.2% or $2.4 million). The percentage of Segment Revenues derived from aftermarket parts and service was 58.7% in 2019 compared to 56.6% in 2018.
Segment Adjusted EBITDA in 2019 was $225.1 million, a decrease of $112.7 million, or 33.4%, from $337.8 million in 2018. Segment Adjusted EBITDA Margin decreased 420 bps to 25.9% from 30.1% in 2018. The decrease in Segment Adjusted EBITDA was due primarily to lower revenues from upstream energy exposed markets of $110.4 million, the unfavorable impact of foreign currencies of $3.9 million and higher selling and administrative expenses of $2.8 million, partially offset by improved pricing in other markets in our Energy segment of $2.4 million.
Medical Segment Results
|
Years Ended December 31,
|
Percent Change
|
Constant Currency
Percent Change
|
||||||||||||||
|
2019
|
2018
|
2019 vs. 2018
|
2019 vs. 2018
|
|||||||||||||
|
Segment Revenues
|
$
|
280.4
|
$
|
265.4
|
5.7
|
%
|
8.6
|
%
|
||||||||
|
Segment Adjusted EBITDA
|
$
|
84.4
|
$
|
75.0
|
12.5
|
%
|
16.3
|
%
|
||||||||
|
Segment Margin
|
30.1
|
%
|
28.3
|
%
|
180 bps
|
|||||||||||
2019 vs. 2018
Segment Revenues
for 2019
were $280.4 million, an increase of $15.0 million, or 5.7%, compared to $265.4 million in 2018. The increase in Segment Revenues was primarily due to higher volume including acquisitions (6.9% or $18.3 million) and improved pricing (1.7% or $4.6 million), partially offset by unfavorable impact of foreign currencies (3.0% or $7.9 million). The percentage of Segment Revenues derived from aftermarket parts and service was 2.6% in 2019 compared to 3.3% in 2018.
Segment Adjusted EBITDA in 2019 was $84.4 million, an increase of $9.4 million, or 12.5%, from $75.0 million in 2018. Segment Adjusted EBITDA Margin increased 180 bps to 30.1% from 28.3% in 2018. The increase in Segment Adjusted EBITDA was due primarily to higher volume including acquisitions of $9.1 million, improved pricing of $4.6 million and lower selling and administrative costs of $1.4 million, partially offset by higher material and other manufacturing costs of $2.9 million and unfavorable impact of foreign currencies of $2.7 million.
Unaudited Quarterly Results of Operations
|
(in millions, except per share amounts)
|
|
Year Ended December 31, 2019
(1)
|
|
|
Year Ended December 31, 2018
|
|
||||||||||||||||||||||||||
|
|
|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q1
|
Q2
|
Q3
|
Q4
|
|
|||||||||||||||||||||
|
Revenues
|
|
$
|
620.3
|
|
|
$
|
629.1
|
|
|
$
|
596.7
|
|
|
$
|
605.8
|
|
|
$
|
619.6
|
|
|
$
|
668.2
|
|
|
$
|
689.3
|
|
|
$
|
712.7
|
|
|
Gross profit
|
|
|
230.5
|
|
|
|
234.4
|
|
|
|
221.5
|
|
|
|
225.3
|
|
|
|
231.9
|
|
|
|
249.3
|
|
|
|
262.4
|
|
|
|
268.9
|
|
|
Operating income
|
|
|
80.2
|
|
|
|
74.6
|
|
|
|
72.9
|
|
|
|
47.6
|
|
|
|
89.8
|
|
|
|
101.4
|
|
|
|
117.7
|
|
|
|
134.1
|
|
|
Net income
|
|
|
47.1
|
|
|
|
44.9
|
|
|
|
41.3
|
|
|
|
25.8
|
|
|
|
42.4
|
|
|
|
60.3
|
|
|
|
72.2
|
|
|
|
94.5
|
|
|
Weighted average shares, basic
|
|
|
201.6
|
|
|
|
203.4
|
|
|
|
204.2
|
|
|
|
204.8
|
|
|
|
201.6
|
|
|
|
201.8
|
|
|
|
201.9
|
|
|
|
201.1
|
|
|
Weighted average shares, diluted
|
|
|
207.7
|
|
|
|
208.9
|
|
|
|
209.0
|
|
|
|
209.4
|
|
|
|
209.9
|
|
|
|
209.6
|
|
|
|
209.1
|
|
|
|
207.7
|
|
|
Basic earnings per share
|
|
|
0.23
|
|
|
|
0.22
|
|
|
|
0.20
|
|
|
|
0.13
|
|
|
|
0.21
|
|
|
|
0.30
|
|
|
|
0.36
|
|
|
|
0.47
|
|
|
Diluted earnings per share
|
|
|
0.23
|
|
|
|
0.21
|
|
|
|
0.20
|
|
|
|
0.12
|
|
|
|
0.20
|
|
|
|
0.29
|
|
|
|
0.35
|
|
|
|
0.45
|
|
|
Adjusted EBITDA
(2)
|
|
|
140.1
|
|
|
|
147.6
|
|
|
|
142.2
|
|
|
|
134.9
|
|
|
|
148.2
|
|
|
|
161.6
|
|
|
|
182.2
|
|
|
|
189.8
|
|
| (1) |
See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Factors Affecting the Comparability of our Results of Operations.”
|
| (2) |
Set forth below are the reconciliations of Net Income to Adjusted EBITDA
|
|
|
|
Year Ended December 31, 2019
|
|
|
Year Ended December 31, 2018
|
|
||||||||||||||||||||||||||
|
|
|
|
Q1
|
Q2
|
Q3
|
Q4
|
Q1
|
Q2
|
Q3
|
Q4
|
|
|||||||||||||||||||||
|
Net Income
|
|
|
47.1
|
|
|
|
44.9
|
|
|
|
41.3
|
|
|
|
25.8
|
|
|
|
42.4
|
|
|
|
60.3
|
|
|
|
72.2
|
|
|
|
94.5
|
|
|
Plus:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
22.4
|
|
|
|
22.4
|
|
|
|
23.2
|
|
|
|
20.9
|
|
|
|
26.0
|
|
|
|
26.1
|
|
|
|
24.4
|
|
|
|
23.1
|
|
|
Provision for income taxes
|
|
|
12.0
|
|
|
|
8.3
|
|
|
|
9.0
|
|
|
|
2.5
|
|
|
|
23.4
|
|
|
|
17.2
|
|
|
|
22.6
|
|
|
|
16.9
|
|
|
Depreciation and amortization expense
|
|
|
45.5
|
|
|
|
44.4
|
|
|
|
43.1
|
|
|
|
45.1
|
|
|
|
45.0
|
|
|
|
45.3
|
|
|
|
44.4
|
|
|
|
45.7
|
|
|
Restructuring and related business transformation costs
(a)
|
|
|
4.1
|
|
|
|
2.0
|
|
|
|
9.9
|
|
|
|
9.6
|
|
|
|
4.5
|
|
|
|
8.4
|
|
|
|
12.3
|
|
|
|
13.6
|
|
|
Acquisition related expenses and non-cash charges
(b)
|
|
|
1.6
|
|
|
|
17.1
|
|
|
|
15.9
|
|
|
|
20.0
|
|
|
|
4.6
|
|
|
|
5.7
|
|
|
|
2.8
|
|
|
|
3.6
|
|
|
Environmental remdiation loss reserve
(c)
|
|
|
0.1
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Expenses related to public stock offerings
(d)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1.4
|
|
|
|
0.5
|
|
|
|
0.3
|
|
|
|
0.7
|
|
|
Establish public company financial reporting compliance
(e)
|
|
|
0.6
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.8
|
|
|
|
1.1
|
|
|
|
1.3
|
|
|
|
1.1
|
|
|
Stock-based compensation
(f)
|
|
|
9.3
|
|
|
|
7.1
|
|
|
|
0.5
|
|
|
|
6.2
|
|
|
|
2.7
|
|
|
|
(0.8
|
)
|
|
|
1.1
|
|
|
|
(5.3
|
)
|
|
Loss on extinguishment of debt
(g)
|
|
|
-
|
|
|
|
0.2
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.2
|
|
|
|
0.9
|
|
|
|
-
|
|
|
Foreign currency transaction losses (gains), net
|
|
|
3.1
|
|
|
|
0.6
|
|
|
|
(0.6
|
)
|
|
|
5.0
|
|
|
|
2.6
|
|
|
|
(2.4
|
)
|
|
|
(0.8
|
)
|
|
|
(1.3
|
)
|
|
Shareholder litigation settlement recoveries
(h)
|
|
|
(6.0
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(4.5
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(5.0
|
)
|
|
Other adjustments
(i)
|
|
|
0.3
|
|
|
|
0.6
|
|
|
|
(0.1
|
)
|
|
|
(0.2
|
)
|
|
|
(0.7
|
)
|
|
|
-
|
|
|
|
0.7
|
|
|
|
2.2
|
|
|
Adjusted EBITDA
|
|
|
140.1
|
|
|
|
147.6
|
|
|
|
142.2
|
|
|
|
134.9
|
|
|
|
148.2
|
|
|
|
161.6
|
|
|
|
182.2
|
|
|
|
189.8
|
|
| (a) |
Restructuring and related business transformation costs consist of (i) restructuring charges, (ii) severance, sign-on, relocation and executive search costs, (iii) facility reorganization, relocation and other costs, (iv) information technology infrastructure transformation, (v) gains and losses on asset disposals, (vi) consultant and other advisor fees and (vii) other miscellaneous costs.
|
| (b) |
Represents costs associated with successful and/or abandoned acquisitions, including third-party expenses, post-closure integration costs (including certain incentive and non-incentive cash compensation costs) and non-cash charges and credits arising from fair value purchase accounting adjustments.
|
| (c) |
Represents estimated environmental remediation costs and losses related to a former production facility.
|
| (d) |
Represents certain expenses related to our secondary offerings.
|
| (e) |
Represents third party expenses to comply with the requirements of Sarbanes-Oxley and the accelerated adoption of the new accounting standards (ASC 606 –
Revenue from Contracts with Customers
and ASC 842 –
Leases
) in the first quarter of 2018 and 2019 respectively, one year ahead of the required adoption dates for a private company.
|
| (f) |
Represents stock-based compensation expense recognized for stock options outstanding for the year ended December 31, 2019 of $19.2 million, increased by $3.9 million due to costs associated with employer taxes.
|
Represents stock-based compensation expense recognized for the year ended December 31, 2018 of $2.8 million, reduced by $5.1 million primarily due to a decrease in the estimated accrual for employer taxes related to DSUs as a result of a lower per share stock price.
| (g) |
Represents losses on extinguishment of portions of the U.S. Term Loan, the amendment of the revolving credit facility and losses reclassified from AOCI into income related to the amendment of the interest rate swaps in conjunction with the debt repayment.
|
| (h) |
Represents insurance recoveries of the Company’s shareholder litigation settlement in 2014.
|
| (i) |
Includes (i) non-cash impact of net LIFO reserve adjustments, (ii) effects of amortization of prior service costs and amortization of losses in pension and other postemployment (‘‘OPEB’’) expense, (iii) certain legal and compliance costs and (iv) other miscellaneous adjustments.
|
Liquidity and Capital Resources
Our investment resources include cash generated from operations and borrowings under our Revolving Credit Facility and the Receivables Financing Agreement.
For a description of our material indebtedness, see Note 10 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K.
As of December 31, 2019, we had $4.4 million of outstanding letters of credit written against the Revolving Credit Facility and $445.6 million of unused availability. We also had $27.6 million of letters of credit outstanding against the Receivables Financing Agreement and $62.4 million unused availability.
As of December 31, 2019 and 2018 we were in compliance with all of our debt covenants and no event of default had occurred or was ongoing.
Liquidity
A substantial portion of our liquidity needs arise from debt service requirements, and from the ongoing cost of operations, working capital and capital expenditures.
|
|
Year Ended December 31,
|
|||||||
|
2019
|
2018
|
|||||||
|
Cash and cash equivalents
|
$
|
505.5
|
$
|
221.2
|
||||
|
Short-term borrowings and current maturities of long-term debt
|
$
|
7.6
|
$
|
7.9
|
||||
|
Long-term debt
|
1,603.8
|
1,664.2
|
||||||
|
Total debt
|
$
|
1,611.4
|
$
|
1,672.1
|
||||
We can increase the borrowing availability under the Senior Secured Credit Facilities by up to $250.0 million in the form of additional commitments under the Revolving Credit Facility and/or incremental term loans plus an additional amount so long as we do not exceed a specified senior secured leverage ratio. We can incur additional secured indebtedness under the Term Loan Facilities if certain specified conditions are met under the credit agreement governing the Senior Secured Credit Facilities. Our liquidity requirements are significant primarily due to debt service requirements. See Note 10 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K for further details.
Our principal sources of liquidity have been existing cash and cash equivalents, cash generated from operations and borrowings under the Senior Secured Credit Facilities and the Receivables Financing Agreement. Our principal uses of cash will be to provide working capital, meet debt service requirements, fund capital expenditures and finance strategic plans, including possible acquisitions. We may also seek to finance capital expenditures under capital leases or other debt arrangements that provide liquidity or favorable borrowing terms. We continue to consider acquisition opportunities, but the size and timing of any future acquisitions and the related potential capital requirements cannot be predicted. In the event that suitable businesses are available for acquisition upon acceptable terms, we may obtain all or a portion of the necessary financing through the incurrence of additional long-term borrowings. As market conditions warrant, we may from time to time, seek to repay loans that we have borrowed, including the borrowings under the Senior Secured Credit Facilities. Based on our current level of operations and available cash, we believe our cash flow from operations, together with availability under the Revolving Credit Facility and the Receivables Financing Agreement, will provide sufficient liquidity to fund our current obligations, projected working capital requirements, debt service requirements and capital spending requirements for the foreseeable future. Our business may not generate sufficient cash flows from operations or future borrowings may not be available to us under our Revolving Credit Facility or the Receivables Financing Agreement in an amount sufficient to enable us to pay our indebtedness, or to fund our other liquidity needs. Our ability to do so depends on, among other factors, prevailing economic conditions, many of which are beyond our control. In addition, upon the occurrence of certain events, such as a change in control, we could be required to repay or refinance our indebtedness. We may not be able to refinance any of our indebtedness, including the Senior Secured Credit Facilities, on commercially reasonable terms or at all. Any future acquisitions, joint ventures, or other similar transactions may require additional capital and there can be no assurance that any such capital will be available to us on acceptable terms or at all.
The majority of our cash is in jurisdictions outside of the United States. We do not assert ASC 740-30 (formerly APB 23) indefinite reinvestment of our historical non-U.S. earnings or future non-U.S. earnings. The Company records a deferred foreign tax liability to cover all estimated withholding, state income tax and foreign income tax associated with repatriating all non-U.S. earnings back to the United States. Our deferred income tax liability as of December 31, 2019 is $7.8 million which consists mainly of withholding taxes.
Working Capital
|
|
For the Years Ended December 31,
|
|||||||
|
2019
|
2018
|
|||||||
|
Net Working Capital
|
||||||||
|
Current assets
|
$
|
1,543.9
|
$
|
1,331.2
|
||||
|
Less: Current liabilities
|
574.6
|
596.4
|
||||||
|
Net working capital
|
$
|
969.3
|
$
|
734.8
|
||||
|
Operating Working Capital
|
||||||||
|
Accounts receivable and contract assets
|
$
|
488.1
|
$
|
545.0
|
||||
|
Plus: Inventories (excluding LIFO)
|
489.5
|
510.7
|
||||||
|
Less: Accounts payable
|
322.9
|
340.0
|
||||||
|
Less: Contract liabilities
|
51.7
|
69.6
|
||||||
|
Operating working capital
|
$
|
603.0
|
$
|
646.1
|
||||
Net working capital increased $234.5 to $969.3 as of December 31, 2019 from $734.8 million as of December 31, 2018. Operating working capital decreased $43.1 million to $603.0 as of December 31, 2019 from $646.1 million as of December 31, 2018. Operating working capital as of December 31, 2019 was 24.6% of 2019 revenues as compared to 24.0% as of December 31, 2018 as a percentage of 2018 revenues. The decrease in operating working capital was primarily due to lower accounts receivable and lower inventories, partially offset by higher contract assets, lower accounts payable and lower contract liabilities. The decrease in accounts receivable was primarily due to lower sales in 2019 compared to 2018. The decrease in inventory was due to concerted supply chain optimization initiatives. The increase in contract assets was due to the timing of revenue recognition and billing on our overtime contracts. The decrease in contract liabilities was due to the timing of customer milestone payments for in-process engineered to order contracts. The decrease in accounts payable was primarily due to the timing of vendor cash disbursements.
Cash Flows
The following table reflects the major categories of cash flows for the years ended December 31, 2019 and 2018, respectively.
|
Year Ended December 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Cash flows - operating activities
|
$
|
343.3
|
$
|
444.5
|
||||
|
Cash flows - investing activities
|
(54.3
|
)
|
(235.0
|
)
|
||||
|
Cash flows - financing activities
|
(11.5
|
)
|
(373.0
|
)
|
||||
|
Free cash flow
(1)
|
300.1
|
392.3
|
||||||
| (1) |
See “Item 6. Selected Financial Data” for a reconciliation to the most directly comparable GAAP measure.
|
Operating activities
Cash provided by operating activities decreased $101.2 to $343.3 in 2019 from $444.5 million in 2018, due to lower net income (excluding non-cash charges for depreciation and amortization, non-cash restructuring charges, stock-based compensation expense, foreign currency transaction losses (gains), net, net losses (gains) on asset dispositions, loss on the extinguishment of debt, non-cash change in the LIFO reserve and deferred income taxes) and from cash generated by reduced operating working capital.
Operating working capital generated cash of $38.7 million in 2019 compared to generating cash of $54.9 million in 2018. Changes in account receivables generated cash of $54.7 million in 2019 compared to generating cash of $13.2 million in 2018. Changes in contract assets used cash of $9.1 million in 2019 compared to using cash of $19.9 million in 2018. Changes in inventory generated cash of $18.7 million in 2019 compared to using cash of $13.0 million in 2018. Changes in accounts payable used cash of $9.2 million in 2019 compared to generating cash of $69.6 million in 2018. Changes in contract liabilities used cash of $16.4 million in 2019 compared to generating cash of $5.0 million in 2018.
Investing activities
Cash flows used by investing activities included capital expenditures of $43.2 million (1.8% of consolidated revenues) and $52.2 million (1.9% of consolidated revenues) in 2019 and 2018, respectively. We currently expect capital expenditures to total approximately $45.0 million to $55.0 million in 2020. Cash paid in business combinations was $12.0 million in 2019 and $186.3 million in 2018. Net proceeds from the disposal of property, plant and equipment were $0.9 million and $3.5 million in 2019 and 2018, respectively.
Financing activities
Cash used in financing activities of $11.5 million in 2019 reflects repayments of long-term borrowings of $32.8 million, purchases of treasury stock of $18.6 million, payments of $2.3 million for contingent consideration and $0.5 million of debt issuance cost payments, partially offset by proceeds from stock option exercises of $42.7 million associated with approved stock-based compensation plans.
Cash used in financing activities of $373.0 million in 2018 reflects repayments of long-term borrowings of $337.6 million, purchases of treasury stock of $40.7 million, payments of $1.4 million for contingent consideration and $0.1 million of other items, partially offset by proceeds from stock option exercises of $6.8 million associated with approved stock-based compensation plans.
Free cash flow
Free cash flow decreased $92.2 million to $300.1 million in 2019 from $392.3 million in 2018 due to decreased cash provided by operating activities of $101.2 million, partially offset by a decrease in capital expenditures of $9.0 million in 2019 compared to 2018.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements that have or are materially likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Contractual Obligations
The following table summarizes our future minimum payments as of December 31, 2019 for all contractual obligations for years subsequent to the year ended December 31, 2019.
|
Payments Due by Period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
2020
|
2021-2022
|
2023-2024
|
More than
5 years
|
|||||||||||||||
|
Debt
|
$
|
1,601.6
|
$
|
6.9
|
$
|
13.9
|
$
|
1,580.8
|
$
|
-
|
||||||||||
|
Estimated interest payments
(1)
|
313.9
|
83.4
|
123.8
|
101.6
|
5.1
|
|||||||||||||||
|
Finance leases
|
17.9
|
0.7
|
1.6
|
2.1
|
13.5
|
|||||||||||||||
|
Operating leases
|
58.1
|
16.9
|
22.0
|
11.6
|
7.6
|
|||||||||||||||
|
Purchase obligations
(2)
|
186.7
|
162.6
|
23.3
|
0.3
|
0.5
|
|||||||||||||||
|
Total
|
$
|
2,178.2
|
$
|
270.5
|
$
|
184.6
|
$
|
1,696.4
|
$
|
26.7
|
||||||||||
| (1) |
Estimated interest payments for long-term debt were calculated as follows: for fixed-rate debt and term debt, interest was calculated based on applicable rates and payment dates; for variable-rate debt and/or non-term debt, interest rates and payment dates were estimated based on management’s determination of the most likely scenarios for each relevant debt instrument.
|
| (2) |
Purchase obligations consist primarily of agreements to purchase inventory or services made in the normal course of business to meet operational requirements. The purchase obligation amounts do not represent the entire anticipated purchases in the future, but represent only those items for which we are contractually obligated as of December 31, 2019. For this reason, these amounts will not provide a complete and reliable indicator of our expected future cash outflows.
|
Total pension and other postretirement benefit liabilities recognized on our consolidated balance sheet as of December 31, 2019 were $101.9 million. The total pension and other postretirement benefit liabilities are included in our consolidated balance sheet line items “Accrued liabilities” and “Pensions and other postretirement benefits.” Because these liabilities are impacted by, among other items, plan funding levels, changes in plan demographics and assumptions and investment return on plan assets, these liabilities do not represent expected liquidity needs. Accordingly, we did not include these liabilities in the “Contractual Obligations” table above.
We fund our U.S. qualified pension plans in accordance with the Employee Retirement Income Security Act of 1974 regulations for the minimum annual required contribution and Internal Revenue Service regulations for the maximum annual allowable tax deduction. We are committed to making the required minimum contributions and expect to contribute a total of approximately $0.1 million to our U.S. qualified pension plans during 2020. Furthermore, we expect to contribute a total of approximately $0.3 million to our postretirement life insurance benefit plans during 2020. Future contributions are dependent upon various factors including the performance of the plan assets, benefit payment experience and changes, if any, to current funding requirements. Therefore, no amounts were included in the “Contractual Obligations” table related to expected plan contributions. We generally expect to fund all future contributions to our plans with cash flows from operating activities.
Our non-U.S. pension plans are funded in accordance with local laws and income tax regulations. We expect to contribute a total of approximately $5.0 million to our non-U.S. qualified pension plans during 2019. No amounts have been included in the “Contractual Obligations” table related to these plans due to the same reasons indicated above.
Disclosure of amounts in the “Contractual Obligations” table regarding expected benefit payments in future years for our pension plans and other postretirement benefit plans cannot be properly reflected due to the ongoing nature of the obligations of these plans. We currently anticipate the annual benefit payments for the U.S. plans to be in the range of approximately $4.5 million to $5.4 million for the next several years, and the annual benefit payments for the non-U.S. plans to be in the range of approximately $10.2 million to $12.2 million for the next several years.
Contingencies
We are a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of our size and in our sector. We believe that such proceedings, lawsuits and administrative actions will not materially adversely affect our operations, financial condition, liquidity or competitive position. We have accrued liabilities and other liabilities on our consolidated balance sheet, including a total litigation reserve of $118.1 million as of December 31, 2019 with respect to potential liability arising from our asbestos-related litigation. Other than our asbestos-related litigation reserves, we only have
de minimis
accrued liabilities and other liabilities on our consolidated balance sheet with respect to other legal proceedings, lawsuits and administrative actions. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth in “Item 3. Legal Proceedings.”
Critical Accounting Estimates
Accounting estimates and assumptions discussed in this section are those that we consider to be the most critical to an understanding of our financial statements because they involve significant judgments and uncertainties. Certain of these estimates include determining fair value. All of these estimates reflect our best judgment about current, and for some estimates, future economic and market conditions and their effect based on information available as of the date of these financial statements. If these conditions change from those expected, it is reasonably possible that the judgments and estimates described below could change, which may result in future impairments of goodwill, intangibles and long-lived assets, increases in reserves for contingencies, establishment of valuation allowances on deferred tax assets and increase in tax liabilities, among other effects. Also see Note 1 “Summary of Significant Accounting Policies” to our audited consolidated financial statements included elsewhere in this Form 10-K, which discusses the significant accounting policies that we have selected from acceptable alternatives.
Impairment of Goodwill and Other Identified Intangible Assets
We test goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Upon adoption of ASU 2019-04, the impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, we consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. We determined fair values for all of the reporting units using a combination of the income and market multiples approaches which are weighted 75% and 25%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. We use our internal forecasts to estimate future cash flows and include an estimate of long-term future growth rates based on our most recent views of the long-term outlook for each business. Actual results may differ from those assumed in our forecasts. We derive our discount rates using a capital asset pricing model and analyzing published rates for industries relevant to our reporting units to estimate the cost of equity financing. We use discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in our internally developed forecasts. Discount rates used in our 2019 reporting unit valuations ranged from 9.0% to 10.0%. Additionally, we assumed 3.0% terminal growth rates for all reporting units.
Under the market multiples approach, fair value is determined based on multiples derived from the stock prices of publically traded guideline companies to develop a business enterprise value (“BEV”) for our reporting units. The application of the market multiples method entails the development of book value multiples based on the market value of the guideline companies. The multiples are developed by first calculating the market value of equity of the guideline companies and then adjusting these multiples for cash and debt to arrive at a BEV multiple. Identifying appropriate guideline companies and computing appropriate market multiples is subjective. We considered various public companies that had reasonably similar qualitative factors as our reporting units while also considering quantitative factors such as revenue growth, profitability and total assets.
For all reporting units, the excess of the estimated fair value over carrying value (expressed as a percentage of carrying value) was a minimum of 42.9%. With each reporting unit’s fair value in excess of its carrying value, no goodwill impairment was recorded.
We annually test intangible assets with indefinite lives for impairment utilizing a discounted cash flow valuation referred to as the relief from royalty method. We estimated forecasted revenues for a period of five years with discount rates ranging from 9.0% to 10.0%, a terminal growth rate of 3.0%, and royalty rates ranging from 3.0% to 4.0%.
We review identified intangible assets with defined useful lives and subject to amortization for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset.
Also see Note 8 “Goodwill and Other Intangible Assets” to our audited consolidated financial statements included elsewhere in this Form 10-K.
Income Taxes
Our annual tax rate is based on our income, statutory tax rates and tax planning opportunities available to us in the various jurisdictions in which we operate. Tax laws are complex and subject to different interpretations by the taxpayer and respective governmental taxing authorities. Significant judgment is required in determining our tax expense and in evaluating our tax positions, including evaluating uncertainties. We review our tax positions quarterly and adjust the balances as new information becomes available.
On December 22, 2017, the Tax Act was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes, including the determination of the transition tax, the remeasurement of our U.S. deferred tax assets and liabilities as well as the reassessment of the net realizability of our deferred tax assets and liabilities in the period of enactment. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which allowed us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. As a result, we previously provided a provisional estimate of the effect of the Tax Act in our financial statements for 2017 and through the first nine month period of 2018. In the fourth quarter of 2018, we completed our accounting for all of the enactment-date income tax effects of the Tax Act by increasing the total benefit taken in 2017 of $95.3 million to $96.5 million. The total U.S. deferred change due to the Tax Act went from a tax benefit of $89.6 million in 2017 to $74.5 million in 2018, with a 2018 measurement-period adjustment of $15.1 million. The ASC 740-30 (formerly APB 23) liability related to the permanent reinvestment of earnings in foreign subsidiaries assertion, changed from a tax benefit of $69.0 million in 2017 to $72.5 million in 2018, with a 2018 measurement-period adjustment of $3.5 million resulting from a reduction in distributable profits due to restructuring and repatriations and the change in policy that occurred in 2018. The provisional one-time transition tax of $63.3 million in 2017 decreased to $50.5 million in 2018, with a 2018 measurement-period adjustment of $12.8 million. The total $1.2 million benefit had a (0.3)% impact to the overall rate in 2018.
The Tax Act creates a new requirement that certain income (i.e., GILTI) earned by CFCs must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, we are allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). We determined that we will follow the period cost method (option 1 above) going forward. The tax provision for the year ended December 31, 2019 reflects this decision. All of the additional calculations and rule changes found in the Tax Act have been considered in the tax provision for year ended December 31, 2019. The Company recorded a tax expense of $2.0 million in 2019 for the GILTI provisions of the Tax Act that were effective for the first time during 2018.
Deferred income tax assets represent amounts available to reduce income taxes payable on taxable income in future years. Such assets arise because of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as from net operating loss and tax credit carryforwards. We evaluate the recoverability of these future tax deductions and credits by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. These sources of income rely heavily on estimates. To the extent we do not consider it more likely than not that a deferred tax asset will be recovered, a valuation allowance is established. Amounts recorded for deferred tax assets related to tax attribute carryforwards, net of valuation allowances, were $12.7 million and $3.5 million as of December 31, 2019 and 2018, respectively.
Stock-Based Compensation
We account for stock-based compensation plans under the fair value recognition and measurement provisions in accordance with applicable accounting standards, which require all stock-based payments to employees and non-employees, including grants of stock options and deferred stock units (“DSU”), to be measured based on the grant date fair value of the awards.
The fair value of each stock option grant is estimated using the Black-Scholes-Merton valuation model. The model requires certain assumptions including the estimated expected term of the stock options, the risk-free interest rate and the assumed volatility, of which certain assumptions are highly complex and subjective. The expected option life represents the period of time that the options granted are expected to be outstanding based on management's best estimate of the timing of a liquidity event and the contractual term of the stock option. As there is not sufficient trading history of our common stock, we use a group of our competitors which we believe are similar to us, adjusted for our capital structure, in order to estimate volatility. Our exercise price is the stock price on the date in which shares were granted.
Concurrent with the Company’s initial public offering in May of 2017, the Company’s Board authorized the grant of 5.5 million DSUs to all permanent employees that had not previously received stock-based awards under the 2013 Plan. The DSUs vested immediately upon grant, however contain restrictions such that the employee may not sell or otherwise realize the economic benefits of the award until certain dates through April 2019. The fair value of each DSU grant under the Stock-Based Compensation Plan is estimated on the date of grant or modification using the Finnerty discount for lack of marketability pricing model. The discount for lack of marketability is commensurate with the period of sale restrictions related to the Company’s initial public offering.
Prior to our initial public offering, our stock price was calculated based on a combination of the income approach and the market approach. Under the income approach, specifically the discounted cash flow method, forecasted cash flows are discounted to the present value at a risk-adjusted discount rate. The valuation analyses determine discrete free cash flows over several years based on forecast financial information provided by management and a terminal value for the residual period beyond the discrete forecast, which are discounted at an appropriate rate to estimate our enterprise value. Under the market approach, specifically the guideline public company method, we select publicly traded companies with similar financial and operating characteristics as us and calculate valuation multiples based on the guideline public company’s financial information and market data. Subsequent to the initial public offering, the estimation of our stock price is no longer necessary as we rely on the market price to determine the market value of our common stock. For additional information related to the assumptions used, see Note 17 “Stock-Based Compensation Plans” to our audited consolidated financial statements included elsewhere in this Form 10-K.
Loss Contingencies
Loss contingencies are uncertain and unresolved matters that arise in the ordinary course of business and result from events or actions by others that have the potential to result in a future loss. Such contingencies include, but are not limited to, asbestos and silica related litigation, environmental obligations, litigation, regulatory proceedings, product quality and losses resulting from other events and developments.
When a loss is considered probable and reasonably estimable, we record a liability in the amount of our best estimate for the ultimate loss. When there appears to be a range of possible costs with equal likelihood, liabilities are based on the low-end of such range. However, the likelihood of a loss with respect to a particular contingency is often difficult to predict and determining a meaningful estimate of the loss or a range of loss may not be practicable based on the information available and the potential effect of future events and decisions by third parties that will determine the ultimate resolution of the contingency. In particular, as it relates to estimating asbestos and silica contingencies, there are a number of key variables and assumptions including the number and type of new claims to be filed each year, the resolution or outcome of these claims, the average cost of resolution of each new claim, the amount of insurance available, allocation methodologies, the contractual terms with each insurer with whom we have reached settlements, the resolution of coverage issues with other excess insurance carriers with whom we have not yet achieved settlements and the solvency risk with respect to our insurance carriers. Moreover, it is not uncommon for such matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated to determine both the likelihood of potential loss and whether it is possible to reasonably estimate a range of possible loss. When a loss is probable but a reasonable estimate cannot be made, disclosure is provided.
Disclosure also is provided when it is reasonably possible that a loss will be incurred or when it is reasonably possible that the amount of a loss will exceed the recorded provision. We regularly review all contingencies to determine whether the likelihood of loss has changed and to assess whether a reasonable estimate of the loss or range of loss can be made. As discussed above, development of a meaningful estimate of loss or a range of potential loss is complex when the outcome is directly dependent on negotiations with or decisions by third parties, such as regulatory agencies, the court system and other interested parties. Such factors bear directly on whether it is possible to reasonably estimate a range of potential loss and boundaries of high and low.
Recent Accounting Pronouncements
See Note 2 “New Accounting Standards” to our audited consolidated financial statements included elsewhere in this Form 10-K for a discussion of recent accounting standards.
Interest Rate Risk
We are exposed to interest rate risk as a result of our variable-rate borrowings. We manage our exposure to interest rate risk by maintaining a mixture of fixed and variable debt, and from time to time, use pay-fixed interest rate swaps as cash flow hedges of our variable rate debt in order to adjust the relative fixed and variable portions.
As of December 31, 2019, we had variable rate debt outstanding, net of our interest rate swaps, of $776.3 million at a current weighted average interest rate of 3.2%, substantially all of which was incurred under our $2,460.7 million Senior Secured Credit Facility, under which $927.6 million was outstanding under the $1,285.5 million Dollar Term Loan Facility and €601.2 million was outstanding under the €615.0 million Euro Term Loan Facility.
The Dollar Term Loan Facility and the Euro Term Loan Facility bear interest primarily based on LIBOR and EURIBOR, respectively, plus a spread. The Dollar Term Loan Facility is subject to a 0% LIBOR base rate floor and the Euro Term Loan Facility is subject to a 0% EURIBOR base rate floor. Thus, the interest rate on the Dollar Term Loan Facility and the Euro Term Loan Facility will fluctuate when LIBOR or EURIBOR, respectively, exceeds that percentage. As of December 31, 2019, LIBOR was higher than the 0% floor and EURIBOR was lower than the 0% floor.
We use interest rate swaps to offset our exposure to interest rate movements. These outstanding interest rate swaps qualify and are designated as cash flow hedges of forecasted LIBOR-based interest payments. As of December 31, 2019, we were a fixed rate payer on four fixed-floating interest rate swap contracts that effectively fixed the LIBOR-based index used to determine the interest rates charged on our LIBOR-based variable rate borrowings. See Note 18 “Hedging Activities, Derivative Instruments, and Credit Risk” to our audited consolidated financial statements included elsewhere in this Form 10-K.
The following table presents the impact of hypothetical changes in market interest rates across the yield curve by 100 basis points, including the effect of our interest rate swaps for the years ended December 31, 2019 and 2018 on our interest expense.
|
Year Ended December 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Increase (decrease) in market interest rates
|
||||||||
|
100 basis points
|
$
|
4.7
|
$
|
4.8
|
||||
|
(100) basis points
(1) (2)
|
(1.0
|
)
|
(0.3
|
)
|
||||
| (1) |
A decrease in interest rates would not have impacted our interest expense in 2019 on EURIBOR debt which was lower than the 0% base rate floor under the Senior Secured Credit Facility for the entire fiscal year 2019, but would have impacted interest expense in 2019 on LIBOR debt which was higher than the 0% based rate floors under the Senior Secured Credit Facility for the year ended December 31, 2019.
|
| (2) |
A decrease in interest rates would not have impacted our interest expense in 2018 on EURIBOR debt which was lower than the 0% base rate floor under the Senior Secured Credit Facility for the entire fiscal year 2018, but would have impacted interest expense in 2018 on LIBOR debt which was higher than the 0% based rate floors under the Senior Secured Credit Facility for the year ended December 31, 2018.
|
Foreign Currency Risk
We are exposed to foreign currency risks that arise from our global business operations. Changes in foreign currency exchange rates affect the translation of local currency balances of foreign subsidiaries, transaction gains and losses associated with intercompany loans with foreign subsidiaries and transactions denominated in currencies other than a subsidiary’s functional currency. In 2019, the relative strengthening of the U.S. dollar against foreign currencies had an unfavorable impact on our revenues and results of operations while in 2018, the relative weakening of the U.S. dollar against foreign currencies had a favorable impact on our revenues and results of operations. While future changes in foreign currency exchange rates are difficult to predict, our revenues and earnings may be adversely affected if the U.S. dollar strengthens against foreign currencies.
We seek to minimize our exposure to foreign currency risks through a combination of normal operating activities, including by conducting our international business operations primarily in their functional currencies to match expenses with revenues and the use of foreign currency forward exchange contracts and net investment cross-currency interest rate swaps. In addition, to mitigate the risk arising from entering into transactions in currencies other than our functional currencies, we typically settle intercompany trading balances monthly.
The table below presents the percentage of revenues and gross profit by principal currency for the years ended December 31, 2019 and 2018.
|
U.S. Dollar
|
Euro
|
British
Pound
|
Chinese
Renminbi
|
Other
|
||||||||||||||||
|
Year Ended December 31, 2019
|
||||||||||||||||||||
|
Revenues
|
44
|
%
|
31
|
%
|
5
|
%
|
6
|
%
|
14
|
%
|
||||||||||
|
Gross profit
|
42
|
%
|
35
|
%
|
6
|
%
|
7
|
%
|
10
|
%
|
||||||||||
|
Year Ended December 31, 2018
|
||||||||||||||||||||
|
Revenues
|
48
|
%
|
30
|
%
|
5
|
%
|
5
|
%
|
12
|
%
|
||||||||||
|
Gross profit
|
48
|
%
|
31
|
%
|
5
|
%
|
7
|
%
|
9
|
%
|
||||||||||
We utilize foreign currency denominated debt obligations supplemented from time to time with cross currency interest rate swaps designated as net investment hedges to selectively hedge portions of our investment in non-U.S. subsidiaries. The currency effects of the designated debt obligations and cross currency interest rate swaps are reflected in accumulated other comprehensive income within our stockholders’ equity, where they partially offset the currency translation effects of our investments in non-U.S. subsidiaries, which in turn partially offset gains and losses recorded on our net investments globally. These currency translation effects and offsetting impacts of our derivatives for the years ended December 31, 2019 and 2018 are summarized in Note 13 “Accumulated Other Comprehensive (Loss) Income” to our audited consolidated financial statements included elsewhere in this Form 10-K.
We also enter into foreign currency forward contracts to manage the risk arising from transaction gains and losses associated with intercompany loans with foreign subsidiaries. Our foreign currency forward contracts are typically short-term and are rolled forward as necessary upon settlement. As of December 31, 2019, we were party to six foreign currency forward contracts, all of which are carried on our balance sheet at fair value. See Note 18 “Hedging Activities, Derivative Instruments, and Credit Risk” to our audited consolidated financial statements included elsewhere in this Form 10-K.
The table below presents, for the year ended December 31, 2019, the hypothetical effect of a 10% appreciation in the average exchange rate of the U.S. dollar relative to the principal foreign currencies in which our revenues and gross profit are denominated.
|
Year Ended December 31, 2019
|
||||||||||||
|
Euro
|
British
Pound
|
Chinese
Renminbi
|
||||||||||
|
Revenues
|
$
|
(69.2
|
)
|
$
|
(11.9
|
)
|
$
|
(13.5
|
)
|
|||
|
Gross profit
|
(30.1
|
)
|
(5.3
|
)
|
(6.7
|
)
|
||||||
(Dollars in millions, except per share amounts)
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Cost of sales
|
|
|
|
|||||||||
|
Gross Profit
|
|
|
|
|||||||||
|
Selling and administrative expenses
|
|
|
|
|||||||||
|
Amortization of intangible assets
|
|
|
|
|||||||||
|
Impairment of other intangible assets
|
|
|
|
|||||||||
|
Other operating expense, net
|
|
|
|
|||||||||
|
Operating Income
|
|
|
|
|||||||||
|
Interest expense
|
|
|
|
|||||||||
|
Loss on extinguishment of debt
|
|
|
|
|||||||||
|
Other income, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Income (Loss) Before Income Taxes
|
|
|
(
|
)
|
||||||||
|
Provision (benefit) for income taxes
|
|
|
(
|
)
|
||||||||
|
Net Income
|
|
|
|
|||||||||
|
Less: Net income attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Net Income Attributable to Gardner Denver Holdings, Inc.
|
$
|
|
$
|
|
$
|
|
||||||
|
Basic earnings per share
|
$
|
|
$
|
|
$
|
|
||||||
|
Diluted earnings per share
|
$
|
|
$
|
|
$
|
|
||||||
The accompanying notes are an integral part of these consolidated financial statements.
(Dollars in millions)
|
|
For the Years Ended December 31,
|
|||||||||||
|
|
2019
|
2018
|
2017
|
|||||||||
|
Comprehensive Income Attributable to Gardner Denver Holdings, Inc.
|
||||||||||||
|
Net income attributable to Gardner Denver Holdings, Inc.
|
$
|
|
$
|
|
$
|
|
||||||
|
Other comprehensive (loss) income, net of tax:
|
||||||||||||
|
Foreign currency translation adjustments, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Unrecognized gains on cash flow hedges, net
|
|
|
|
|||||||||
|
Pension and other postretirement prior service cost and gain or loss, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Other comprehensive (loss) income, net of tax
|
(
|
)
|
(
|
)
|
|
|||||||
|
Comprehensive income attributable to Gardner Denver Holdings, Inc.
|
$
|
|
$
|
|
$
|
|
||||||
|
Comprehensive Income Attributable to Noncontrolling Interests
|
||||||||||||
|
Net income attributable to noncontrolling interests
|
$
|
|
$
|
|
$
|
|
||||||
|
Other comprehensive income, net of tax
|
|
|
|
|||||||||
|
Comprehensive income attributable to noncontrolling interests
|
$
|
|
$
|
|
$
|
|
||||||
|
Total Comprehensive Income
|
$
|
|
$
|
|
$
|
|
||||||
The accompanying notes are an integral part of these consolidated financial statements.
(Dollars in millions, except share and per share amounts)
|
|
December 31,
|
December 31,
|
||||||
|
2019
|
2018
|
|||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Accounts receivable, net of allowance for doubtful accounts of $
|
|
|
||||||
|
Inventories
|
|
|
||||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property, plant and equipment, net of accumulated depreciation of $
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Other intangible assets, net
|
|
|
||||||
|
Deferred tax assets
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
Liabilities and Stockholders’ Equity
|
||||||||
|
Current liabilities
|
||||||||
|
Short-term borrowings and current maturities of long-term debt
|
$
|
|
$
|
|
||||
|
Accounts payable
|
|
|
||||||
|
Accrued liabilities
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Long-term debt, less current maturities
|
|
|
||||||
|
Pensions and other postretirement benefits
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Other liabilities
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
Commitments and contingencies (Note 20)
|
|
|
||||||
|
Stockholders’ equity
|
||||||||
|
Common stock, $
|
|
|
||||||
|
Capital in excess of par value
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock at cost;
|
(
|
)
|
(
|
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
||||
The accompanying notes are an integral part of these consolidated financial statements.
(Dollars in millions)
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Number of Common Shares Issued (in millions)
|
||||||||||||
|
Balance at beginning of period
|
|
|
|
|||||||||
|
Common stock issued for initial public offering
|
|
|
|
|||||||||
|
Issuance of common stock for stock-based compensation plans
|
|
|
|
|||||||||
|
Balance at end of period
|
|
|
|
|||||||||
|
Common Stock
|
||||||||||||
|
Balance at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
|
Common stock issued for initial public offering
|
|
|
|
|||||||||
|
Issuance of common stock for stock-based compensation plans
|
|
|
|
|||||||||
|
Balance at end of period
|
$
|
|
$
|
|
$
|
|
||||||
|
Capital in Excess of Par Value
|
||||||||||||
|
Balance at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
|
Common stock issued for initial public offering, net of underwriting discounts and commissions
|
|
|
|
|||||||||
|
Costs related to initial public offering
|
|
|
(
|
)
|
||||||||
|
Issuance of common stock for stock-based compensation plans
|
|
|
|
|||||||||
|
Issuance of treasury stock for stock-based compensation plans
|
(
|
)
|
(
|
)
|
|
|||||||
|
Stock-based compensation
|
|
|
|
|||||||||
|
Purchase of noncontrolling interest
|
|
|
|
|||||||||
|
Balance at end of period
|
$
|
|
$
|
|
$
|
|
||||||
|
Accumulated Deficit
|
||||||||||||
|
Balance at beginning of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Net income attributable to Gardner Denver Holdings, Inc.
|
|
|
|
|||||||||
|
Cumulative-effect adjustment upon adoption of new accounting standard (ASU 2017-12)
|
|
(
|
)
|
|
||||||||
|
Cumulative-effect adjustment upon adoption of new accounting standard (ASU 2018-02)
|
|
|
|
|||||||||
|
Balance at end of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Accumulated Other Comprehensive Loss
|
||||||||||||
|
Balance at beginning of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Foreign currency translation adjustments, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Unrecognized gains on cash flow hedges, net
|
|
|
|
|||||||||
|
Pension and other postretirement prior service cost and gain or loss, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Cumulative-effect adjustment upon adoption of new accounting standard (ASU 2017-12)
|
|
|
|
|||||||||
|
Cumulative-effect adjustment upon adoption of new accounting standard (ASU 2018-02)
|
(
|
)
|
|
|
||||||||
|
Balance at end of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Treasury Stock
|
||||||||||||
|
Balance at beginning of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Purchases of treasury stock
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Share repurchase program
|
|
(
|
)
|
|
||||||||
|
Issuance of treasury stock for stock-based compensation plans
|
|
|
|
|||||||||
|
Balance at end of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
|
Total Gardner Denver Holdings, Inc. Stockholders’ Equity
|
$
|
|
$
|
|
$
|
|
||||||
|
Noncontrolling Interests
|
||||||||||||
|
Balance at beginning of period
|
|
|
$
|
|
||||||||
|
Net income (loss) attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Purchase of noncontrolling interest
|
|
|
(
|
)
|
||||||||
|
Transfer of noncontrolling interest AOCI to consolidated AOCI
|
|
|
|
|||||||||
|
Balance at end of period
|
$
|
|
$
|
|
$
|
|
||||||
|
Total Stockholders’ Equity
|
$
|
|
$
|
|
$
|
|
||||||
The accompanying notes are an integral part of these consolidated financial statements.
(Dollars in millions)
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Cash Flows From Operating Activities
|
||||||||||||
|
Net income
|
$
|
|
$
|
|
$
|
|
||||||
|
Adjustments to reconcile net income to net cash provided by operating activities
|
||||||||||||
|
Amortization of intangible assets
|
|
|
|
|||||||||
|
Depreciation in cost of sales
|
|
|
|
|||||||||
|
Depreciation in selling and administrative expenses
|
|
|
|
|||||||||
|
Impairment of other intangible assets
|
|
|
|
|||||||||
|
Non-cash restructuring charges
|
|
|
|
|||||||||
|
Stock-based compensation expense
|
|
|
|
|||||||||
|
Foreign currency transaction losses (gains), net
|
|
(
|
)
|
|
||||||||
|
Net loss (gain) on asset disposition
|
|
(
|
)
|
|
||||||||
|
Loss on extinguishment of debt
|
|
|
|
|||||||||
|
Non-cash change in LIFO reserve
|
|
|
|
|||||||||
|
Deferred income taxes
|
(
|
)
|
|
(
|
)
|
|||||||
|
Changes in assets and liabilities
|
||||||||||||
|
Receivables
|
|
|
(
|
)
|
||||||||
|
Inventories
|
|
(
|
)
|
(
|
)
|
|||||||
|
Accounts payable
|
(
|
)
|
|
|
||||||||
|
Accrued liabilities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Other assets and liabilities, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Net cash provided by operating activities
|
|
|
|
|||||||||
|
Cash Flows From Investing Activities
|
||||||||||||
|
Capital expenditures
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net cash paid in business combinations
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Proceeds from the termination of derivatives
|
|
|
|
|||||||||
|
Disposals of property, plant and equipment
|
|
|
|
|||||||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Cash Flows From Financing Activities
|
||||||||||||
|
Principal payments on long-term debt
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Premium paid on extinguishment of senior notes
|
|
|
(
|
)
|
||||||||
|
Proceeds from long-term debt
|
|
|
|
|||||||||
|
Proceeds from the issuance of common stock, net of share issuance costs
|
|
|
|
|||||||||
|
Purchases of treasury stock
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Proceeds from stock option exercises
|
|
|
|
|||||||||
|
Payments of contingent consideration
|
(
|
)
|
(
|
)
|
|
|||||||
|
Payments of debt issuance costs
|
(
|
)
|
|
(
|
)
|
|||||||
|
Purchase of shares from noncontrolling interests
|
|
|
(
|
)
|
||||||||
|
Other
|
|
(
|
)
|
|
||||||||
|
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(
|
)
|
|
||||||||
|
Increase (decrease) in cash and cash equivalents
|
|
(
|
)
|
|
||||||||
|
Cash and cash equivalents, beginning of year
|
|
|
|
|||||||||
|
Cash and cash equivalents, end of year
|
$
|
|
$
|
|
$
|
|
||||||
|
Supplemental Cash Flow Information
|
||||||||||||
|
Cash paid for income taxes
|
$
|
|
$
|
|
$
|
|
||||||
|
Cash paid for interest
|
$
|
|
$
|
|
$
|
|
||||||
|
Debt issuance costs in accounts payable
|
$
|
|
$
|
|
$
|
|
||||||
|
Debt issuance costs in accrued liabilities
|
$
|
|
$
|
|
$
|
|
||||||
|
Capital expenditures in accounts payable
|
$
|
|
$
|
|
$
|
|
||||||
|
Property and equipment acquired under capital leases
|
$
|
|
$
|
|
$
|
|
||||||
The accompanying notes are an integral part of these consolidated financial statements.
(Amounts in millions, except share and per share amounts)
| Note 1: |
Summary of Significant Accounting Policies
|
Gardner Denver Holdings, Inc. is a holding company whose operating subsidiaries are Gardner Denver, Inc. (“GDI”) and certain of GDI’s subsidiaries. GDI is a diversified, global manufacturer of highly engineered, application-critical flow control products and provider of related aftermarket parts and services. The accompanying consolidated financial statements include the accounts of Gardner Denver Holdings, Inc. and its majority-owned subsidiaries (collectively referred to herein as “Gardner Denver” or the “Company”).
In May 2017, the Company sold a total of
47,495,000
shares of common stock in an initial public offering of shares of common stock. On November 15, 2017, May 2, 2018 and October 31, 2018, the Company completed secondary offerings of
25,300,000
shares,
30,533,478
and
20,000,000
shares, respectively, of common stock held by affiliates of Kohlberg Kravis Roberts & Co. L.P. (“KKR”). As a result of the secondary offerings, the Company is no longer considered a “controlled company” within the meaning of the corporate governance standards of the New York Stock Exchange (“NYSE”). KKR owns
70,671,135
shares of common stock, or approximately
34
% of the total outstanding common stock based on the number of shares outstanding as of December 31, 2019.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for doubtful accounts, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income (loss), and are reported in accumulated other comprehensive (loss) income, a separate component of stockholders’ equity, and included as a component of other comprehensive (loss) income. Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
On January 1, 2018, the Company adopted the Financial Accounting Standards Board (“FASB”) ASU 2014-09,
Revenue from Contracts with Customers (Topic 606)
(“ASC 606”)
.
The Company adopted the guidance using a modified retrospective approach. Results for the years ended December 31, 2019 and 2018 were recorded under ASC 606 in the Consolidated Statements of Operations. The results in the Consolidated Statements of Operations for the year ended December 31, 2017 were not adjusted from ASC 605,
Revenue Recognition
(“ASC 605”). See Note 14 “Revenue from Contracts with Customers” for more discussion of the adoption of ASC 606 and the related significant accounting policies.
L
eases
On January 1, 2019, the Company adopted FASB ASU 2016-02,
Leases (Topic 842)
(“ASC 842”) utilizing the optional transition method. The guidance required the Company to recognize right-of-use lease assets and lease liabilities on the balance sheet for those leases classified as operating leases. The Consolidated Balance Sheet as of December 31, 2019 reflects the adoption of ASC 842. The Consolidated Balance Sheet as of December 31, 2018 was not adjusted from ASC 840,
Leases
(“ASC 840”). See Note 16 “Leases” for further discussion of the Company’s operating and financing leases.
Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and administrative expenses consist of (i) employee related salary,
stock-based compensation expense
,
benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) KKR fees and expenses; (vii) expenses related to the Company’s
public stock offerings
and to establish public company reporting compliance; and (viii) other miscellaneous expenses.
Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2019 and 2018, cash of $
3.4
million and $
3.4
million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company.
Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment.
Trade accounts receivable are recorded at net realizable value. This value includes an appropriate allowance for doubtful accounts for estimated losses that may result from the Company’s inability to fully collect amounts due from its customers. The allowance is determined based on a combination of factors, including the length of time that the trade receivables are past due, history of write-offs, and the Company’s knowledge of circumstances relating to specific customers’ ability to meet their financial obligations.
Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings —
10
to
30
years; machinery and equipment —
7
to
10
years; office furniture and equipment —
3
to
10
years; and tooling, dies, patterns, etc. —
3
to
5
years.
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as trademarks are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value.
The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted
75
% and
25
%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value.
The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
See Note 8 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets.
Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. The estimated useful lives are as follows: customer lists and relationships —
11
-
13
years, acquired technology —
12
-
25
years, certain trademarks —
10
-
20
years, and other intangibles —
1
-
5
years.
The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically
12
months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility of certain of the Company’s competitors’ stocks over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units are valued at the share price on the date of grant.
In 2017, deferred stock units were granted and their respective fair values were estimated on the date of grant or modification using the Finnerty discount for lack of marketability pricing model. The discount for lack of marketability is commensurate with the period of sale restrictions related to the Company’s initial public offering.
See Note 17 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans.
The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2019 and 2018 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
See Note 11 “Benefit Plans” for disclosures related to Gardner Denver’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations.
The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income taxes are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized.
Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed.
On December 22, 2017, the Tax Act was enacted into law and the new legislation contains several key tax provisions that affected the Company, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to
21
% effective January 1, 2018, among others. The Company was required to recognize the effect of the Tax Act in the period of enactment. This included the determination of the transition tax, remeasurement of the Company’s U.S. deferred tax assets and liabilities as well as the reassessment of the net realizability of the Company’s deferred tax assets and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Job Act (“SAB 118”), which allowed the Company to record provisional amounts during a measurement period not to extend more than one year subsequent to the enactment date. As a result, the Company previously provided a provisional estimate of the effect of the Tax Act in its financial statements for 2017 and through the first nine months of 2018. In the fourth quarter of 2018, the Company completed its accounting for all of the enactment-date income tax effects of the Tax Act and increased the total benefit taken in 2017 of $
95.3
million to $
96.5
million. Due to the Tax Act, the total U.S. deferred changed from a tax benefit of $
89.6
million in 2017 to $
74.5
million in 2018, with a 2018 measurement-period adjustment of $
15.1
million. The ASC 740-30 (formally APB 23) liability reduction, relating to the permanently reinvested earnings in foreign subsidiaries assertion, changed from a tax benefit of $
69.0
million in 2017 to $
72.5
million in 2018, with a 2018 measurement-period adjustment of $
3.5
million due to the policy change that occurred in 2018. The provisional one-time transition tax of $
63.3
million in 2017 decreased to $
50.5
million in 2018, with a 2018 measurement-period adjustment of $
12.8
million. The total $
1.2
million benefit had a (
0.3
)% impact to the overall rate in 2018.
The Tax Act creates a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above) going forward. The tax provision for the year ended December 31, 2019 reflects this decision. All of the additional calculations and rule changes found in the Tax Act have been considered in the tax provision for the year ended December 31, 2019. The Company recorded a tax expense of $
2.0
million in 2019 for the GILTI provisions of the Tax Act that were effective for the first time during 2018.
For the years ended December 31, 2019, 2018 and 2017, the Company spent approximately $
25
million, $
24
million, and $
26
million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, or (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge or an eligible net investment in a foreign operation, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations.
Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
The Company’s comprehensive income consists of net income and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges (consisting of interest rate swaps), net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 13 “Accumulated Other Comprehensive (Loss) Income.”
The Company incurs costs in connection with the closure and consolidation of facilities and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.
A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred.
Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
| Note 2: |
New Accounting Standards
|
ASU 2016-02, Leases (Topic 842)
On January 1, 2019, the Company adopted FASB ASU 2016-02,
Leases (Topic 842)
(“ASC 842”) utilizing the optional transition method. The amendments in this update replaced most of the existing GAAP lease accounting guidance in order to increase transparency and comparability among organizations by recognizing right-of-use lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under current GAAP. The amendments also expanded disclosure requirements for key information about leasing arrangements. The Company elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby these contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018. The Company updated its internal lease accounting policy to address the new standard, revised the Company’s business processes and controls and completed the implementation and data input for the Company’s lease accounting software solution. The most significant impact of the standard on the Company was the recognition of an approximate $
61.3
million operating right of use (“ROU”) asset and an approximate $
61.4
million operating lease liability on the Consolidated Balance Sheet. The standard did not have a material impact on the Company’s Consolidated Statements of Operations or the Company’s Consolidated Statements of Cash Flows. See Note 16 “Leases” for further discussion of the Company’s operating and financing leases.
ASU 2018-02, Income Statement – Reporting Comprehensive Income (Topic 220) – Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
On January 1, 2019, the Company adopted FASB ASU 2018-02
, Income Statement – Reporting Comprehensive Income (Topic 220) – Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income
(“ASU 2018-02”). The standard allowed a reclassification from accumulated other comprehensive (loss) income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act as of January 1, 2019. The Company recorded a cumulative-effect adjustment on the adoption date decreasing “Accumulated deficit” in the Consolidated Balance Sheets by $
8.2
million and increasing “Accumulated other comprehensive loss” in the Consolidated Balance Sheets by $
8.2
million.
Recently Issued Accounting Pronouncements
In December 2019, the FASB issued ASU 2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. The amendments in this update simplify the accounting for income taxes by removing certain exceptions and amending and clarifying existing guidance. The guidance is effective for public companies beginning with the annual report for fiscal year 2020. Early adoption is permitted.
The Company is currently assessing the impact of this ASU on its consolidated financial statements and evaluating the timing of
adoption.
In August 2018, the FASB issued ASU 2018-13,
Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement
. The amendments in this update eliminate, add and modify certain disclosure
requirements for fair value measurements as part of its disclosure framework project. The guidance is effective for public companies
beginning in the first quarter of 2020. This ASU will have an immaterial impact on the Company’s consolidated financial statements.
In August 2018, the FASB issued ASU 2018-14,
Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans
. The amendments in this eliminate, add and modify certain disclosure requirements for defined benefit pension plans.
The guidance is effective for public companies beginning with its annual report for fiscal year 2020. This ASU will have an immaterial impact on the Company’s consolidated financial statements.
In August 2018, the FASB issued ASU 2018-15,
Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40); Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract
. The amendments in this update require implementation costs incurred by customers in cloud computing arrangements (i.e., hosting arrangements) to be capitalized under the same premises of authoritative guidance for internal-use software, and deferred over the noncancellable term of the cloud computing arrangement plus any option renewal periods that are reasonably certain to be exercised by the customer or for which the exercise is controlled by the service provider. The Company is required to adopt this new guidance in the first quarter of 2020. The Company concluded that this ASU will have an immaterial impact on the Company’s consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13,
Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
(“ASU 2016-13”), which adds an impairment model that is based on expected losses rather than incurred losses and is called the Current Expected Credit Losses (“CECL”) model. This impairment model is applicable to loans, debt securities, trade receivables, net investments in leases, off-balance sheet credit exposures, reinsurance receivables as well as any other financial asset with the contractual right to receive cash. Under the new model, an allowance equal to the estimate of lifetime expected credit losses is recognized which will result in more timely loss recognition. The guidance is intended to reduce complexity by decreasing the number of credit impairment models. This guidance must be adopted using a modified retrospective transition method through a cumulative-effect adjustment to retained earnings in the period of adoption. The Company is required to adopt this new guidance in the first quarter of 2020. The Company reviewed the impact of this ASU on its consolidated financial statements and concluded that any cumulative-effect adjustment would be immaterial.
| Note 3: |
Business Combinations
|
The Company acquired
seven
businesses during the three years ended December 31, 2019.
Proforma information has not been provided as the acquisitions did not have a material impact on the Company’s Consolidated Statements of Operations individually or in the aggregate.
Acquisition of Air Compressors and Blowers North Limited
On August 19, 2019, the Company acquired Air Compressors and Blowers North Limited (“ACBN”), a provider of vacuum pumps, blowers and compressors. The Company acquired certain assets of ACBN for total consideration of $
7.0
million, which consisted of cash payments of $
5.9
million and a $
1.1
million deferred payment. The deferred payment is expected to be paid by the end of the first quarter of 2021 and is recorded in “Other liabilities” in the Consolidated Balance Sheets. The revenues and operating income of ACBN are included in the Company’s consolidated financial statements from the acquisition date and are included in the Industrials segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of Oina VV AB
On July 3, 2019, the Company acquired Oina VV AB (“Oina”) which specializes in customized pump solutions for liquid handling processes for use in medical, process and industrial applications. The Company acquired all of the assets and assumed certain liabilities of Oina for total consideration, net of cash acquired, of $
10.0
million, which consisted of cash payments of $
5.6
million, a $
1.6
million holdback, and up to $
2.8
million in contingent earn-out provisions. The $
1.6
million holdback is expected to be paid by the end of the first quarter of 2021 and is recorded in “Other liabilities” in the Consolidated Balance Sheets. The revenues and operating income of Oina are included in the Company’s consolidated financial statements from the acquisition date and are included in the Medical segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of MP Pumps, Inc.
On December 12, 2018, the Company acquired MP Pumps, Inc. (“MP Pumps”), a leading manufacturer of specialty industrial pumps and associated aftermarket parts. The Company acquired all of the assets and assumed certain liabilities of MP Pumps for total consideration, net of cash acquired, of $
58.5
million, which consisted of cash payments of $
57.8
million and a $
0.7
million holdback. Purchase price adjustments reduced the holdback to $
0.5
million and it was paid in the first quarter of 2019 and recorded in “Net cash paid in business combinations” in the Consolidated Statements of Cash Flows. The revenues and operating income of MP Pumps are included in the Company’s consolidated financial statements from the acquisition date and are included in the Industrials segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of DV Systems, Inc.
On November 2, 2018, the Company acquired DV Systems, Inc. (“DV Systems”), a leading manufacturer of rotary screws and piston compressors and associated aftermarket parts. The Company acquired all of the assets and assumed certain liabilities of DV Systems for total consideration, net of cash acquired, of $
16.1
million, which consisted of cash payments of $
14.8
million and a $
1.3
million holdback. Purchase price adjustments increased the holdback to $
1.4
million of which $
0.3
million was paid in the fourth quarter of 2019 and recorded in “Payments of contingent consideration” in the Consolidated Statements of Cash Flows. Of the $
1.1
million holdback, $
0.6
million is expected to be paid by the end of the first quarter of 2020 and $
0.5
million is expected to be paid by the end the fourth quarter of 2020. The remaining $
1.1
million holdback is recorded in “Accrued liabilities”. The revenues and operating income of DV Systems are included in the Company’s consolidated financial statements from the acquisition date and are included in the Industrials segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of PMI Pump Parts
On May 29, 2018, the Company acquired PMI Pump Parts (“PMI”), a leading manufacturer of plungers and other well service pump consumable products. The Company acquired all of the assets and assumed certain liabilities of PMI for total consideration, net of cash acquired, of $
21.0
million, which consisted of cash payments of $
18.8
million, a $
2.0
million promissory note and a $
0.2
million holdback. The $
0.2
million holdback and $
1.0
million of the promissory note were paid in the fourth quarter of 2018. The remaining $
1.0
million of the promissory note was paid in the second quarter of 2019 and recorded in “Payments of contingent consideration” in the Consolidated Statements of Cash Flows. The revenues and operating income of PMI are included in the Company’s consolidated financial statements from the acquisition date and are included in the Energy segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of Runtech Systems Oy
On February 8, 2018, the Company acquired
100
% of the stock of Runtech Systems Oy (“Runtech”), a leading global manufacturer of turbo vacuum technology systems and optimization solutions for industrial applications. The Company acquired all of the assets and assumed certain liabilities of Runtech for total cash consideration of $
94.9
million, net of cash acquired. The revenues and operating income of Runtech are included in the Company’s consolidated financial statements from the acquisition date and are included in the Industrials segment. The purchase price allocation resulted in the recording of $
63.6
million of goodwill and $
31.3
million of amortizable intangible assets as of the acquisition date.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of LeROI Compressors
On June 5, 2017, the Company acquired
100
% of the stock of LeROI Compressors (“LeROI”), a leading North American manufacturer of gas compression equipment and solutions for vapor recovery, biogas and other process and industrial applications. The Company acquired all of the assets and assumed certain liabilities of LeROI for total cash consideration of $
20.4
million, net of cash acquired. Included in the cash consideration was an indemnity holdback of $
1.9
million. During 2018, the holdback was adjusted to $
1.7
million for repairs and further reduced by a $
0.2
million payment made in the fourth quarter of 2018. The holdback payment was recorded in “Payments of contingent consideration” in the Consolidated Statements of Cash Flows. Of the $
1.5
million holdback, $
1.0
million was paid in the second quarter of 2019 and $
0.5
million is expected to be paid by the end of the second quarter of 2021. The remaining $
0.5
million holdback is recorded in “Other liabilities.” The revenues and operating income of LeROI are included in the Company’s consolidated financial statements from the acquisition date and are included in the Industrials segment.
None
of the goodwill resulting from this acquisition is deductible for tax purposes.
Acquisition of the Non-Controlling Interest in Tamrotor Kompressorit Oy
On March 3, 2017, the Company acquired the remaining
49
% non-controlling interest of Tamrotor Kompressorit Oy (“Tamrotor”), a distributor of the Company’s Industrials segment air compression products. The Company acquired the remaining interest in Tamrotor for total cash consideration of $
5.2
million, consisting entirely of payments to the former shareholders. Included in the cash consideration was a holdback of $
0.5
million that was paid in the third quarter of 2017.
Acquisition Revenues and Operating Income
The revenue included in the financial statements for these acquisitions subsequent to their acquisition date was $
137.6
million, $
96.2
million and $
13.9
million for the years ended December 31, 2019, 2018 and 2017, respectively. For the years ended December 31, 2019, 2018 and 2017, operating income included in the financial statements for the acquisitions described above, subsequent to their date of acquisition was $
19.1
million, $
8.3
million and $
1.4
million, respectively.
Transaction with Ingersoll Rand
On April 30, 2019, the Company entered into a definitive agreement with Ingersoll-Rand plc (“Ingersoll Rand”) pursuant to which Ingersoll Rand will separate its Industrial segment (“Ingersoll Rand Industrial”) and then combine it with the Company (the “Merger Agreement”). The transaction is expected to close during early 2020 and will be effected through a “Reverse Morris Trust” transaction pursuant to which Ingersoll Rand Industrial is expected to be spun-off to Ingersoll Rand’s shareholders and simultaneously merged with and surviving as a wholly-owned subsidiary of Gardner Denver (the “Merger”). Under the terms of the Merger Agreement, which has been unanimously approved by the Boards of Directors of Ingersoll Rand and the Company, at the time of close, Ingersoll Rand will receive $
1.9
billion in cash from Ingersoll Rand Industrial that will be funded by newly-issued debt assumed by the Company in the Merger. Upon close of the transaction, existing Ingersoll Rand shareholders will receive
50.1
%
of the shares of the Company on a fully diluted basis.
| Note 4: |
Restructuring
|
Restructuring Programs 2014 to 2016
The Company announced restructuring programs
in 2014 and 2016 impacting the Industrials, Energy and Medical segments. These programs were substantially completed as of December 31, 2017.
Through December 31, 2017, $
48.0
million had been charged to expense through “Other operating expense, net” in the Consolidated Statements of Operations ($
38.5
million for Industrials, $
6.3
million for Energy and $
3.2
million for Medical). The Company does not anticipate any material future expense related to these restructuring programs and any remaining liabilities will be paid as contractually obligated.
As of December 31, 2018, a restructuring reserve of $
1.3
million related to these programs was included in “Accrued liabilities” and a restructuring reserve of $
0.1
million was included in “Other liabilities” in the Consolidated Balance Sheets.
As of December 31, 2019, there were
no
remaining restructuring reserves related to these programs in the Consolidated Balance Sheets.
Restructuring Program 2018 to 2019
In the third quarter of 2018, the Company announced a restructuring program that primarily involved workforce reductions and facility consolidation. This restructuring program was substantially completed as of December 31, 2019. Through December 31, 2019, $
26.5
million was charged to expense through ‘‘Other operating expense, net’’ in the Consolidated Statements of Operations ($
15.9
million for Industrials, $
7.9
million for Energy, $
1.6
million for Medical and $
1.1
million for Corporate). Additionally, $
3.3
million of non-cash asset write-offs in the Energy segment were charged to expense through ‘‘Other operating expense, net’’ in the Consolidated Statements of Operations. The Company does not anticipate any material future expense related to this restructuring program and any remaining liabilities will be paid as contractually obligated.
|
Balance as of December 31, 2017
|
$
|
|
||
|
Charged to expense - termination benefits
|
|
|||
|
Charged to expense - other
|
|
|||
|
Payments
|
(
|
)
|
||
|
Other, net
|
|
|||
|
Balance as of December 31, 2018
|
$
|
|
||
|
Charged to expense - termination benefits
|
|
|||
|
Charged to expense - other
|
|
|||
|
Payments
|
(
|
)
|
||
|
Other, net
|
|
|||
|
Balance as of December 31, 2019
|
$
|
|
The restructuring reserve related to these programs was $
5.0
million and $
8.8
million as of December 31, 2019 and 2018, respectively, and recorded in “Accrued liabilities” in the Consolidated Balance Sheets.
| Note 5: |
Allowance for Doubtful Accounts
|
|
|
2019
|
2018
|
2017
|
|||||||||
|
Balance at beginning of the period
|
$
|
|
$
|
|
$
|
|
||||||
|
Provision charged to expense
|
|
|
|
|||||||||
|
Write-offs, net of recoveries
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Charged to other accounts
(1)
|
(
|
)
|
(
|
)
|
|
|||||||
|
Balance at end of the period
|
$
|
|
$
|
|
$
|
|
||||||
| (1) |
|
Note 6:
Inventories
Inventories as of December 31, 2019 and 2018 consisted of the following.
|
|
2019
|
2018
|
||||||
|
Raw materials, including parts and subassemblies
|
$
|
|
$
|
|
||||
|
Work-in-process
|
|
|
||||||
|
Finished goods
|
|
|
||||||
|
|
|
|||||||
|
Excess of LIFO costs over FIFO costs
|
|
|
||||||
|
Inventories
|
$
|
|
$
|
|
||||
As of December 31, 2019, $
371.3
million (
74
%) of the Company’s inventory is accounted for on a first-in, first-out (“FIFO”) basis and the remaining $
131.2
million (
26
%) is accounted for on a last-in, first-out (“LIFO”) basis.
As of December 31, 2018, $
390.8
million (
75
%) of the Company’s inventory is accounted for on a first-in, first-out (“FIFO”) basis and the remaining $
133.1
million (
25
%) is accounted for on a last-in, first-out (“LIFO”) basis.
Note 7:
Property, Plant and Equipment
Property, plant and equipment, net as of December 31, 2019 and 2018 consisted of the following.
|
|
2019
|
2018
|
||||||
|
Land and land improvements
|
$
|
|
$
|
|
||||
|
Buildings
|
|
|
||||||
|
Machinery and equipment
|
|
|
||||||
|
Tooling, dies, patterns, etc
|
|
|
||||||
|
Office furniture and equipment
|
|
|
||||||
|
Other
|
|
|
||||||
|
Construction in progress
|
|
|
||||||
|
|
|
|||||||
|
Accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
|
Property, plant and equipment, net
|
$
|
|
$
|
|
||||
Note 8:
Goodwill and Other Intangible
Assets
Goodwill
The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2019 and 2018 are as follows.
|
|
Industrials
|
Energy
|
Medical
|
Total
|
||||||||||||
|
Balance as of December 31, 2017
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Acquisitions
|
|
|
|
|
||||||||||||
|
Foreign currency translation and other
(1)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Balance as of December 31, 2018
|
|
|
|
|
||||||||||||
|
Acquisitions
|
|
|
|
|
||||||||||||
|
Foreign currency translation and other
(1)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Balance as of December 31, 2019
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| (1) |
|
The Company acquired
two
businesses during the year ended December 31, 2019. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed.
The goodwill attributable to the
two
businesses is as follows.
|
2019 Acquisitions
|
Date of Acquisition
|
Industrials
|
Energy
|
Medical
|
Total
|
||||||||||||
|
Oina
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
ACBN
|
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
The Company acquired
four
businesses during the year ended December 31, 2018. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill.
The goodwill attributable to the
four
businesses is as follows.
|
2018 Acquisitions
|
Date of Acquisition
|
Industrials
|
Energy
|
Medical
|
Total
|
||||||||||||
|
Runtech
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
PMI Pumps
|
|
|
|
|
|
||||||||||||
|
DV Systems
|
|
|
|
|
|
||||||||||||
|
MP Pumps
|
|
|
|
|
|
||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
For the years ended December 31, 2019, 2018 and 2017, each reporting unit’s fair value was in excess of its net carrying value, and therefore,
no
goodwill impairment was recorded.
As of December 31, 2019 and 2018, goodwill included a total of $
563.9
million of accumulated impairment losses within the Energy segment since the date of the KKR Transaction.
Other Intangible Assets
Other intangible assets as of December 31, 2019 and 2018 consisted of the following.
|
|
2019
|
2018
|
||||||||||||||
|
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
||||||||||||
|
Amortized intangible assets:
|
||||||||||||||||
|
Customer lists and relationships
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Technology
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Trademarks
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Backlog
|
|
|
|
(
|
)
|
|||||||||||
|
Other
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Unamortized intangible assets:
|
||||||||||||||||
|
Trademarks
|
|
—
|
|
—
|
||||||||||||
|
Total other intangible assets
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
Amortization of intangible assets was $
124.3
million, $
125.8
million and $
118.9
million for the years ended December 31, 2019, 2018 and 2017, respectively. Amortization of intangible assets is anticipated to be approximately $
112.5
million annually in 2020 through 2024 based upon currency exchange rates as of December 31, 2019.
The Company tests indefinite-lived intangible assets for impairment annually in the fourth quarter of each year using data as of October 1 of that year. The Company determines fair values for each of the indefinite-lived intangible assets using a relief from royalty methodology.
The Company did
no
t record an impairment charge
for the years ended December 31, 2019 and 2018,
related to indefinite-lived intangible assets as a result of the annual impairment test.
In the fourth quarter of 2017, as a result of the annual impairment test of indefinite-lived intangible assets, the Company recorded an impairment charge of $
1.6
million related to indefinite-lived trademarks, including $
1.3
million related to
two
trademarks in the Industrials segment and $
0.3
million related to an indefinite-lived trademark in the Energy segment.
The impairments were included in “Impairments of other intangible assets” in the Consolidated Statements of Operations.
Note 9:
Accrued Liabilities
Accrued liabilities as of December 31, 2019 and 2018 consisted of the following:
|
|
2019
|
2018
|
||||||
|
Salaries, wages, and related fringe benefits
|
$
|
|
$
|
|
||||
|
Restructuring
|
|
|
||||||
|
Taxes
|
|
|
||||||
|
Contract liabilities
|
|
|
||||||
|
Product warranty
|
|
|
||||||
|
Accrued interest
|
|
|
||||||
|
Operating lease liabilities
(1)
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total accrued liabilities
|
$
|
|
$
|
|
||||
| (1) |
|
A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2019 and 2018 is as follows.
|
|
2019
|
2018
|
||||||
|
Balance at the beginning of period
|
$
|
|
$
|
|
||||
|
Product warranty accruals
|
|
|
||||||
|
Settlements
|
(
|
)
|
(
|
)
|
||||
|
Charged to other accounts
(1)
|
(
|
)
|
|
|||||
|
Balance at the end of period
|
$
|
|
$
|
|
||||
| (1) |
|
Note 10: Debt
Debt as of December 31, 2019 and 2018 consisted of the following.
|
|
2019
|
2018
|
||||||
|
Short-term borrowings
|
$
|
|
$
|
|
||||
|
Long-term debt
|
||||||||
|
Revolving credit facility, due 2024
(1)
|
$
|
|
$
|
|
||||
|
Receivables financing agreement, due 2020
|
|
|
||||||
|
Term loan denominated in U.S. dollars, due
(2)
|
|
|
||||||
|
Term loan denomoinated in Euros, due
(3)
|
|
|
||||||
|
Finance leases and other long-term debt
|
|
|
||||||
|
Unamortized debt issuance costs
|
(
|
)
|
(
|
)
|
||||
|
Total long-term debt, net, including current maturities
|
|
|
||||||
|
Current maturities of long-term debt
|
|
|
||||||
|
Total long-term debt, net
|
$
|
|
$
|
|
||||
| (1) |
|
| (2) |
|
| (3) |
|
Senior Secured Credit Facilities
The Company entered into a senior secured credit agreement with UBS AG, Stamford Branch, as administrative agent, and other agents and lenders party thereto (the “Senior Secured Credit Facilities”) on July 30, 2013.
The Senior Secured Credit Facilities entered into on July 30, 2013 provided senior secured financing in the equivalent of approximately $
2,825.0
million, consisting of: (i) a senior secured term loan facility (the “Original Dollar Term Loan Facility”) in an aggregate principal amount of $
1,900.0
million; (ii) a senior secured term loan facility (the “Original Euro Term Loan Facility,” together with the Original Dollar Term Loan Facility, the “Term Loan Facilities”) in an aggregate principal amount of €
400.0
million; and (iii) a senior secured revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of $
400.0
million available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably acceptable foreign currencies, subject to certain sublimits for the foreign currencies.
The borrower of the Dollar Term Loan Facility and the Euro Term Loan Facility is Gardner Denver, Inc. Prior to the Company entering into Amendment No. 1, GD German Holdings II GmbH became an additional borrower and successor in interest to Gardner Denver Holdings GmbH & Co. KG. GD German Holdings II GmbH, GD First (UK) Limited and Gardner Denver, Inc. are the listed borrowers under the Revolving Credit Facility. The Revolving Credit Facility includes borrowing capacity available for letters of credit up to $
200.0
million and for borrowings on same-day notice, referred to as swingline loans.
The Senior Secured Credit Facilities provide that the Company will have the right at any time to request incremental term loans and/or revolving commitments in an aggregate principal amount of up to (i) if as of the last day of the most recently ended test period the Consolidated Senior Secured Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) is equal to or less than
5.50
to 1.00, $
250.0
million plus (ii) voluntary prepayments and voluntary commitment reductions of the Senior Secured Credit Facilities prior to the date of any such incurrence plus (iii) an additional amount if, after giving effect to the incurrence of such additional amount, the Company does not exceed a Consolidated Senior Secured Debt to Consolidated EBITDA Ratio of
4.50
to 1.00. The lenders under the Senior Secured Credit Facilities are not under any obligation to provide any such incremental commitments or loans, and any such addition of, or increase in commitments or loans, will be subject to certain customary conditions.
The Company entered into Amendment No.
1
to the Senior Secured Credit Facilities with UBS AG, Stamford Branch, as administrative agent, and the lenders and other parties thereto on March
4,
2016
(“Amendment No
.1
”), Amendment No.
2
on August
17,
2017
(“Amendment No
.2
”) and Amendment No.
3
on December
13,
2018
(“Amendment No
.3
”).
Amendment No. 1 reduced the aggregate principal borrowing capacity of the Revolving Credit Facility by $
40.0
million to $
360.0
million, extended the term of the Revolving Credit Facility to
April 30, 2020
with respect to consenting lenders and provided for customary bail-in provisions to address certain European regulatory requirements. On July 30, 2018, the Revolving Credit Facility principal borrowing capacity decreased to $
269.9
million resulting from the maturity of the tranches of the Revolving Credit Facility which were owned by lenders that elected not to modify the original Revolving Credit Facility maturity date. Any principal amounts outstanding as of April 30, 2020 will be due at that time and required to be paid in full.
Amendment No.
1
reduced the minimum aggregate principal amount for extension amendments to the facilities from
$
50.0
million
to
$
35.0
million
.
Amendment No. 2 refinanced the Original Dollar Term Loan Facility with a replacement $
1,285.5
million senior secured U.S. dollar term loan facility (the ‘‘Dollar Term Loan Facility’’) and the Original Euro Term Loan Facility with a replacement €
615.0
million senior secured euro term loan facility (the ‘‘Euro Term Loan Facility’’). Further the maturity for both term loan facilities was extended to July 30, 2024 and LIBOR Floor was reduced from 1.0% to 0.0%.
Amendment No.
3
amended the definition of “Change of Control” to (i) remove the requirement that certain specified equity holders maintain a minimum ownership level of the outstanding voting stock of the Company, (ii) increase the threshold at which the acquisition of ownership by a person, entity or group of other equity holders constitutes a “Change of Control” from 35% of the outstanding voting stock of the Company to 50% of the outstanding voting stock of the Company and (iii) make certain other corresponding technical changes and updates.
The Company entered into Amendment No.
4
to the Senior Secured Credit Facilities with UBS AG, Stamford Branch, as Resigning Agent and Citibank, N.A. as Successor Agent on June
28,
2019
(“Amendment No.
4
”). Amendment No.
4
(i) refinanced the existing senior secured revolving credit facility with a replacement
$
450.0
million
senior secured revolving credit facility (the “New Revolving Credit Facility”); (ii) extended the maturity of the revolving credit facility to June
28, 2024,
(iii) terminated the revolving credit facility commitments of certain lenders under the existing senior secured revolving credit facility under the Senior Secured Credit Facilities, (iv) provided for up to
$
200.0
million
of the New Revolving Credit Facility to be available for the purpose of issuing letters of credit; (v) provided for the replacement of GD
First
(UK) Limited by Gardner Denver Holdings, Ltd. as the UK Borrower under the Amended Senior Secured Credit Facilities; (vi) transferred the Administrative Agent, Collateral Agent and Swingline Lender roles under the Amended Senior Secured Credit Facilities to Citibank, N.A; and (vii) made certain other corresponding technical changes and updates. At the consummation of the pending merger between Gardner Denver Holdings, Inc., and Ingersoll-Rand plc, Amendment No.
4
increases the aggregate amount of the New Revolving Credit Facility to
$
1,000.0
million
and increases the capacity under the New Revolving Credit Facility to issue letters of credit to
$
400.0
million
. As a result of Amendment No.
4,
the Company wrote off
$
0.2
million
of debt issuance costs to the “Loss on extinguishment of debt” in the Consolidated Statements of Operations for the year ended December
31,
2019.
As of December
31,
2019,
the Company had
no
outstanding borrowings,
$
4.4
million
of outstanding letters of credit under the New Revolving Credit Facility and unused availability of
$
445.6
million
.
Interest Rate and Fees
Borrowings under the Dollar Term Loan Facility, the Euro Term Loan Facility and the New Revolving Credit Facility bear interest at a rate equal to, at the Company’s option, either (a) the greater of LIBOR for the relevant interest period or
0.00
% per annum, in each case adjusted for statutory reserve requirements, plus an applicable margin or (b) a base rate (the ‘‘Base Rate’’) equal to the highest of (1) the rate of interest publicly announced by the administrative agent as its prime rate in effect at its principal office in Stamford, Connecticut, (2) the federal funds effective rate plus
0.50
% and (3) LIBOR for an interest period of
one month
, adjusted for statutory reserve requirements, plus
1.00
%, in each case, plus an applicable margin. The applicable margin for (i) the Dollar Term Loan Facility is
2.75
% for LIBOR loans and
1.75
% for Base Rate loans, (ii) the Revolving Credit Facility is
2.25
% for LIBOR loans and
1.25
% for Base Rate loans and (iii) the Euro Term Loan Facility is
3.00
% for LIBOR loans.
The applicable margins under the New Revolving Credit Facility may decrease based upon the Company’s achievement of certain Consolidated Senior Secured Debt to Consolidated EBITDA Ratios. In addition to paying interest on outstanding principal under the Senior Secured Credit Facilities, the Company is required to pay a commitment fee of
0.50
% per annum to the lenders under the New Revolving Credit Facility in respect of the unutilized commitments thereunder. The commitment fee rate was reduced to
0.375
% because the Company’s Consolidated Senior Secured Debt to Consolidated EBITDA Ratio is less than or equal to
3.0
to 1.0. The Company must also pay customary letter of credit fees.
Prepayments
The Senior Secured Credit Facilities require the Company to prepay outstanding term loans, subject to certain exceptions, with: (i)
50
% of annual excess cash flow (as defined in the Senior Secured Credit Facilities) commencing with the fiscal year ended December 31, 2014 (which percentage will be reduced to
25
% if the Company’s Secured Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) is less than or equal to
3.50
to 1.00 but greater than
3.00
to 1.00, and which prepayment will not be required if the Secured Debt to Consolidated EBITDA Ratio is less than or equal to
3.00
to 1.00); (ii)
100
% of the net cash proceeds of non-ordinary course asset sales or other dispositions of property, subject to reinvestment rights; and (iii)
100
% of the net cash proceeds of any incurrence of debt, other than proceeds from debt permitted under the Senior Secured Credit Facilities.
The foregoing mandatory prepayments will be applied to the scheduled installments of principal of the Term Loan Facilities in direct order of maturity.
The Company may voluntarily repay outstanding loans under the Senior Secured Credit Facilities at any time without premium or penalty, subject to certain customary conditions, including reimbursements of the lenders’ redeployment costs actually incurred in the case of a prepayment of LIBOR borrowings other than on the last day of the relevant interest period.
Amortization and Final Maturity
The Dollar Term Loan Facility amortizes in equal quarterly installments in aggregate annual amounts equal to
1.00
% of the original principal amount of the Dollar Term Loan Facility, with the balance being payable on July 30, 2024. In June 2018, September 2018 and December 2018 the Company used excess cash to repay $
100.0
million, $
150.0
million and $
73.3
million, respectively, of principal on outstanding borrowings under the Dollar Term Loan Facility. As a result of the June 2018 prepayment, the Company is no longer subject to mandatory quarterly principal installment payments on the Dollar Term Loan Facility. The prepayments resulted in the write-off of unamortized debt issuance costs of $
0.5
million for the year ended December 31, 2018, included in “Loss on extinguishment of debt” in the Consolidated Statements of Operations.
In March
2019,
the Company used excess cash to repay
$
25.0
million
of principal on outstanding borrowings under the Dollar Term Loan Facility.
The Euro Term Loan Facility includes repayments in equal quarterly installments in aggregate annual amounts equal to
1.00
% of the original principal amount of the Euro Term Loan Facility, with the balance being payable on July 30, 2024.
In May 2017, the Company used a portion of the proceeds from the initial public offering to repay $
276.8
million principal amount of outstanding borrowings under the Original Dollar Term Loan Facility at par plus accrued and unpaid interest to the date of prepayment of $
1.5
million. The prepayment resulted in the write-off of unamortized debt issuance costs of $
4.3
million and unamortized discounts of $
0.7
million included in “Loss on extinguishment of debt” in the Consolidated Statements of Operations.
Guarantee and Security
All obligations of the borrowers under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and all of its material, wholly-owned U.S. restricted subsidiaries, with customary exceptions including where providing such guarantees are not permitted by law, regulation or contract or would result in adverse tax consequences.
All obligations of the borrowers under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured, subject to permitted liens and other exceptions, by substantially all of the assets of the borrowers and each guarantor, including but not limited to: (i) a perfected pledge of the capital stock issued by the borrowers and each subsidiary guarantor and (ii) perfected security interests in substantially all other tangible and intangible assets of the borrowers and the guarantors (subject to certain exceptions and exclusions). The obligations of the non-U.S. borrowers are secured by certain assets in jurisdictions outside of the United States.
Certain Covenants and Events of Default
The Senior Secured Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the Company’s ability to: incur additional indebtedness and guarantee indebtedness; create or incur liens; engage in mergers or consolidations; sell, transfer or otherwise dispose of assets; create limitations on subsidiary distributions; pay dividends and distributions or repurchase its own capital stock; and make investments, loans or advances, prepayments of junior financings, or other restricted payments. In addition, certain restricted payments constituting dividends or distributions (subject to certain exceptions) are subject to compliance with a Consolidated Total Debt to Consolidated EBITDA Ratio (as defined in the Senior Secured Credit Facilities) of
5.00
to 1.00. Investments in unrestricted subsidiaries are permitted up to an aggregate amount that does not exceed the greater of $
100.0
million and
25
% of Consolidated EBITDA.
The Revolving Credit Facility also requires the Company’s Consolidated Senior Secured Debt to Consolidated EBITDA Ratio to not exceed
6.25
to 1.00 for each fiscal quarter when outstanding revolving credit loans and swingline loans plus non-cash collateralized letters of credit under the Revolving Credit Facility (excluding (a) letters of credit in an aggregate amount not to exceed $
80.0
million existing on the date of the closing of the Senior Secured Credit Facilities and any extensions thereof, replacement letters of credit or letters of credit issued in lieu thereof, in each case, to the extent the face amount of such letters of credit is not increased above the face amount of the letter of credit being extended, replaced or substituted and (b)
non-cash collateralized letters of credit in an aggregate amount not to exceed Letters of Credit Outstanding on the Amendment No.
4
Effective Date), exceeds (i)
40.0
%
of the aggregate
2019
Revolving Credit Commitments or (ii) prior to the earlier to occur of the satisfaction of the Increased Availability Condition and the
2019
Revolving Commitment Reduction Date,
40.0%
of the lesser of (A)
$
450.0
million and (B) the aggregate
2019
Revolving Credit Commitments.
The Senior Secured Credit Facilities also contain certain customary affirmative covenants and events of default.
Receivables Financing Agreement
In May 2016, the Company entered into the Receivables Financing Agreement, providing for aggregated borrowing of up to $
75.0
million governed by a borrowing base. The Receivables Financing Agreement provides for a lower cost alternative for the issuance of letters of credit with the remaining unused capacity providing additional liquidity. On June 30, 2017, the Company signed the first amendment of the Receivables Financing Agreement which increased the aggregated borrowing capacity by $
50.0
million to $
125.0
million governed by a borrowing base and extended the term to
June 30, 2020
. The Receivables Financing Agreement terminates on June 30, 2020, unless terminated earlier pursuant to its terms. As of December 31, 2019, the Company had
no
outstanding borrowings, $
27.6
million of letters of credit outstanding and $
62.4
million of capacity available under the Receivables Financing Agreement.
Borrowings under the Receivables Financing Agreement accrue interest at a reserve-adjusted LIBOR or a base rate, plus
1.6
%. Letters of credit accrue interest at
1.6
%. The Company may prepay borrowings or letters of credit or draw on the Receivables Financing Agreement upon
business day prior written notice and may terminate the Receivables Financing Agreement with
15
days’ prior written notice.
As part of the Receivables Financing Agreement, eligible accounts receivable of certain of the Company’s subsidiaries are sold to a wholly owned “bankruptcy remote” special purpose vehicle (“SPV”). The SPV pledges the receivables as security for loans and letters of credit. The SPV is included in the Company’s consolidated financial statements and therefore, the accounts receivable owned by it are included in the Company’s Consolidated Balance Sheets. However, the accounts receivable owned by the SPV are separate and distinct from the Company’s other assets and are not available to the Company’s other creditors should the Company become insolvent.
The Receivables Financing Agreement contains various customary representations and warranties and covenants, and default provisions which provide for the termination and acceleration of the commitments and loans under the agreement in circumstances including, but not limited to, failure to make payments when due, breach of representations, warranties or covenants, certain insolvency events or failure to maintain the security interest in the trade receivables, a change in control and defaults under other material indebtedness.
Senior Notes
In May 2017, the Company used a portion of the proceeds from the initial public offering to redeem all $
575.0
million aggregate principal amount of its Senior Notes at a price of
105.156
% of the principal amount redeemed, equal to $
604.6
million, plus accrued and unpaid interest to the date of redemption of $
10.2
million. The redemption of the Senior Notes resulted in the write-off of unamortized debt issuance costs of $
15.8
million which was included in “Loss on extinguishment of debt” in the Consolidated Statements of Operations. The premium paid on the Senior Notes, $
29.7
million, was included in “
Loss on extinguishment of debt
” in the Consolidated Statements of Operations.
Total Debt Maturities
Total debt maturities for the five years subsequent to December 31, 2019 and thereafter are approximately $
7.6
million, $
7.7
million, $
7.8
million, $
7.9
million, $
1,575.0
million and $
13.5
million, respectively.
| Note 11: |
Benefit Plans
|
Pension and Postretirement Benefit Plans
The Company sponsors a number of pension and postretirement plans worldwide. Pension plan benefits are provided to employees under defined benefit pay-related and service-related plans, which are non-contributory in nature. The Company’s funding policy for the U.S. defined benefit pension plans is to contribute at least the minimum required contribution required by Employee Retirement Income Security Act (“ERISA”), as amended by the Pension Protection Act of 2016 (as amended by MAP-21, HAFTA, and BBA 15). The Company intends to make additional contributions, as necessary, to prevent benefit restrictions in the plans. The Company’s annual contributions to the non-U.S. pension plans are consistent with the requirements of applicable local laws.
The Company also provides postretirement healthcare and life insurance benefits in the United States and South Africa to a limited group of current and retired employees. All of the Company’s postretirement benefit plans are unfunded.
|
|
Pension Benefits
|
|||||||||||||||||||||||
|
U.S. Plans
|
Non-U.S. Plans
|
Other Postretirement Benefits
|
||||||||||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||||||||
|
Reconciliation of Benefit Obligations:
|
||||||||||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Service cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Interest cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Plan amendments
|
|
|
|
|
|
|
||||||||||||||||||
|
Actuarial losses (gains)
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Benefit payments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
|
Plan settlements
|
(
|
)
|
(
|
)
|
|
|
|
|
||||||||||||||||
|
Effect of foreign currency exchange rate changes
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
|
Benefit obligations ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Reconciliation of Fair Value of Plan Assets:
|
||||||||||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Actual return on plan assets
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||
|
Employer contributions
|
|
|
|
|
||||||||||||||||||||
|
Plan settlements
|
(
|
)
|
(
|
)
|
|
|
||||||||||||||||||
|
Benefit payments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||
|
Effect of foreign currency exchange rate changes
|
|
|
|
(
|
)
|
|||||||||||||||||||
|
Fair value of plan assets ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Funded Status as of Period End
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||
|
|
U.S. Pension Plans
|
Non-U.S. Pension Plans
|
Other
Postretirement Benefits
|
|||||||||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||||||||
|
Net actuarial losses (gains)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||||||
|
Prior service cost
|
|
|
|
|
|
|
||||||||||||||||||
|
Amounts included in accumulated other comprehensive (loss) income
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||||||||
For defined benefit pension plans, the Company estimates that $
2.9
million of net losses and $
0.2
million of prior service costs will be amortized from accumulated other comprehensive (loss) income into net periodic benefit cost during the year ending December 31, 2020. For other postretirement benefit plans, the Company estimates
no
net losses and prior service costs will be amortized from accumulated other comprehensive (loss) income into net periodic benefit cost during the year ending December 31, 2020.
|
|
2019
|
2018
|
||||||
|
Other assets
|
$
|
|
$
|
|
||||
|
Accrued liabilities
|
(
|
)
|
(
|
)
|
||||
|
Pension and other postretirement benefits
|
(
|
)
|
(
|
)
|
||||
|
|
U.S. Pension Plans
|
Non-U.S. Pension Plans
|
||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
Projected benefit obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Accumulated benefit obligation
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Fair value of plan assets
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
The accumulated benefit obligation for all U.S. defined benefit pension plans was $
59.8
million and $
57.4
million as of December 31, 2019 and 2018, respectively. The accumulated benefit obligation for all non-U.S. defined benefit pension plans was $
339.1
million and $
299.1
million as of December 31, 2019 and 2018, respectively.
|
|
U.S. Pension Plans
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Net Periodic Benefit Cost (Income):
|
||||||||||||
|
Service cost
|
$
|
|
$
|
|
$
|
|
||||||
|
Interest cost
|
|
|
|
|||||||||
|
Expected return on plan assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Amortization of prior-service cost
|
|
|
|
|||||||||
|
Amortization of net actuarial loss
|
|
|
|
|||||||||
|
Net periodic benefit cost (income)
|
|
(
|
)
|
(
|
)
|
|||||||
|
Loss due to settlement
|
|
|
|
|||||||||
|
Total net periodic benefit cost (income) recognized
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
|
||||||||||||
|
Net actuarial (gain) loss
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
Amortization of net actuarial loss
|
(
|
)
|
|
|
||||||||
|
Prior service cost
|
|
|
|
|||||||||
|
Amortization of prior service cost
|
|
|
|
|||||||||
|
Effect of foreign currency exchange rate changes
|
|
|
|
|||||||||
|
Total recognized in other comprehensive (loss) income
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
Total recognized in net periodic benefit (income) cost and other comprehensive (loss) income
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
|
Non-U.S. Pension Plans
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Net Periodic Benefit Cost (Income):
|
||||||||||||
|
Service cost
|
$
|
|
$
|
|
$
|
|
||||||
|
Interest cost
|
|
|
|
|||||||||
|
Expected return on plan assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Amortization of prior-service cost
|
|
|
|
|||||||||
|
Amortization of net actuarial loss
|
|
|
|
|||||||||
|
Net periodic benefit cost (income)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Loss due to curtailments
|
|
|
|
|||||||||
|
Total net periodic benefit cost (income) recognized
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
|
||||||||||||
|
Net actuarial loss (gain)
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Amortization of net actuarial loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Prior service cost
|
|
|
|
|||||||||
|
Amortization of prior service cost
|
(
|
)
|
|
|
||||||||
|
Effect of foreign currency exchange rate changes
|
|
(
|
)
|
|
||||||||
|
Total recognized in other comprehensive (loss) income
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Total recognized in net periodic benefit cost (income) and other comprehensive (loss) income
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
|
Other Postretirement Benefits
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Net Periodic Benefit Cost:
|
||||||||||||
|
Service cost
|
$
|
|
$
|
|
$
|
|
||||||
|
Interest cost
|
|
|
|
|||||||||
|
Expected return on plan assets
|
|
|
|
|||||||||
|
Amortization of prior-service cost
|
|
|
|
|||||||||
|
Amortization of net actuarial loss
|
|
|
|
|||||||||
|
Net periodic benefit cost
|
$
|
|
$
|
|
$
|
|
||||||
|
Loss due to curtailments or settlements
|
|
|
|
|||||||||
|
Total net periodic benefit cost recognized
|
$
|
|
$
|
|
$
|
|
||||||
|
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
|
||||||||||||
|
Net actuarial loss (gain)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Amortization of net actuarial loss
|
|
|
|
|||||||||
|
Prior service cost
|
|
|
|
|||||||||
|
Amortization of prior service cost
|
|
|
|
|||||||||
|
Effect of foreign currency exchange rate changes
|
|
|
|
|||||||||
|
Total recognized in other comprehensive (loss) income
|
$
|
|
$
|
|
$
|
|
||||||
|
Total recognized in net periodic benefit cost and other comprehensive (loss) income
|
$
|
|
$
|
|
$
|
|
||||||
The discount rate selected to measure the present value of the Company’s benefit obligations was derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under a plan. The Company selects the expected long-term rate of return on plan assets in consultation with the plans’ actuaries. This rate is intended to reflect the expected average rate of earnings on the funds invested or to be invested to provide plan benefits and the Company’s most recent plan assets target allocations. The plans are assumed to continue in force for as long as the assets are expected to be invested. In estimating the expected long-term rate of return on plan assets, appropriate consideration is given to historical performance of the major asset classes held or anticipated to be held by the plans and to current forecasts of future rates of return for those asset classes. Because assets are held in qualified trusts, expected returns are not adjusted for taxes.
|
|
Pension Benefits - U.S. Plans
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
|
Expected long-term rate of return on plan assets
|
|
%
|
|
%
|
|
%
|
||||||
|
|
Pension Benefits - Non-U.S. Plans
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
|
Expected long-term rate of return on plan assets
|
|
%
|
|
%
|
|
%
|
||||||
|
Rate of compensation increases
|
|
%
|
|
%
|
|
%
|
||||||
|
|
Other Postretirement Benefits
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
The following weighted-average actuarial assumptions were used to determine benefit obligations for the years ended December 31, 2019 and 2018:
|
|
Pension Benefits - U.S. Plans
|
|||||||
|
2019
|
2018
|
|||||||
|
Discount rate
|
|
%
|
|
%
|
||||
|
|
Pension Benefits - Non-U.S. Plans
|
|||||||
|
2019
|
2018
|
|||||||
|
Discount rate
|
|
%
|
|
%
|
||||
|
Rate of compensation increases
|
|
%
|
|
%
|
||||
|
|
Other Postretirement Benefits
|
|||||||
|
2019
|
2018
|
|||||||
|
Discount rate
|
|
%
|
|
%
|
||||
|
|
Other Postretirement Benefits
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Healthcare cost trend rate assumed for next year
|
|
%
|
|
%
|
|
%
|
||||||
|
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)
|
|
%
|
|
%
|
|
%
|
||||||
|
Year that the date reaches the ultimate trend rate
|
|
|
|
|||||||||
A one-percentage-point increase or decrease in assumed healthcare cost trend rates as of December 31, 2019 would have less than a $
0.1
million impact on total service and interest cost components of net periodic benefit costs and less than a $
0.1
million impact on the postretirement benefit obligation.
|
|
Pension Benefits
|
|||||||||||
|
U.S. Plans
|
Non-U.S.Plans
|
Other Postretirement
Benefits
|
||||||||||
|
2020
|
$
|
|
$
|
|
$
|
|
||||||
|
2021
|
$
|
|
$
|
|
$
|
|
||||||
|
2022
|
$
|
|
$
|
|
$
|
|
||||||
|
2023
|
$
|
|
$
|
|
$
|
|
||||||
|
2024
|
$
|
|
$
|
|
$
|
|
||||||
|
Aggregate 2025-2029
|
$
|
|
$
|
|
$
|
|
||||||
In 2020, the Company expects to contribute approximately $
0.1
million to the U.S. pension plans, approximately $
5.0
million to the non-U.S. pension plans, and $
0.3
million to the other postretirement benefit plans.
Plan Asset Investment Strategy
The Company’s overall investment strategy and objectives for its pension plan assets is to (i) meet current and future benefit payment needs through diversification across asset classes, investing strategies and investment managers to achieve an optimal balance between risk and return and between income and growth of assets through capital appreciation, (ii) secure participant retirement benefits, (iii) minimize reliance on contributions as a source of benefit security, and (iv) maintain sufficient liquidity to pay benefit obligations and proper expenses. The composition of the actual investments in various securities changes over time based on short and long-term investment opportunities. None of the plan assets of Gardner Denver’s defined benefit plans are invested in the Company’s common stock. The Company uses both active and passive investment strategies.
In 2018, the Company modified its investment strategy for the U.S. pension plans to a liabilities driven investment strategy to reduce the impact of market fluctuations by matching the pension plan assets to the present value of the future liabilities.
Plan Asset Risk Management
The target financial objectives for the pension plans are established in conjunction with periodic comprehensive reviews of each plan’s liability structure. The Company’s asset allocation policy is based on detailed asset and liability model (“ALM”) analyses. A formal ALM study of each major plan is undertaken every 2-5 years or whenever there has been a material change in plan demographics, benefit structure, or funded status. In order to determine the recommended asset allocation, the advisors model varying return and risk levels for different theoretical portfolios, using a relative measure of excess return over treasury bills, divided by the standard deviation of the return (the “Sharpe Ratio”). The Sharpe Ratio for different portfolio options was used to compare each portfolio’s potential return, on a risk-adjusted basis. The Company selected a recommended portfolio that achieved the targeted composite return with the least amount of risk.
The Company’s primary pension plans are in the U.S. and UK which together comprise approximately
73
% of the total benefit obligations and
89
% of total plan assets as of December 31, 2019.
The following table presents the long-term target allocations for these two plans as of December 31, 2019.
|
|
U.S. Plan
|
UK Plan
|
||||||
|
Asset category:
|
||||||||
|
Cash and cash equivalents
|
|
%
|
|
%
|
||||
|
Equity
|
|
%
|
|
%
|
||||
|
Fixed income
|
|
%
|
|
%
|
||||
|
Real estate and other
|
|
%
|
|
%
|
||||
|
Total
|
|
%
|
|
%
|
||||
Fair Value Measurements
|
|
December 31, 2019
|
|||||||||||||||||||
|
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
|
Significant
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Investments
Measured at
NAV
(5)
|
Total
|
||||||||||||||||
|
Asset Category
|
||||||||||||||||||||
|
Cash and cash equivalents
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Equity funds:
|
||||||||||||||||||||
|
U.S. large-cap
|
|
|
|
|
|
|||||||||||||||
|
International equity
(2)
|
|
|
|
|
|
|||||||||||||||
|
Total equity funds
|
|
|
|
|
|
|||||||||||||||
|
Fixed income funds:
|
||||||||||||||||||||
|
Corporate bonds - international
|
|
|
|
|
|
|||||||||||||||
|
UK index-linked gilts
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - government securities
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - short duration
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - intermediate duration
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - long corporate
|
|
|
|
|
|
|||||||||||||||
|
Total fixed income funds
|
|
|
|
|
|
|||||||||||||||
|
Other types of investments:
|
||||||||||||||||||||
|
International real estate
(3)
|
|
|
|
|
|
|||||||||||||||
|
Other
(4)
|
|
|
|
|
|
|||||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
|
December 31, 2018
|
|||||||||||||||||||
|
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
|
Significant
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
Investments
Measured at
NAV
(5)
|
Total
|
||||||||||||||||
|
Asset Category
|
||||||||||||||||||||
|
Cash and cash equivalents
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Equity funds:
|
||||||||||||||||||||
|
U.S. large-cap
|
|
|
|
|
|
|||||||||||||||
|
International equity
(2)
|
|
|
|
|
|
|||||||||||||||
|
Total equity funds
|
|
|
|
|
|
|||||||||||||||
|
Fixed income funds:
|
||||||||||||||||||||
|
Corporate bonds - international
|
|
|
|
|
|
|||||||||||||||
|
UK index-linked gilts
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - intermediate duration
|
|
|
|
|
|
|||||||||||||||
|
U.S. fixed income - long corporate
|
|
|
|
|
|
|||||||||||||||
|
Total fixed income funds
|
|
|
|
|
|
|||||||||||||||
|
Other types of investments:
|
||||||||||||||||||||
|
International real estate
(3)
|
|
|
|
|
|
|||||||||||||||
|
Other
(4)
|
|
|
|
|
|
|||||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
| (1) |
|
| (2) |
|
| (3) |
|
| (4) |
|
| (5) |
|
Defined Contribution Plans
The Company also sponsors defined contribution plans at various locations throughout the world. Benefits are determined and funded regularly based on terms of the plans or as stipulated in a collective bargaining agreement. The Company’s full-time salaried and hourly employees in the U.S. are eligible to participate in Company-sponsored defined contribution savings plans, which are qualified plans under the requirements of Section 401(k) of the Internal Revenue Code. The Company’s contributions to the savings plans are in the form of cash. The Company’s total contributions to all worldwide defined contribution plans for the years ended December 31, 2019, 2018, and 2017 were $
19.5
million, $
15.9
million and $
13.7
million, respectively.
Other Benefit Plans
The Company offers a long-term service award program for qualified employees at certain of its non-U.S. locations. Under this program, qualified employees receive a service gratuity (“Jubilee”) payment once they have achieved a certain number of years of service. The Company’s actuarially calculated obligation equaled $
4.3
million and $
4.1
million as of December 31, 2019 and 2018, respectively.
There are various other employment contracts, deferred compensation arrangements, covenants not to compete, and change in control agreements with certain employees and former employees. The liabilities associated with such arrangements are not material to the Company’s consolidated financial statements.
| Note 12: |
Stockholders’ Equity
|
As of December 31, 2019 and 2018,
1,000,000,000
shares of voting common stock were authorized. Shares of common stock outstanding were
205,065,744
and
198,169,855
as of December 31, 2019 and 2018, respectively. The Company is governed by the General Corporation Law of the State of Delaware. All authorized shares of voting common stock have a par value of $
0.01
. Shares of common stock reacquired are considered issued and reported as Treasury shares.
| Note 13: |
Accumulated Other Comprehensive (Loss) Income
|
The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges (consisting of interest rate swaps), net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 11 “Benefit Plans” and Note 18 “Hedging Activities, Derivative Instruments and Credit Risk.”
On January 1, 2019, the Company adopted ASU 2018-02 which reclassified stranded tax effects resulting from the Tax Cuts and Jobs Act from accumulated other comprehensive (loss) income to retained (deficit) earnings. The Company recorded a cumulative-effect adjustment which increased “Accumulated other comprehensive loss” in the Consolidated Balance Sheet by $
8.2
million.
On January 1, 2018, the Company adopted FASB ASU 2017-12,
Derivatives and Hedging (Topic 815) – Targeted Improvements to Accounting for Hedging Activities
using the modified retrospective approach. The Company recorded a cumulative effect-adjustment on the adoption date increasing the opening balance of “Accumulated deficit” in the Consolidated Balance Sheets by $
0.3
million and decreasing “Accumulated other comprehensive loss” in the Consolidated Balance Sheet by $
0.3
million.
The before tax (loss) income and related income tax effect are as follows.
|
|
Foreign
Currency
Translation
Adjustments, Net
|
Unrealized
(Losses) Gains
on Cash Flow
Hedges
|
Pension and
Postretirement
Benefit Plans
|
Total
|
||||||||||||
|
Balance as of December 31, 2016
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Before tax income
|
|
|
|
|
||||||||||||
|
Income tax effect
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Other comprehensive income
|
|
|
|
|
||||||||||||
|
Balance as of December 31, 2017
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Before tax (loss) income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Income tax effect
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
|
Other comprehensive (loss) income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Cumulative effect adjustment upon adoption of new accounting standard (ASU 2017-12)
|
|
|
|
|
||||||||||||
|
Balance as of December 31, 2018
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Before tax income (loss)
|
|
|
(
|
)
|
|
|||||||||||
|
Income tax effect
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
|
Other comprehensive (loss) income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
|
Balance as of December 31, 2019
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Changes in accumulated other comprehensive (loss) income by component for the periods described below are presented in the following table
(1)
.
|
|
Foreign
Currency
Translation
Adjustments, Net
|
Unrealized
Gains (Losses)
on Cash Flow
Hedges
|
Pension and
Postretirement
Benefit Plans
|
Total
|
||||||||||||
|
Balance as of December 31, 2016
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive income before reclassifications
|
|
|
|
|
||||||||||||
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
|
|
|
|
||||||||||||
|
Other comprehensive income
|
|
|
|
|
||||||||||||
|
Balance as of December 31, 2017
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive (loss) income before reclassifications
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
|
|
|
|
||||||||||||
|
Other comprehensive (loss) income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Cumulative effect adjustment upon adoption of new accounting standard (ASU 2017-12)
|
|
|
|
|
||||||||||||
|
Balance as of December 31, 2018
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive loss before reclassifications
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Amounts reclassified from accumulated other comprehensive (loss) income
|
|
|
|
|
||||||||||||
|
Other comprehensive (loss) income
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||
|
Cumulative effect adjustment upon adoption of new accounting standard (ASU 2018-02)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
|
Balance as of December 31, 2019
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
| (1) |
|
Reclassifications out of accumulated other comprehensive (loss) income for the years ended December 31, 2019, 2018 and 2017 are presented in the following table.
|
Amount Reclassified from Accumulated Other Comprehensive (Loss) Income
|
|||||||||||||
|
Details about Accumulated
Other Comprehensive
(Loss) Income Components
|
2019
|
2018
|
2017
|
Affected Line in the
Statement Where Net
Income is Presented
|
|||||||||
|
Loss on cash flow hedges Interest rate swaps
|
$
|
|
$
|
|
$
|
|
Interest expense
|
||||||
|
|
|
|
Total before tax
|
||||||||||
|
(
|
)
|
(
|
)
|
(
|
)
|
Benefit for income taxes
|
|||||||
|
$
|
|
$
|
|
$
|
|
Net of tax
|
|||||||
|
Amortization of defined benefit pension and other postretirement benefit items
|
$
|
|
$
|
|
$
|
|
(1)
|
||||||
|
|
|
|
Total before tax
|
||||||||||
|
(
|
)
|
(
|
)
|
(
|
)
|
Benefit for income taxes
|
|||||||
|
$
|
|
$
|
|
$
|
|
Net of tax
|
|||||||
|
Total reclassifications for the period
|
$
|
|
$
|
|
$
|
|
Net of tax
|
||||||
| (1) |
|
| Note 14: |
Revenue from Contracts with Customers
|
Overview
The Company recognizes revenue when
the Company has satisfied its obligation and
control is transferred to the customer. The amount of revenue recognized includes adjustments for any variable consideration, such as rebates, sales discounts, liquidated damages, etc., which are included in the transaction price, and allocated to each performance obligation. The variable consideration is estimated throughout the course of the contract using the Company’s best estimates. Judgments impacting variable consideration related to material rebate and sales discount programs, and significant contracts containing liquidated damage clauses are governed by management review processes.
The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered.
The Company has certain long duration engineered to order (“ETO”) contracts that require highly engineered solutions designed to customer specific applications. For contracts where the contractual deliverables have no alternative use and the contract termination clauses provide for the recovery of cost plus a reasonable margin, revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations, generally measured as the ratio of actual costs incurred to date to the estimated total costs to complete the contract. For contracts with termination provisions that do not provide for recovery of cost and a reasonable margin, revenue is recognized at a point in time, generally at shipment or delivery to the customer. Identification of performance obligations, determination of alternative use, assessment of contractual language regarding termination provisions, and estimation of total project costs are all significant judgments required in the application of ASC 606.
Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. In the event a contract modification is for goods or services that are not distinct in the contract, and therefore, form part of a single performance obligation that is partially satisfied as of the modification date, the effect of the contract modification on the transaction price and the Company’s measure of progress for the performance obligation to which it relates, is recognized on a cumulative catch-up basis.
Taxes assessed by a government authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Sales commissions are due at either collection of payment from customers or recognition of revenue. Applying the practical expedient from ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations.
Disaggregation of Revenue
The following table provides disaggregated revenue by reportable segment for the year ended December 31, 2019.
|
|
Industrials
|
Energy
|
Medical
|
Total
|
||||||||||||
|
Primary Geographic Markets
|
||||||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other Americas
|
|
|
|
|
||||||||||||
|
Total Americas
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
EMEA
|
|
|
|
|
||||||||||||
|
Asia Pacific
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Product Categories
|
||||||||||||||||
|
Original equipment
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Aftermarket
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Pattern of Revenue Recognition
|
||||||||||||||||
|
Revenue recognized at point in time
(3)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revenue recognized over time
(4)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
The following table provides disaggregated revenue by reportable segment for the year ended December 31, 2018.
|
|
Industrials
|
Energy
|
Medical
|
Total
|
||||||||||||
|
Primary Geographic Markets
|
||||||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other Americas
|
|
|
|
|
||||||||||||
|
Total Americas
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
EMEA
|
|
|
|
|
||||||||||||
|
Asia Pacific
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Product Categories
|
||||||||||||||||
|
Original equipment
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Aftermarket
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Pattern of Revenue Recognition
|
||||||||||||||||
|
Revenue recognized at point in time
(3)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revenue recognized over time
(4)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| (1) |
|
| (2) |
|
| (3) |
|
| (4) |
|
Performance Obligations
The majority of the Company’s contracts have a single performance obligation as the promise to transfer goods and/or services. For contracts with multiple performance obligations, the Company utilizes observable prices to determine standalone selling price or cost plus margin if a standalone price is not available. The Company
has elected to account for shipping and handling activities as fulfillment costs and not a separate performance obligation. If control transfers and related revenue is recognized for the related good before the shipping and handling activities occur, the related costs of those shipping and handling activities are accrued.
The Company’s primary performance obligations include delivering standard or configured to order (“CTO”) goods to customers, designing and manufacturing a broad range of equipment customized to a customer’s specifications in ETO arrangements, rendering of services (maintenance and repair contracts), and certain extended or service type warranties. For incidental items that are immaterial in the context of the contract, costs are expensed as incurred or accrued at delivery.
As of December 31, 2019, for contracts with an original duration greater than one year, the Company expects to recognize revenue in the future related to unsatisfied (or partially satisfied) performance obligations of $
156.3
million in the next
twelve months
and $
52.4
million in periods thereafter. The performance obligations that are unsatisfied (or partially satisfied) are primarily related to orders for goods or services that were placed prior to the end of the reporting period and have not been delivered to the customer, on-going work on ETO contracts where revenue is recognized over time and service contracts with an original duration greater than one year.
Contract Balances
The following table provides the contract balances as of December 31, 2019 and December 31, 2018 presented in the Consolidated Balance Sheets.
|
|
December 31,
2019
|
December 31,
2018
|
||||||
|
Accounts receivable
|
$
|
|
$
|
|
||||
|
Contract assets
|
|
|
||||||
|
Contract liabilities
|
|
|
||||||
Accounts receivable –
Amounts due where the Company’s right to receive cash is unconditional.
Contract assets
– The Company’s rights to consideration for the satisfaction of performance obligations subject to constraints apart from timing. Contract assets are transferred to receivables when the right to collect consideration becomes unconditional. Contract assets are presented net of progress billings and related advances from customers.
Contract liabilities
– Advance payments received from customers for contracts for which revenue is not yet recognized. Contract liability balances are generally recognized in revenue within twelve months.
Contract assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. Contract assets and liabilities are presented net on a contract level, where required.
Payments from customers are generally due 30-60 days after invoicing. Invoicing for sales of standard products generally coincides with shipment or delivery of goods. Invoicing for CTO and ETO contracts typically follows a schedule for billing at contractual milestones. Payment milestones normally include down payments upon the contract signing, completion of product design, completion of customer’s preliminary inspection, shipment or delivery, completion of installation, and customer’s on-site inspection. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets.
The Company has elected the practical expedient from ASC 606-10-32-18 and does not adjust the transaction price for the effects of a financing component if, at contract inception, the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
| Note 15: |
Income Taxes
|
Income (loss) before income taxes for the years ended December 31, 2019, 2018 and 2017 consisted of the following.
|
|
2019
|
2018
|
2017
|
|||||||||
|
U.S.
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
|
Non-U.S.
|
|
|
|
|||||||||
|
Income (loss) before income taxes
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
The following table details the components of the provision (benefit) for income taxes for the years ended December 31, 2019, 2018 and 2017.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Current:
|
||||||||||||
|
U.S. federal
|
$
|
|
$
|
|
$
|
|
||||||
|
U.S. state and local
|
|
|
|
|||||||||
|
Non-U.S.
|
|
|
|
|||||||||
|
Deferred:
|
||||||||||||
|
U.S. federal
|
(
|
)
|
|
(
|
)
|
|||||||
|
U.S. state and local
|
|
(
|
)
|
|
||||||||
|
Non-U.S.
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Provision (benefit) for income taxes
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
Certain prior period amounts within this Note have been reclassified to conform to the current period presentation.
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2019, 2018 and 2017 as follows.
|
|
2019
|
2018
|
2017
|
|||||||||
|
U.S. federal corporate statutory rate
|
|
%
|
|
%
|
|
%
|
||||||
|
State and local taxes, less federal tax benefit
|
|
|
|
|||||||||
|
U.S. deferred change due to U.S. tax law change
|
|
|
|
|||||||||
|
Net effects of foreign tax rate differential
|
|
|
|
|||||||||
|
Sale of subsidiary
|
|
|
(
|
)
|
||||||||
|
Repatriation cost
|
|
(
|
)
|
|
||||||||
|
U.S. transition tax toll charge net of FTC
|
|
(
|
)
|
(
|
)
|
|||||||
|
Global Intangible Low-Tax Income ("GILTI")
|
(
|
)
|
|
|
||||||||
|
ASC 740-30 (formerly APB 23)
|
|
(
|
)
|
|
||||||||
|
Valuation allowance changes
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Uncertain tax positions
|
|
|
|
|||||||||
|
Equity compensation
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Nondeductible foreign interest expense
|
|
|
(
|
)
|
||||||||
|
Capital gain
|
|
|
|
|||||||||
|
Nondeductible acquistion costs
|
|
|
(
|
)
|
||||||||
|
Other, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Effective income tax rate
|
|
%
|
|
%
|
|
%
|
||||||
The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2019 and 2018 are as follows.
|
|
2019
|
2018
|
||||||
|
Deferred Tax Assets:
|
||||||||
|
Reserves and accruals
|
$
|
|
$
|
|
||||
|
Postretirement benefits - pensions
|
|
|
||||||
|
Tax loss carryforwards
|
|
|
||||||
|
Deferred taxes recorded in other comprehensive income
|
|
|
||||||
|
Foreign tax credit carryforwards
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total deferred tax assets
|
|
|
||||||
|
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
|
Deferred Tax Liabilities:
|
||||||||
|
LIFO inventory
|
(
|
)
|
(
|
)
|
||||
|
Property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
|
Intangibles
|
(
|
)
|
(
|
)
|
||||
|
Unremitted foreign earnings
|
(
|
)
|
(
|
)
|
||||
|
Deferred taxes recorded in other comprehensive income
|
(
|
)
|
|
|||||
|
Other
|
(
|
)
|
(
|
)
|
||||
|
Total deferred tax liabilities
|
(
|
)
|
(
|
)
|
||||
|
Net deferred income tax liability
|
$
|
(
|
)
|
$
|
(
|
)
|
||
The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2019 were as follows.
|
|
|
Tax Benefit
|
|
|
Valuation
Allowance
|
|
|
Carryforward
Period Ends
|
||
|
Tax Attributes to be Carried Forward
|
|
|
|
|
|
|
|
|
||
|
U.S. federal net operating loss
|
|
$
|
|
|
|
$
|
|
|
|
Unlimited
|
|
U.S. federal capital loss
|
|
|
|
|
|
|
(
|
|
|
|
|
U.S. federal capital loss
|
|
|
|
|
|
|
(
|
|
-
|
|
|
U.S. federal tax credit
|
|
|
|
|
|
|
(
|
|
-
|
|
|
Alternative minimum tax credit
|
|
|
|
|
|
|
—
|
|
Unlimited
|
|
|
U.S. state and local net operating losses
|
|
|
|
|
|
|
|
|
-
|
|
|
U.S. state and local tax credit
|
|
|
|
|
|
|
|
|
-
|
|
|
Non U.S. net operating losses
|
|
|
|
|
|
|
(
|
|
Unlimited
|
|
|
Non U.S. capital losses
|
|
|
|
|
|
|
(
|
|
Unlimited
|
|
|
Excess interest
|
|
|
|
|
|
|
(
|
|
Unlimited
|
|
|
Other deferred tax assets
|
|
|
|
|
|
|
(
|
|
Unlimited
|
|
|
Total tax carryforwards
|
|
$
|
|
|
|
$
|
(
|
|
|
|
A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2019, 2018 and 2017 are as follows.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Valuation allowance for deferred tax assets at beginning of the period
|
$
|
|
$
|
|
$
|
|
||||||
|
Revaluation and change due to U.S. Tax Reform
|
|
|
|
|||||||||
|
Charged to tax expense
|
(
|
)
|
(
|
)
|
|
|||||||
|
Charged to other accounts
|
|
(
|
)
|
|
||||||||
|
Deductions
(1)
|
|
|
(
|
)
|
||||||||
|
Valuation allowance for deferred tax assets at end of the period
|
$
|
|
$
|
|
$
|
|
||||||
Total unrecognized tax benefits were $
12.5
million, $
11.5
million and $
12.6
million for the years ended December 31, 2019, 2018 and 2017, respectively.
The net increase in this balance primarily relates to increases related to prior-year positions of $
0.6
million and currency fluctuations of $
0.4
million. Included in total unrecognized benefits at December 31, 2019 is $
12.5
million of unrecognized tax benefits that would affect the Company's effective tax rate if recognized, of which
$
0.9
million would be offset by a reduction of a corresponding deferred tax asset. The balance of total unrecognized tax benefits is not expected to significantly increase or decrease within the next twelve months. Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2019, 2018 and 2017.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
||||||
|
Gross increases for tax positions of prior years
|
|
|
|
|||||||||
|
Gross decreases for tax positions of prior years
|
|
|
|
|||||||||
|
Gross increases for tax positions of current year
|
|
|
|
|||||||||
|
Settlements
|
|
|
(
|
)
|
||||||||
|
Lapse of statute of limitations
|
|
(
|
)
|
(
|
)
|
|||||||
|
Changes due to currency fluctuations
|
|
(
|
)
|
|
||||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
||||||
The Company includes interest expense and penalties related to unrecognized tax benefits as part of the provision for income taxes. The Company's income tax liabilities at December 31, 2019 and 2018 include accrued interest and penalties of $
1.3
million and $
0.9
million, respectively.
The statutes of limitations for U.S. Federal tax returns are open beginning with the
tax year, and state returns are open beginning with the
tax year.
The Company is subject to income tax in approximately
35
jurisdictions outside the U.S. The statute of limitations varies by jurisdiction with 2005 being the oldest year still open. The Company's significant operations outside the U.S. are located in the United Kingdom and Germany.
The Company is still under audit in the United Kingdom related to tax years
. During 2019, the Company was notified that the United Kingdom is auditing
tax year. This examination has not been concluded as of the date of these financial statements. In Germany, generally, the tax years
and beyond remain open and
German tax years are currently under audit.
The Company does not assert the ASC 740-30 (formerly APB 23) indefinite reinvestment of the Company’s historical non-U.S. earnings or future non-U.S. earnings. The Company records a deferred foreign tax liability to cover all estimated withholding, state income tax and foreign income tax associated with repatriating all non-U.S. earnings back to the United States. The Company’s deferred income tax liability as of December 31, 2019 was $
7.8
million which primarily consisted of withholding taxes.
| Note 16: |
Leases
|
The Company adopted ASC 842 on January 1, 2019 using the optional transition method. See Note 2 “New Accounting Standards” for further discussion of the adoption.
The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROUs in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets.
At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received.
Subsequent to the commencement date, operating lease liabilities are recorded at the present value of unpaid lease payments discounted at a discount rate established at the commencement date. Due to the absence of an implicit rate in the Company’s lease contracts, an incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread. Operating ROU assets are recorded as the beginning balance less accumulated amortization with accumulated amortization equaling the straight-lined lease expense less the periodic accretion of the lease liability using the effective interest rate method.
Subsequent to the commencement date, financing lease liabilities are increased to reflect interest on the lease liability and decreased for principal lease payments made. The financing ROU asset is measured at cost less amortization expense and any accumulated impairment loss. Amortization expense is calculated on a straight-line basis over the lease term or remaining useful life.
The Company’s lease terms allow for the extension or termination of its leases and accounts for the extension and termination when it is reasonably certain that the Company will exercise the option or terminate the lease. Reassessment of the lease term occurs when there is a significant event or a significant change in circumstances that is within the control of the Company that directly affects whether the Company is reasonably certain to exercise or not to exercise an option to extend or terminate the lease or to purchase the underlying asset.
Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification includes a change to the contractual terms, scope of the lease or the consideration given. In the event that the right to use an additional asset is granted and the lease payments associated with the additional asset are commensurate with the ROU asset’s standalone price, the modification is accounted for as a separate contract and the original contract remains unchanged. In the event that a single lease is modified, the Company reassessed the classification of the modified lease as of the effective date of the modification based on the modified terms and accounts for initial direct costs, lease incentives and any other payments made to or by the Company in connection with the modification in the same manner that items would be accounted for in connection with a new lease. If there is an additional ROU asset included, the lease term is extended or reduced, or the consideration is the only change in the contract, the Company reallocates the remaining consideration in the contract and remeasures the lease liability using a discount rate determined at the effective date of the modification. The remeasured lease liability for the modified lease is an adjustment to the corresponding ROU asset and does not impact the Consolidated Statements of Operations. In the event of a full or partial termination, the carrying value of the ROU asset decreases on a basis proportionate to the full or partial termination and any difference between the reduction in the lease liability and the proportionate reduction of the ROU asset is recognized as a gain or loss at the effective date of the modification.
The Company elected not to recognize short-term leases on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material.
The components of lease expense for the year ended December 31, 2019 was as follows.
|
|
2019
|
|||
|
Operating lease cost
|
$
|
|
||
|
|
||||
|
Finance lease cost
|
||||
|
Amortization of right-of-use assets
|
$
|
|
||
|
Interest on lease liabilities
|
|
|||
|
Total finance lease cost
|
$
|
|
||
|
|
||||
|
Short-term lease cost
|
$
|
|
||
Supplemental cash flow information related to leases for the year ended December 31, 2019 was as follows.
|
|
2019
|
|||
|
Supplemental Cash Flows Information
|
||||
|
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
|
||||
|
Operating cash flows from operating leases
|
$
|
|
||
|
Operating cash flows from finance leases
|
$
|
|
||
|
Financing cash flows from finance leases
|
$
|
|
||
|
Leased Assets Obtained in Exchange for New Operating Lease Liabilities
|
$
|
|
||
Supplemental balance sheet information related to leases was as follows.
|
|
December 31,
2019
|
|||
|
Operating leases
|
||||
|
Other assets
|
$
|
|
||
|
|
||||
|
Accrued liabilities
|
|
|||
|
Other liabilities
|
|
|||
|
Total operating lease liabilities
|
$
|
|
||
|
|
||||
|
Finance Leases
|
||||
|
Property, plant and equipment
|
$
|
|
||
|
|
||||
|
Short-term borrowings and current maturities of long-term debt
|
|
|||
|
Long-term debt, less current maturities
|
|
|||
|
Total finance lease liabilities
|
$
|
|
||
|
|
||||
|
Weighted Average Remaining Lease Term (in years)
|
||||
|
Operating leases
|
|
|||
|
Finance leases
|
|
|||
|
|
||||
|
Weighted Average Discount Rate
|
||||
|
Operating leases
|
|
%
|
||
|
Finance leases
|
|
%
|
||
Maturities of lease liabilities as of December 31, 2019 were as follows.
|
|
Operating
Leases
|
Finance
Leases
|
||||||
|
2020
|
$
|
|
$
|
|
||||
|
2021
|
|
|
||||||
|
2022
|
|
|
||||||
|
2023
|
|
|
||||||
|
2024
|
|
|
||||||
|
Thereafter
|
|
|
||||||
|
Total lease payments
|
$
|
|
$
|
|
||||
|
Less imputed interest
|
(
|
)
|
(
|
)
|
||||
|
Total
|
$
|
|
$
|
|
||||
As of December 31, 2018, future minimum rental payments for operating leases for the five years subsequent to December 31, 2018 and thereafter were approximately $
25.8
million, $
19.5
million, $
13.9
million, $
7.7
million, $
5.4
million and $
9.4
million, respectively. As of December 31, 2018, future minimum rental payments for capital leases for the five years subsequent to December 31, 2018 and thereafter were approximately $
0.8
million, $
1.0
million, $
1.1
million, $
1.2
million, $
1.4
million and $
20.7
million, respectively.
| Note 17: |
Stock-Based Compensation Plans
|
The Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan (“2017 Plan”). Following the Company’s initial public offering, the Company grants stock-based compensation awards pursuant to the 2017 Plan and ceased granting new awards pursuant to the 2013 Plan.
2017 Omnibus Incentive Plan
In May 2017, the Company’s Board approved the 2017 Plan. Under the terms of the Plan, the Company’s Board may grant up to
8.6
million stock based and other incentive awards. Any shares of common stock subject to outstanding awards granted under the Company’s 2013 plan that, after the effective date of the 2017 Plan, expire or are otherwise forfeited or terminated in accordance with their terms are also available for grant under the 2017 Plan. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards typically vest over
or
five years
and expire
ten years
from the date of grant.
2013 Stock Incentive Plan
The Company adopted the 2013 Plan on October 14, 2013 as amended on April 27, 2015 under which the Company had the ability to grant stock-based compensation awards to employees, directors and advisors. The total number of shares available for grant under the 2013 Plan and reserved for issuance was
20.9
million shares. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards vested over either five, four, or three years with
50
% of each award vesting based on time and
50
% of each award vesting based on the achievement of certain financial targets.
Prior to the Company’s initial public offering in May 2017, the Company had certain repurchase rights on stock acquired through the exercise of a stock option that created an implicit service period and created a condition in which an optionee did not receive the economic benefits of the option until the repurchase rights were eliminated. Before the elimination of the repurchase rights,
no
compensation expense was recorded for equity awards. The Company recognized a liability for compensation expense measured at intrinsic value when it was probable that an employee would receive benefits under the terms of the plan due to the termination of employment. The repurchase rights creating the implicit service period were eliminated at the initial public offering.
Stock-Based Compensation Expense
The Company recognized
$
19.2
million
,
$
2.8
million
and
$
77.6
million
of stock-based compensation expense for the years ended December
31, 2019, 2018
and
2017.
For the year ended December
31, 2019,
the
$
19.2
million
of stock-based compensation expense included expense for modifications of certain equity awards for certain former employees of
$
1.0
million
, expense for equity awards granted under the
2013
Plan and
2017
Plan of
$
10.2
million
and an increase in the liability for stock appreciation rights (“SAR”) of
$
8.0
million
. The
$
1.0
million
of stock-based compensation expense for modifications provided continued vesting through scheduled vesting dates of certain equity awards for certain former employees. These costs are included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations.
For the year ended December
31, 2018,
the
$
2.8
million
of stock-based compensation expense included expense for modifications of equity awards for certain former
employees of $
3.8
million and expense for equity awards granted under the 2013 Plan and 2017 Plan of $
7.2
million reduced by a benefit for a reduction in the liability for SARs of $
8.2
million. The $
3.8
million of stock-based compensation expense for modifications provided continued vesting through scheduled vesting dates and extended expiration dates for certain former employees. The incremental stock-based compensation was determined using the Black-Scholes option pricing model based on assumptions which included expected lives of
1.0
to
1.3
years, a risk-free rate of
2.0
%, assumed volatility of
26.8
% to
27.3
% and an expected dividend rate of
0.0
%.
For the year ended December 31, 2017, the Company recognized stock-based compensation expense of approximately $
77.6
million.
As of December 31, 2019, there was $
30.0
million of total unrecognized compensation expense related to outstanding stock options and restricted stock awards.
SARs, granted under the 2013 Plan are expected to be settled in cash and are accounted for as liability awards. As of December 31, 2019 and 2018 a liability of approximately $
7.8
million and $
7.9
million, respectively, for SARs was included in “Accrued liabilities” in the Consolidated Balance Sheets.
Stock Option Awards
A summary of the Company’s stock option (including SARs) activity for the year ended December 31, 2019 is presented in the following table (underlying shares in thousands).
|
Stock-Based Compensation Awards
|
||||||||||||||||
|
|
Shares
|
Weighted-Average
Exercise Price
(per share)
|
Wtd. Avg.
Remaining
Contractual
Term (years)
|
Aggregate
Intrisic Value
of In-The-Money
Options (in millions)
|
||||||||||||
|
Outstanding at December 31, 2018
|
|
$
|
|
|||||||||||||
|
Granted
|
|
$
|
|
|||||||||||||
|
Excercised or Settled
|
(
|
)
|
$
|
|
||||||||||||
|
Forfeited
|
(
|
)
|
$
|
|
||||||||||||
|
Expired
|
(
|
)
|
$
|
|
||||||||||||
|
Outstanding at December 31, 2019
|
|
$
|
|
|
$
|
|
||||||||||
|
Vested at December 31, 2019
|
|
$
|
|
|
$
|
|
||||||||||
The per-share weighted average grant date fair value of stock options granted during the years ended December 31, 2019, 2018 and 2017 was $
10.16
, $
13.67
and $
9.16
, respectively.
The total intrinsic value of stock options exercised was $
109.8
million, $
20.8
million and $
5.8
million during the years ended December 31, 2019, 2018 and 2017, respectively.
The following assumptions were used to estimate the fair value of options and SARs granted during the years ended December 31, 2019, 2018 and 2017.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Assumptions:
|
||||||||||||
|
Expected life of options (in years)
|
|
|
|
|||||||||
|
Risk-free interest rate
|
|
%
|
|
%
|
|
%
|
||||||
|
Assumed volatility
|
|
%
|
|
%
|
|
%
|
||||||
|
Expected dividend rate
|
|
%
|
|
%
|
|
%
|
||||||
Restricted Stock Unit Awards
A summary of the Company’s restricted stock unit activity for the year ended December 31, 2019 is presented in the following table (underlying shares in thousands).
|
|
Shares
|
Weighted-Average
Grant-Date
Fair Value
|
||||||
|
Non-vested as of December 31, 2018
|
|
$
|
|
|||||
|
Granted
|
|
$
|
|
|||||
|
Vested
|
(
|
)
|
$
|
|
||||
|
Forfeited
|
(
|
)
|
$
|
|
||||
|
Non-vested as of December 31, 2019
|
|
$
|
|
|||||
Deferred Stock Units
Concurrent with the Company’s initial public offering in May of 2017, the Company’s Board authorized the grant of
5.5
million deferred stock units (“DSU”) to all permanent employees that had not previously received stock-based awards under the 2013 Plan. While the DSUs vested immediately upon grant, they contained restrictions such that the employee may not sell or otherwise realize the economic benefits of the award until certain dates through May 2019. $
97.4
million of compensation expense for the DSU awards was recognized in the year ended December 31, 2017 and included in “Other operating expense, net” in the Consolidated Statements of Operations.
As of the date of the grant, the fair value of a DSU was determined to be $
17.20
assuming a share price at the pricing date of the initial public offering of $
20.00
and a discount for lack of marketability commensurate with the period of the sale restrictions. The Company estimated the fair value of DSUs at the time of grant using the Finnerty discount for lack of marketability pricing model. The model assumed a holding restriction period of
1.42
years and volatility of
51.5
%.
| Note 18: |
Hedging Activities, Derivative Instruments and Credit Risk
|
Hedging Activities
The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including foreign currency forward contracts and interest rate swaps, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes. Fluctuations in interest rates and foreign currency exchange rates can be volatile, and the Company’s risk management activities do not totally eliminate these risks. Consequently, these fluctuations could have a significant effect on the Company’s financial results.
The Company’s exposure to interest rate risk results primarily from its variable-rate borrowings. The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using pay-fixed interest rate swaps as cash flow hedges of variable rate debt in order to adjust the relative fixed and variable proportions.
A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. Other than the USD, the EUR, GBP, and Chinese Renminbi are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company has certain U.S. subsidiaries borrow in currencies other than the USD.
The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances monthly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of European and other currencies generally mature within
one year
.
Derivative Instruments
The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2019 and December 31, 2018.
|
|
December 31, 2019
|
||||||||||||||||||||
|
Derivative
Classification
|
Notional
Amount
(1)
|
Fair Value
(1)
Other Current
Assets
|
Fair Value
(1)
Other Assets
|
Fair Value
(1)
Accrued
Liabilities
|
Fair Value
(1)
Other
Liabilities
|
||||||||||||||||
|
Derivatives Designated as Hedging Instruments
|
|||||||||||||||||||||
|
Interest rate swap contracts
|
Cash Flow
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
|||||||||||||||||||||
|
Foreign currency forwards
|
Fair Value
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Foreign currency forwards
|
Fair Value
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
|
December 31, 2018
|
||||||||||||||||||||
|
Derivative
Classification
|
Notional
Amount
(1)
|
Fair Value
(1)
Other Current
Assets
|
Fair Value
(1)
Other Assets
|
Fair Value
(1)
Accrued
Liabilities
|
Fair Value
(1)
Other
Liabilities
|
||||||||||||||||
|
Derivatives Designated as Hedging Instruments
|
|||||||||||||||||||||
|
Interest rate swap contracts
|
Cash Flow
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
|||||||||||||||||||||
|
Foreign currency forwards
|
Fair Value
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
|
Foreign currency forwards
|
Fair Value
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
| (1) |
|
Gains and losses on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive (Loss) Income for the years ended December 31, 2019, 2018 and 2017 are presented in the table below.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Interest Rate Swap Contracts
|
||||||||||||
|
(Loss) gain recognized in AOCI on derivatives
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Loss reclassified from AOCI into income (effective portion)
(1)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Loss reclassified from AOCI into income (missed forecast)
(2)
|
|
(
|
)
|
|
||||||||
| (1) |
|
| (2) |
|
As of December 31, 2019, the Company was the fixed rate payor on
four
interest rate swap contracts that effectively fix the LIBOR-based index used to determine the interest rates charged on a total of
$
825.0
million of the Company’s LIBOR-based variable rate borrowings. These contracts carry fixed rates ranging from
3.6
% to
4.3
% and expire in 2020
. These swap agreements qualify as hedging instruments and have been designated as cash flow hedges of forecasted LIBOR-based interest payments. Based on LIBOR-based swap yield curves as of December 31, 2019, the Company expects to reclassify losses of $
14.1
million out of AOCI into earnings during the next 12 months. The Company’s LIBOR-based variable rate borrowings outstanding as of December 31, 2019 were $
927.6
million and €
601.2
million.
The Company had
six
foreign currency forward contracts outstanding as of December 31, 2019 with notional amounts ranging from $
10.0
million to $
56.1
million. These contracts are used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Consolidated Balance Sheets. The amount available to be netted is not material.
The Company’s (losses) gains on derivative instruments not designated as accounting hedges and total net foreign currency transaction (losses) gains for the years ended December 31, 2019, 2018 and 2017 were as follows.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Foreign currency forward contracts (losses) gains
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
Total foreign currency transaction (losses) gains, net
|
(
|
)
|
|
(
|
)
|
|||||||
The Company has a significant investment in consolidated subsidiaries with functional currencies other than the USD, particularly the EUR. On August 17, 2017, the Company designated the €
615.0
million Euro Term Loan as a hedge of the Company’s net investment in subsidiaries with EUR functional currencies. As of December 31, 2019, the Euro Term Loan of €
601.2
million remained designated.
The Company’s gains, net of income tax, associated with changes in the value of debt for the years ended December 31, 2019 and 2018, and the net balance of such gains included in accumulated other comprehensive (loss) income as of December 31, 2019 and 2018 were as follows.
|
|
2019
|
2018
|
||||||
|
Gain, net of income tax, recorded through other comprehensive income
|
$
|
|
$
|
|
||||
|
Balance included in accumulated other comprehensive (loss) income as of December 31, 2019 and 2018, respectively
|
|
|
||||||
With the exception of the cash proceeds from the termination of the cross currency interest rate swap contracts described earlier, all cash flows associated with derivatives are classified as operating cash flows in the Consolidated Statements of Cash Flows.
There were
no
off-balance sheet derivative instruments as of December 31, 2019 or 2018.
Credit Risk
Credit risk related to derivatives arises when amounts receivable from a counterparty exceed those payable. Because the notional amount of the derivative instruments only serves as a basis for calculating amounts receivable or payable, the risk of loss with any counterparty is limited to a fraction of the notional amount. The Company minimizes the credit risk related to derivatives by transacting only with multiple, high-quality counterparties that are major financial institutions with investment-grade credit ratings. The Company has not experienced any financial loss as a result of counterparty nonperformance in the past. The majority of the derivative contracts to which the Company is a party, settle monthly or quarterly, or mature within one year. Because of these factors, the Company believes it has minimal credit risk related to derivative contracts as of December 31, 2019.
Concentrations of credit risk with respect to trade receivables are limited due to the wide variety of customers and industries to which the Company’s products and services are sold, as well as their dispersion across many different geographic areas. As a result, the Company does not believe it has any significant concentrations of credit risk as of December 31, 2019 or 2018.
| Note 19: |
Fair Value Measurements
|
A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows.
| Level 1 |
Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date.
|
| Level 2 |
Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.
|
| Level 3 |
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
|
The Company assessed indefinite-lived intangible assets, trademarks, in conjunction with the 2019 and 2018 annual goodwill impairment tests. The valuation of trademarks was based upon current sales projections and the relief from royalty method was applied. No impairment charges were recorded as a result of these analyses. Each trademark carrying value was in excess of its fair value
for the 2019 and 2018 annual goodwill impairment tests
.
The Company assessed indefinite-lived intangible assets, trademarks, in conjunction with the 2017 annual goodwill impairment test. The valuation of trademarks was based upon current sales projections and the relief from royalty method was applied. As a result of this analysis, trademarks with carrying amounts aggregating to $
36.7
were written down to their estimated fair value of $
35.2
million. These represented Level 3 assets measured on a nonrecurring basis subsequent to their original recognition. This resulted in a total non-cash impairment charge of $
1.5
million. The fair value was determined using the relief from royalty method.
Refer to Note 1 “Summary of Significant Accounting Policies” for a discussion of the valuation assumptions utilized in the valuation of goodwill and indefinite-lived intangible assets.
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis.
|
|
December 31, 2019
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Financial Assets
|
||||||||||||||||
|
Foreign currency forwards
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Trading securities held in deferred compensation plan
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Financial Liabilities
|
||||||||||||||||
|
Foreign currency forwards
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Interest rate swaps
(3)
|
|
|
|
|
||||||||||||
|
Deferred compensation plan
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
December 31, 2018
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Financial Assets
|
||||||||||||||||
|
Foreign currency forwards
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Trading securities held in deferred compensation plan
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Financial Liabilities
|
||||||||||||||||
|
Foreign currency forwards
(1)
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Interest rate swaps
(3)
|
|
|
|
|
||||||||||||
|
Deferred compensation plan
(2)
|
|
|
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
| (1) |
|
| (2) |
|
| (3) |
|
| Note 20: |
Contingencies
|
The Company is a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of its size and sector. The Company believes that such proceedings, lawsuits and administrative actions will not materially adversely affect its operations, financial condition, liquidity or competitive position. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth below.
Asbestos and Silica Related Litigation
The Company has been named as a defendant in a number of asbestos-related and silica-related personal injury lawsuits. The plaintiffs in these suits allege exposure to asbestos or silica from multiple sources and typically the Company is one of approximately
25
or more named defendants.
Predecessors to the Company sometimes manufactured, distributed and/or sold products allegedly at issue in the pending asbestos and silica-related lawsuits (the “Products”). However, neither the Company nor its predecessors ever mined, manufactured, mixed, produced or distributed asbestos fiber or silica sand, the materials that allegedly caused the injury underlying the lawsuits. Moreover, the asbestos-containing components of the Products, if any, were enclosed within the subject Products.
Although the Company has never mined, manufactured, mixed, produced or distributed asbestos fiber or silica sand nor sold products that could result in a direct asbestos or silica exposure, many of the companies that did engage in such activities or produced such products are no longer in operation. This has led to law firms seeking potential alternative companies to name in lawsuits where there has been an asbestos or silica related injury.
The Company believes that the pending and future asbestos and silica-related lawsuits are not likely to, in the aggregate, have a material adverse effect on its consolidated financial position, results of operations or liquidity, based on: the Company’s anticipated insurance and indemnification rights to address the risks of such matters; the limited potential asbestos exposure from the Products described above; the Company’s experience that the vast majority of plaintiffs are not impaired with a disease attributable to alleged exposure to asbestos or silica from or relating to the Products or for which the Company otherwise bears responsibility; various potential defenses available to the Company with respect to such matters; and the Company’s prior disposition of comparable matters. However, inherent uncertainties of litigation and future developments, including, without limitation, potential insolvencies of insurance companies or other defendants, an adverse determination in the Adams County Case (discussed below), or other inability to collect from the Company’s historical insurers or indemnitors, could cause a different outcome. While the outcome of legal proceedings is inherently uncertain, based on presently known facts, experience, and circumstances, the Company believes that the amounts accrued on its balance sheet are adequate and that the liabilities arising from the asbestos and silica-related personal injury lawsuits will not have a material adverse effect on the Company’s consolidated financial position, results of operations or liquidity. “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets include a total litigation reserve of $
118.1
million and $
105.8
million as of December 31, 2019 and December 31, 2018 respectively, with regards to potential liability arising from the Company’s asbestos-related litigation. Asbestos related defense costs are excluded from the asbestos claims liability and are recorded separately as services are incurred. In the event of unexpected future developments, it is possible that the ultimate resolution of these matters may be material to the Company’s consolidated financial position, results of operation or liquidity.
The Company has entered into a series of agreements with certain of its or its predecessors’ legacy insurers and certain potential indemnitors to secure insurance coverage and/or reimbursement for the costs associated with the asbestos and silica-related lawsuits filed against the Company. The Company has also pursued litigation against certain insurers or indemnitors, where necessary. The Company has an insurance recovery receivable for probable asbestos related recoveries of approximately $
122.4
million and $
103.0
million as of December 31, 2019 and December 31, 2018, respectively, which was included in “Other assets” in the Consolidated Balance Sheets. During the year ended December 31, 2018, the Company received asbestos related insurance recoveries of $
14.4
million, of which $
6.2
million related to the recovery of indemnity payments, and was recorded as a reduction of the insurance recovery receivable in “Other assets” in the Consolidated Balance Sheets, and $
8.2
million related to the reimbursement of previously expensed legal defense costs, and was recorded as a reduction of “Selling and administrative expenses” in the Consolidated Statements of Operations.
The largest such recent action, Gardner Denver, Inc. v. Certain Underwriters at Lloyd’s, London, et al., was filed on July 9, 2010, in the Eighth Judicial Circuit, Adams County, Illinois, as case number 10-L-48 (the “Adams County Case”). In the lawsuit, the Company seeks, among other things, to require certain excess insurer defendants to honor their insurance policy obligations to the Company, including payment in whole or in part of the costs associated with the asbestos-related lawsuits filed against the Company. In October 2011, the Company reached a settlement with one of the insurer defendants, which had issued both primary and excess policies, for approximately the amount of such defendant’s policies that were subject to the lawsuit. Since then, the case has been proceeding through the discovery and motions process with the remaining insurer defendants. On January 29, 2016, the Company prevailed on the first phase of that discovery and motions process (“Phase I”). Specifically, the Court in the Adams County Case ruled that the Company has rights under all of the policies in the case, subject to their terms and conditions, even though the policies were sold to the Company’s former owners rather than to the Company itself. On June 9, 2016, the Court denied a motion by several of the insurers who sought permission to appeal the Phase I ruling immediately rather than waiting until the end of the whole case as is normally required. The case is now proceeding through the discovery process regarding the remaining issues in dispute (“Phase II”).
A majority of the Company’s expected future recoveries of the costs associated with the asbestos-related lawsuits are the subject of the Adams County Case.
The amounts recorded by the Company for asbestos-related liabilities and insurance recoveries are based on currently available information and assumptions that the Company believes are reasonable based on an evaluation of relevant factors. The actual liabilities or insurance recoveries could be higher or lower than those recorded if actual results vary significantly from the assumptions. There are a number of key variables and assumptions including the number and type of new claims to be filed each year, the resolution or outcome of these claims, the average cost of resolution of each new claim, the amount of insurance available, allocation methodologies, the contractual terms with each insurer with whom the Company has reached settlements, the resolution of coverage issues with other excess insurance carriers with whom the Company has not yet achieved settlements, and the solvency risk with respect to the Company’s insurance carriers. Other factors that may affect the future liability include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, legal rulings that may be made by state and federal courts, and the passage of state or federal legislation. The Company makes the necessary adjustments for the asbestos liability and corresponding insurance recoveries on an annual basis unless facts or circumstances warrant assessment as of an interim date.
Environmental Matters
The Company has been identified as a potentially responsible party (“PRP”) with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. Persons potentially liable for such costs and damages generally include the site owner or operator and persons that disposed or arranged for the disposal of hazardous substances found at those sites. Although these laws impose joint and several liability on PRPs, in application the PRPs typically allocate the investigation and cleanup costs based upon the volume of waste contributed by each PRP. Based on currently available information, the Company was only a small contributor to these waste sites, and the Company has, or is attempting to negotiate, de minimis settlements for their cleanup. The cleanup of the remaining sites is substantially complete and the Company’s future obligations entail a share of the sites’ ongoing operating and maintenance expense. The Company is also addressing
four
on-site cleanups for which it is the primary responsible party.
Three
of these cleanup sites are in the operation and maintenance stage and
one
is in the implementation stage.
The Company has undiscounted accrued liabilities of $
6.6
million and $
6.9
million as of December 31, 2019 and December 31, 2018, respectively, on its Consolidated Balance Sheets to the extent costs are known or can be reasonably estimated for its remaining financial obligations for the environmental matters discussed above and does not anticipate that any of these matters will result in material additional costs beyond amounts accrued. Based upon consideration of currently available information, the Company does not anticipate any material adverse effect on its results of operations, financial condition, liquidity or competitive position as a result of compliance with federal, state, local or foreign environmental laws or regulations, or cleanup costs relating to these matters.
| Note 21: |
Other Operating Expense
|
The components of “Other operating expense, net”
for the years ended December 31, 2019, 2018 and 2017
were as follows.
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Other Operating Expense, Net
|
||||||||||||
|
Foreign currency transaction losses (gains), net
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Restructuring charges
(1)
|
|
|
|
|||||||||
|
Environmental remediation expenses
(2)
|
|
|
|
|||||||||
|
Shareholder litigation settlement recoveries
(3
|
(
|
)
|
(
|
)
|
|
|||||||
|
Acquisition related expenses and non-cash charges
(4)
|
|
|
|
|||||||||
|
(Gains) losses on asset and business disposals
|
|
(
|
)
|
|
||||||||
|
Other, net
(5)
|
|
(
|
)
|
|
||||||||
|
Total other operating expense, net
|
$
|
|
$
|
|
$
|
|
||||||
Certain prior period amounts have been reclassified to conform to the current period presentation.
| (1) |
|
| (2) |
|
| (3) |
|
| (4) |
|
| (5) |
|
| Note 22: |
Segment Reporting
|
A description of the Company’s
three
reportable segments, including the specific products manufactured and sold follows below.
In the Industrials segment, the Company designs, manufactures, markets and services a broad range of air compression, vacuum and blower products across a wide array of technologies and applications. Almost every manufacturing and industrial facility, and many service and process industries, use air compression and vacuum products in a variety of applications such as operation of pneumatic air tools, vacuum packaging of food products and aeration of waste water. The Company maintains a leading position in its markets and serves customers globally. The Company offers comprehensive aftermarket parts and an experienced direct and distributor-based service network world-wide to complement all of its products.
In the Energy segment, the Company designs, manufactures, markets and services a diverse range of positive displacement pumps, liquid ring vacuum pumps and compressors, and engineered loading systems and fluid transfer equipment, consumables, and associated aftermarket parts and services. It serves customers in the upstream, midstream, and downstream oil and gas markets, and various other markets including petrochemical processing, power generation, transportation, and general industrial. The Company is one of the largest suppliers in these markets and has long-standing customer relationships. Its positive displacement pumps are used in the oilfield for drilling, hydraulic fracturing, completion and well servicing. Its liquid ring vacuum pumps and compressors are used in many power generation, mining, oil and gas refining and processing, chemical processing and general industrial applications including flare gas and vapor recovery, geothermal gas removal, vacuum de-aeration, enhanced oil recovery, water extraction in mining and paper and chlorine compression in petrochemical operations. Its engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials.
In the Medical segment, the Company designs, manufactures and markets a broad range of highly specialized gas, liquid and precision syringe pumps and compressors primarily for use in the medical, laboratory and biotechnology end markets. The Company’s customers are mainly medium and large durable medical equipment suppliers that integrate the Company’s products into their final equipment for use in applications such as oxygen therapy, blood dialysis, patient monitoring, wound treatment, and others. Further, with the recent acquisitions, the Company has expanded into liquid handling components and systems used in biotechnology applications including clinical analysis instrumentation. The Company also has a broad range of end use deep vacuum products for laboratory science applications.
The Chief Operating Decision Maker (“CODM”) evaluates the performance of the Company’s reportable segments based on, among other measures, Segment Adjusted EBITDA. Management closely monitors the Segment Adjusted EBITDA of each reportable segment to evaluate past performance and actions required to improve profitability. Inter-segment sales and transfers are not significant. Administrative expenses related to the Company’s corporate offices and shared service centers in the United States and Europe, which includes transaction processing, accounting and other business support functions, are allocated to the business segments. Certain administrative expenses, including senior management compensation, treasury, internal audit, tax compliance, certain information technology, and other corporate functions, are not allocated to the business segments.
The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income (Loss) Before Income Taxes for the years ended December 31, 2019, 2018 and 2017.
|
|
2019
|
2018
|
2017
|
|||||||||
|
Revenue
|
||||||||||||
|
Industrials
|
$
|
|
$
|
|
$
|
|
||||||
|
Energy
|
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Total Revenue
|
$
|
|
$
|
|
$
|
|
||||||
|
Segment Adjusted EBITDA
|
||||||||||||
|
Industrials
|
$
|
|
$
|
|
$
|
|
||||||
|
Energy
|
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Total Segment Adjusted EBITDA
|
|
|
|
|||||||||
|
Less items to reconcile Segment Adjusted EBITDA to Income (Loss) Before Income Taxes:
|
||||||||||||
|
Corporate expenses not allocated to segments
(1)
|
|
|
|
|||||||||
|
Interest expense
|
|
|
|
|||||||||
|
Depreciation and amortization expense
|
|
|
|
|||||||||
|
Impairment of other intangible assets
(2)
|
|
|
|
|||||||||
|
KKR fees and expenses
(3)
|
|
|
|
|||||||||
|
Restructuring and related business transformation costs
(4)
|
|
|
|
|||||||||
|
Acquisition related expenses and non-cash charges
(5)
|
|
|
|
|||||||||
|
Environmental remediation loss reserve
(6)
|
|
|
|
|||||||||
|
Expenses related to public stock offerings
(7)
|
|
|
|
|||||||||
|
Establish public company financial reporting compliance
(8)
|
|
|
|
|||||||||
|
Stock-based compensation
(9)
|
|
(
|
)
|
|
||||||||
|
Loss on extinguishment of debt
(10)
|
|
|
|
|||||||||
|
Foreign currency transaction losses (gains), net
|
|
(
|
)
|
|
||||||||
|
Shareholder litigation settlement recoveries
(11)
|
(
|
)
|
(
|
)
|
|
|||||||
|
Other adjustments
(12)
|
|
|
|
|||||||||
|
Income (Loss) Before Income Taxes
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
| (1) |
|
| (2) |
|
| (3) |
|
| (4) |
|
|
|
Year Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Restructuring charges
|
$
|
|
$
|
|
$
|
|
||||||
|
Severance, sign-on, relocation and executive search costs
|
|
|
|
|||||||||
|
Facility reorganization, relocation and other costs
|
|
|
|
|||||||||
|
Information technology infrastructure transformation
|
|
|
|
|||||||||
|
Losses (gains) on asset and business disposals
|
|
(
|
)
|
|
||||||||
|
Consultant and other advisor fees
|
|
|
|
|||||||||
|
Other, net
|
|
|
|
|||||||||
|
Total restructuring and related business transformation costs
|
$
|
|
$
|
|
$
|
|
||||||
| (5) |
|
| (6) |
|
| (7) |
|
| (8) |
|
| (9) |
Represents stock-based compensation expense recognized for stock options outstanding for the year ended December 31, 2019 of $
|
Represents stock-based compensation expense recognized for stock options outstanding for the year ended December 31, 2018 of $
2.8
million, reduced by $
5.1
million primarily due to a decrease in the estimated accrual for employer taxes related to DSUs as a result of a lower per share stock price.
Represents stock-based compensation expense recognized for the year ended December 31, 2017 for stock options outstanding of $
77.6
million and DSUs granted to employees at the date of the initial public offering of $
97.4
million and employer taxes related to DSUs granted to employees at the date of the initial public offering of $
19.2
million.
| (10) |
|
| (11) |
|
| (12) |
|
The following tables provide summarized information about the Company’s reportable segments.
Identifiable Assets
|
|
2019
|
2018
|
2017
|
|||||||||
|
Industrials
|
$
|
|
$
|
|
$
|
|
||||||
|
Energy
|
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Total
|
|
|
|
|||||||||
|
General corporate (unallocated)
|
|
|
|
|||||||||
|
Total identifiable assets
|
$
|
|
$
|
|
$
|
|
||||||
Depreciation and Amortization Expense
|
|
2019
|
2018
|
2017
|
|||||||||
|
Industrials
|
$
|
|
$
|
|
$
|
|
||||||
|
Energy
|
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Total depreciation and amortization expense
|
$
|
|
$
|
|
$
|
|
||||||
Capital Expenditures
|
|
2019
|
2018
|
2017
|
|||||||||
|
Industrials
|
$
|
|
$
|
|
$
|
|
||||||
|
Energy
|
|
|
|
|||||||||
|
Medical
|
|
|
|
|||||||||
|
Total capital expenditures
|
$
|
|
$
|
|
$
|
|
||||||
The following table presents property, plant and equipment by geographic region for the years ended December 31, 2019, 2018 and 2017.
|
|
Property, Plant and Equipment, net
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
||||||
|
Other Americas
|
|
|
|
|||||||||
|
Total Americas
|
|
|
|
|||||||||
|
EMEA
(1)
|
|
|
|
|||||||||
|
Asia Pacific
|
|
|
|
|||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
||||||
| Note 23: |
Related Party
|
Affiliates of KKR participated as (i) a lender in the Company’s Senior Secured Credit Facilities discussed in Note 10 “Debt,” (ii) an underwriter in the Company’s initial public offering and its secondary offering by certain selling stockholders in May 2018, and (iii) a provider of services for the fiscal years 2019 and 2017 debt refinancing transactions. KKR held a position in the Euro Term Loan Facility of €
49.0
million and €
33.5
million as of December 31, 2019 and 2018, respectively. KKR Capital Markets LLC, an affiliate of KKR, acted as an underwriter in connection with the initial public offering of the Company’s stock and received underwriter discounts and commissions of approximately $
8.9
million for the year ended December 31, 2017. In May 2018, KKR Capital Markets LLC acted as an underwriter in connection with the secondary offering of the Company’s stock by certain selling stockholders and received underwriter discounts and commissions of approximately $
5.2
million.
In June 2019, KKR Capital Markets LLC was the joint lead arranger and bookrunner of Amendment No. 4 to the Credit Agreement and earned $
0.4
million in structuring fees for their involvement in the Amendment.
In August 2017, KKR Capital Markets LLC received $
1.5
million for services rendered in connection with the debt refinancing transaction.
The Company entered into a monitoring agreement, dated July 30, 2013, with KKR pursuant to which KKR will provide management, consulting and financial advisory services to the Company and its divisions, subsidiaries, parent entities and controlled affiliates. Under the terms of the monitoring agreement the Company was, among other things, obligated to pay KKR (or such affiliate(s) as KKR designates) an aggregate annual management fee in the initial annual amount of $
3.5
million, payable in arrears at the end of each fiscal quarter, plus upon request all reasonable out of pocket expenses incurred in connection with the provision of services under the agreement. The management fee increased at a rate of
5
% per year effective on January 1, 2014. In connection with the Company’s initial public offering, the monitoring agreement was terminated in accordance with its terms and the Company paid a termination fee of $
16.2
million during the year ended December 31, 2017 which was included in “Selling and administrative expenses” in the Consolidated Statements of Operations. Prior to the termination of the monitoring agreement, the Company incurred management fees to KKR of $
1.1
million for the year ended December 31, 2017.
| Note 24: |
Earnings Per Share
|
The computations of basic and diluted income per share are as follows.
|
|
Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Net income attributable to Gardner Denver Holdings, Inc.
|
$
|
|
$
|
|
$
|
|
||||||
|
Average shares outstanding:
|
||||||||||||
|
Basic
|
|
|
|
|||||||||
|
Diluted
|
|
|
|
|||||||||
|
Earnings per share:
|
||||||||||||
|
Basic
|
$
|
|
$
|
|
$
|
|
||||||
|
Diluted
|
$
|
|
$
|
|
$
|
|
||||||
For the years ended December 31, 2019, 2018 and 2017, there were
1.8
million,
0.8
million and
0.7
million anti-dilutive shares that were not included in the computation of diluted earnings per share.
| Note 25: |
Share Repurchase Program
|
On August 1, 2018, the Board of Directors of Gardner Denver authorized a share repurchase program pursuant to which the Company may repurchase up to $
250.0
million of its common stock effective through July 31, 2020, the date on which the repurchase program will expire. Under the repurchase program, Gardner Denver is authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Act of 1934. The share repurchase program does not obligate Gardner Denver to acquire any particular amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion. The timing and amount of any purchases of common stock will be based on Gardner Denver’s liquidity, general business and market conditions, debt covenant restrictions and other factors, including alternative investment opportunities and Gardner Denver’s desire to repay indebtedness.
For the year ended December 31, 2018, the Company repurchased
1,203,178
shares under the August 1, 2018 program at a weighted average price of $
24.31
per share for an aggregate value of $
29.2
million.
There were
no
shares repurchased under the August 1, 2018 program for the year ended December 31, 2019.
To the stockholders and the Board of Directors of Gardner Denver Holdings, Inc.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Gardner Denver Holdings, Inc., and subsidiaries (the "Company") as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2019, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). We also have audited the Company’s internal control over financial reporting as of December 31, 2019, based on criteria established in
Internal Control — Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in
Internal Control — Integrated Framework (2013)
issued by COSO.
Change in Accounting Principle
As discussed in Note 2 to the financial statements, the Company changed its method of accounting for leases in the year ended December 31, 2019 due to the adoption of Financial Accounting Standards Board ASU No. 2016-02, Leases (Topic 842) using the optional transition method with effect from January 1, 2019.
Basis for Opinions
The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Asbestos-Related and Silica-Related Litigation – Liability and Insurance Recovery Receivable – Refer to Note 20 to the Financial Statements
Critical Audit Matter Description
The Company has been named as a defendant in a number of asbestos-related and silica-related personal injury lawsuits. The plaintiffs in these suits allege exposure to asbestos or silica from multiple sources and typically the Company is one of approximately 25 or more named defendants. At December 31, 2019, the Company has recorded an estimated liability of $118.1 million with respect to the Company’s asbestos-related and silica- related litigation. The Company uses a third-party actuary to assist in determining certain assumptions and in calculating the estimated liability. The estimated liability is based on currently available information and assumptions, including the estimated future number and type of new claims to be filed each year, the estimated future resolution or outcome of new and pending claims, and the estimated average cost of resolution of each new and pending claim.
The Company has entered into a series of agreements with certain of its or its predecessors’ legacy insurers and certain potential indemnitors to secure insurance coverage and/or reimbursement for the costs associated with the asbestos- and silica-related lawsuits filed against the Company. The Company has also pursued litigation against certain insurers or indemnitors, where necessary. The Company has an insurance recovery receivable for probable asbestos and silica-related recoveries of $122.4 million. The estimated asset is based on key variables and assumptions used to determine the recorded amounts, including the amount of insurance available, allocation methodologies, the resolution of coverage issues with other excess coverage carriers with whom the Company has not yet achieved settlements, and the solvency risk with respect to the Company’s insurance carriers.
We identified the liability for asbestos and silica litigation and the related insurance recovery receivable as a critical audit matter because of the significant judgments made by management to estimate the liability and related recoverability of insurance proceeds. This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our actuarial and insurance recovery specialists, when performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions related to estimated future claims development, the estimated resolution or outcome of these claims, the estimated average cost of resolution of each claim and, separately, the expected recoverability of claims through insurance.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the estimated liability for asbestos-related and silica-related litigation included the following, among others:
| ● |
We tested the effectiveness of internal controls related to the estimated liability for asbestos-related and silica-related litigation, including those over the estimated future claims development, the estimated resolution or outcome of these claims, and the estimated average cost of resolution of each claim.
|
| ● |
We evaluated the methods and assumptions used by the Company to determine the estimated liability by:
|
| o |
Testing the underlying claim and settlement cost data that served as inputs for the actuarial analysis, including testing historical and pending claims by comparing key attributes to accounting records and legal documents to assess the accuracy and completeness of the data.
|
| o |
With the assistance of our actuarial specialists, we evaluated whether the estimates of future claim numbers and types, number of claims expected to be dismissed or sustained and the estimated average cost of resolution used in the Company’s calculations were reasonable in relation to historical claim trends at the Company.
|
| o |
With the assistance of our actuarial specialists, we independently recalculated the liability based on the Company’s estimates of future claim numbers and types and assumptions of estimated future resolution or outcome of the claims and estimated average cost of resolution of each claim.
|
| o |
With the assistance of our actuarial specialists, we developed independent estimates of the liability using available third-party estimates of future claim numbers and types that we determined were reputable and widely-accepted in the industry and compared our independent estimates to the Company’s recorded liability.
|
Our audit procedures related to the insurance recovery receivable for probable asbestos and silica-related recoveries included the following, among others:
| ● |
We tested the effectiveness of internal controls related to the insurance recovery receivable for probable asbestos and silica-related recoveries.
|
| ● |
With the assistance of our insurance recovery specialists, we evaluated the Company’s analysis of the solvency of insurance carriers with policies with the Company or its predecessors. With the assistance of these specialists, we read the Company’s analysis and supporting documentation of policy coverage by year as compared to estimated claims per year to assess the Company’s determination of coverage by claim year. With the assistance of these specialists, we obtained legal opinions regarding recoverability that the Company had obtained from external counsel and read associated legal proceedings to evaluate the Company’s assessment of the probability of recovery.
|
/s/ DELOITTE & TOUCHE LLP
Milwaukee, WI
February 26, 2020
We have served as the Company's auditor since 2013.
None.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of December 31, 2019. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2019.
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.
The Company’s internal control over financial reporting includes those policies and procedures that:
| ● |
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
|
| ● |
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and
|
| ● |
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.
|
Because of its inherent limitations, internal control over financial reporting may not prevent and detect misstatements. Also, projections of any evaluation of effectiveness of future periods are subject to the risk that controls may become inadequate because of the changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of our management, including our executive officer and our principal financial officer, we evaluated the effectiveness of our internal control over financial reporting based on the framework in
Internal Control – Integrated Framework (2013)
issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on that evaluation, management has concluded that our internal control over financial reporting was effective as of December 31, 2019.
Deloitte & Touche LLP, an independent registered public accounting firm, has audited the Consolidated Financial Statements included in this Form 10-K, and, as part of their audit, has issued its attestation report, included herein, on the effectiveness of our internal control over financial reporting. See “Report of Independent Registered Public Accounting Firm” in Part II, Item 8. Financial Statements and Supplementary Data in this Form 10-K.
Changes in Internal Control Over Financial Reporting
Regulations under the Exchange Act require public companies, including our Company, to evaluate any change in our “internal control over financial reporting” as such term is defined in Rule 13a-15(f) and Rule 15d-15(f) of the Exchange Act. There have been no changes in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
None.
PART III.
The information required by this Item will be included in our definitive proxy statement for the 2020 Annual Meeting of Stockholders and is incorporated herein by reference. We will file such definitive proxy statement with the SEC pursuant to Regulation 14A within 120 days of the fiscal year ended December 31, 2019.
The information required by this Item will be included in our definitive proxy statement for the 2020 Annual Meeting of Stockholders and is incorporated herein by reference. We will file such definitive proxy statement with the SEC pursuant to Regulation 14A within 120 days of the fiscal year ended December 31, 2019.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Except as set forth below, the information required by this Item will be included in our definitive proxy statement for the 2020 Annual Meeting of Stockholders and is incorporated herein by reference. We will file such definitive proxy statement with the SEC pursuant to Regulation 14A within 120 days of the fiscal year ended December 31, 2019.
Equity Compensation Plan Information
The following table provides information as of December 31, 2019 about our common stock that may be issued upon the exercise of options, warrants and rights granted to employees, consultants or directors under all of the existing equity compensation plans including our 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan. All equity compensation plans are described more fully in Note 17 “Stock-Based Compensation Plans” to our audited consolidated financial statements included elsewhere in this Form 10-K.
|
Plan Category
|
Number of Securities
to be issued upon
Exercise of Outstanding
Options, Warrants
And Rights
(1)
|
Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
(2)
|
Number of Securities
Remaining Available for
Future Issuance under Equity
Compensation Plans (excluding
Securities reflected in
the first column)
(3)
|
|||||||||
|
Equity compensation plans approved by securityholders
|
8,480,011
|
$
|
14.34
|
6,848,079
|
||||||||
| (1) |
Total includes 5,962,883 stock options and 25,370 share-settled stock appreciation rights under the Company’s 2013 Stock Incentive Plan and 1,772,604 stock options, 719,154 restricted stock units and no share-settled stock appreciation rights under the Company’s 2017 Omnibus Incentive Plan.
|
| (2) |
The weighted average exercise price relates only to stock options. The calculation of the weighted average exercise price does not include outstanding equity awards that are received or exercised for no consideration.
|
| (3) |
These shares are available for grant as of December 31, 2019 under the Company’s 2017 Omnibus Incentive Plan. This includes 8,550,000 shares initially authorized for issuance under the Company’s 2017 Omnibus Incentive Plan and shares subject to awards under the Company’s 2013 Stock Incentive Plan that expired or were otherwise forfeited or terminated in accordance with their terms without the delivery of shares of the Company’s common stock in settlement thereof.
|
The information required by this Item will be included in our definitive proxy statement for the 2020 Annual Meeting of Stockholders and is incorporated herein by reference. We will file such definitive proxy statement with the SEC pursuant to Regulation 14A within 120 days of the fiscal year ended December 31, 2019.
The information required by this Item will be included in our definitive proxy statement for the 2020 Annual Meeting of Stockholders and is incorporated herein by reference. We will file such definitive proxy statement with the SEC pursuant to Regulation 14A within 120 days of the fiscal year ended December 31, 2019.
PART IV
Financial Statements, Financial Statement Schedule and Exhibits
The consolidated financial statements listed in the accompanying index to consolidated financial statements are filed as part of this Annual Report on Form 10-K.
All financial statement schedules are omitted since the required information is not present or is not present in amounts sufficient to require submission of the schedules, or because the information required is included in the consolidated financial statements and notes thereto.
The exhibits listed in the accompanying exhibit index are filed as part of this Annual Report on Form 10-K.
Index to Consolidated Financial Statements
|
|
47
|
|
|
|
48
|
|
|
|
49
|
|
|
|
50
|
|
|
|
51
|
|
|
|
52
|
|
|
|
98
|
Schedule to Consolidated Financial Statements
|
|
112
|
Exhibits
|
Exhibit Number
|
|
Exhibit Description
|
|
Agreement and Plan of Merger, dated as of April 30, 2019, by and among Ingersoll-Rand plc, Ingersoll-Rand U.S. Holdco, Inc., Gardner Denver Holdings, Inc. and Charm Merger Sub Inc. (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by Ingersoll-Rand plc on May 6, 2019 (File No. 001-34400))
|
||
|
|
Second Amended and Restated Certificate of Incorporation of Gardner Denver Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
|
|
|
|
|
|
Amended and Restated Bylaws of Gardner Denver Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
Exhibit Number
|
|
Exhibit Description
|
|
|
Form of Common Stock Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 4 to the Registrant’s Registration Statement on Form S-1 filed on May 3, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
|
Amended and Restated Registration Rights Agreement, dated as of May 17, 2017, by and among KKR Renaissance Aggregator L.P.; KKR Renaissance Aggregator GP LLC; Gardner Denver Holdings, Inc. and each of the other parties thereto (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
Description of Gardner Denver Holdings, Inc.’s Securities
|
||
|
|
|
|
|
|
2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.1 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Senior Secured Credit Agreement, dated as of July 30, 2013, among Renaissance Acquisition Corp., the foreign borrowers described therein, Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.), UBS AG, Stamford Branch, as administrative agent, and other agents and lenders party thereto (incorporated by reference to Exhibit 10.2 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Amendment No. 1, dated as of March 4, 2016, to the Senior Secured Credit Agreement, among Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.), Gardner Denver, Inc., GD German Holdings II GmbH (as successor in interest to Gardner Denver Holdings GmbH & Co. KG), GD First (UK) Limited, UBS AG, Stamford Branch, as administrative agent, and other agents and lenders party thereto (incorporated by reference to Exhibit 10.3 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Amendment No. 2, dated as of August 17, 2017, to the Senior Secured Credit Agreement, among Gardner Denver Holdings, Inc., Gardner Denver, Inc., GD German Holdings II GmbH, GD First (UK) Limited, UBS AG, Stamford Branch, as administrative agent, and the other parties and lenders party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on August 18, 2017 (File no. 001-38095))
|
|
|
|
|
|
|
|
Amendment No. 3, dated as of December 13, 2018, to the Senior Secured Credit Agreement dated as of July 30, 2013, among Gardner Denver Holdings, Inc., Gardner Denver, Inc., GD German Holdings II GmbH, GD First (UK) Limited, UBS AG, Stamford Branch, as administrative agent, and the other parties and lenders part thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on December 14, 2018 (File no. 001-38095)
|
|
|
|
|
|
|
|
Pledge Agreement, dated as of July 30, 2013, among Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.), Renaissance Acquisition Corp., the subsidiary pledgors identified therein and UBS AG, Stamford Branch, as collateral agent (incorporated by reference to Exhibit 10.4 to the Registrant’s Registration Statement on Form S-1
filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Security Agreement, dated as of July 30, 2013, among Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.), Renaissance Acquisition Corp., the subsidiary grantors identified therein and UBS AG, Stamford Branch, as collateral agent (incorporated by reference to Exhibit 10.5 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Guarantee Agreement, dated as of July 30, 2013, among Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.), the subsidiary guarantors identified therein and UBS AG, Stamford Branch, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Receivables Financing Agreement, dated as of May 17, 2016, by and among Gardner Denver Finance II LLC, Gardner Denver, Inc., as initial servicer, the various lenders and LC participants from time to time party thereto, PNC Bank, National Association, as LC bank and administrative agent, and PNC Capital Markets LLC, as structuring agent. (incorporated by reference to Exhibit 10.7 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
Exhibit Number
|
|
Exhibit Description
|
|
|
Indemnification Agreement, dated as of July 30, 2013, by and among KKR Renaissance Aggregator L.P.; KKR Renaissance Aggregator GP LLC; Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.); Gardner Denver, Inc. and Kohlberg Kravis Roberts & Co. L.P. (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Stockholders Agreement, dated as of May 17, 2018, between Gardner Denver Holdings, Inc. and KKR Renaissance Aggregator L.P. (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
|
|
|
|
|
|
Form of Management Stockholder’s Agreement (incorporated by reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Director Stockholder’s Agreement (incorporated by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Advisor Stockholder’s Agreement (incorporated by reference to Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Director Stock Option Agreement under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.16 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Management Stock Option Agreement (December 2013) under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.17 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Management Stock Option Agreement (May 2015) under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.18 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Management Stock Option Agreement (May 2016, 3 year vesting) under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.19 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Management Stock Option Agreement (May 2016, 5 year vesting) under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.20 to the Registrant’s Registration Statement on Form S-1
filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Management Stock Option Agreement (December 2016) under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.21 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Amendment to Stock Option Agreement or Stock Appreciation Right Agreement under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and its Subsidiaries (incorporated by reference to Exhibit 10.22 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
Exhibit Number
|
|
Exhibit Description
|
|
|
Stock Option Agreement, dated as of March 7, 2014, under the 2013 Stock Incentive Plan for Key Employees of Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) between Gardner Denver Holdings, Inc. (formerly known as Renaissance Parent Corp.) and Andrew Schiesl (incorporated by reference to Exhibit 10.23 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Form of Sale Participation Agreement (incorporated by reference to Exhibit 10.24 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Offer Letter, dated April 17, 2015, between Vicente Reynal and Gardner Denver, Inc. (incorporated by reference to Exhibit 10.25 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Offer Letter, dated November 19, 2015, between Vicente Reynal and Gardner Denver, Inc. (incorporated by reference to Exhibit 10.26 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Offer Letter, dated November 18, 2015, between Todd Herndon and Gardner Denver, Inc. (incorporated by reference to Exhibit 10.27 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Offer Letter, dated September 2, 2016, between Todd Herndon and Gardner Denver, Inc. (incorporated by reference to Exhibit 10.28 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Offer Letter, dated November 25, 2013, between Gardner Denver, Inc. and Andy Schiesl (incorporated by reference to Exhibit 10.31 to the Registrant’s Registration Statement on Form S-1 filed on February 28, 2017 (File no. 333-216320))
|
|
|
|
|
|
|
|
Employment Contract, dated September 11, 2018 between Gardner Denver Deutschland GmbH and Enrique Miñarro Viseras (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on October 29, 2018 (File No. 001-38095))
|
|
|
|
|
|
|
|
Offer Letter, dated December 18, 2015, between Gardner Denver, Inc. and Neil Snyder (incorporated by reference to Exhibit 10.39 to the Registrant’s Annual Report on Form 10-K filed on February 16, 2018 (File No. 001-38095))
|
|
|
|
|
|
|
|
2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
|
|
|
|
|
|
Monitoring Fee Termination Agreement, dated as of May 17, 2017, between Gardner Denver Holdings, Inc. Kohlberg Kravis Roberts & Co. L.P. (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on May 17, 2017 (File no. 001-38095))
|
|
|
|
|
|
|
|
Form of Restricted Stock Unit Grant Notice and Agreement (2018) under the Gardner Denver Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on April 27, 2018 (File No. 001-38095))
|
|
|
|
|
|
|
|
Form of Director Restricted Stock Unit Grant Notice and Agreement under the Gardner Denver Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on April 27, 2018 (File no. 001-38095))
|
|
|
|
|
|
|
|
Form of Stock Option Grant Notice and Agreement under the Gardner Denver Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.42 to the Registrant’s Annual Report on Form 10-K filed on February 16, 2018 (File no. 001-38095))
|
|
|
|
|
|
|
|
Gardner Denver, Inc. Supplemental Excess Defined Contribution Plan (January 1, 2019 Restatement) (incorporated by reference to Exhibit 10.36 to the Registrants Annual Report on Form 10-K filed on February 27, 2019 (File no. 001-38095))
|
|
Exhibit Number
|
|
Exhibit Description
|
|
|
Transition Agreement, dated as of February 27, 2019, between Gardner Denver, Inc. and Philip T. Herndon (incorporated by reference to Exhibit 10.37 to the Registrants Annual Report on Form 10-K filed on February 27, 2019 (File No. 001-38095))
|
|
|
|
|
|
|
|
|
Amendment No. 4 to the Credit Agreement, dated as of June 28, 2019, among Gardner Denver Holdings, Inc., GD German Holdings II GmbH, Gardner Denver Holdings Ltd., UBS AS, Stamford Branch as the Resigning Agent, Citibank, N.A. as the Successor Agent and the lenders and other entities party thereto (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on July 2, 2019 (File No. 001-38095))
|
|
|
|
|
|
|
|
Separation and Distribution Agreement, dated as of April 30, 2019, by and between Ingersoll-Rand plc and Ingersoll Rand U.S. HoldCo., Inc. (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed by Ingersoll-Rand plc on May 6, 2019 (File No. 001-34400))
|
|
|
|
|
|
|
|
Amendment No. 1 to the Stockholders Agreement, dated as of April 30, 2019, between Gardner Denver Holdings, Inc. and KKR Renaissance Aggregator L.P. (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed on May 6, 2019 (File No. 001-38095))
|
|
|
|
|
|
|
Transition Agreement, dated as of October 28, 2019, between Gardner Denver, Inc. and Neil Snyder (incorporated by reference to Exhibit 10.4 to the Registrants Quarterly Report on Form 10-Q filed on October 30, 2019 (File No. 001-38095))
|
|
|
Offer Letter, dated October 3, 2019, between Gardner Denver Holdings, Inc. and Emily A. Weaver
|
||
|
Form of Stock Option Grant Notice and Agreement under the Gardner Denver Holdings, Inc. 2017 Omnibus Incentive Plan
|
||
|
Form of Restricted Stock Unit Grant Notice and Agreement (2019) under the Gardner Denver Holdings, Inc. 2017 Omnibus Incentive Plan
|
||
|
|
|
|
|
|
Subsidiaries of Gardner Denver Holdings, Inc. as of December 31, 2019
|
|
|
|
|
|
|
|
Consent of Independent Registered Public Accounting Firm
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)
|
|
|
|
|
|
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a)
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350
|
|
|
|
|
|
|
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350
|
|
|
|
|
|
|
101.INS
|
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
|
|
101.SCH
|
|
Inline XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101)
|
| † |
Identifies exhibits that consists of a management contract or compensatory plan or arrangement.
|
The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time.
None.
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf on the 26
th
day of February 2020, by the undersigned, thereunto duly authorized.
|
|
Gardner Denver Holdings, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Vicente Reynal
|
|
|
|
Name: Vicente Reynal
|
|
|
|
Title: Chief Executive Officer
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on the 26
th
day of February
2020,
by the following persons on behalf of the registrant and in the capacities indicated.
|
Signature
|
|
Capacity
|
|
/s/
Vicente Reynal
|
|
Chief Executive Officer and Director
|
|
Vicente Reynal
|
|
(principal executive officer), Director
|
|
|
|
|
|
/s/
Emily A. Weaver
|
|
Vice President and Chief Financial Officer
|
|
Emily A. Weaver
|
|
(principal financial officer)
|
|
|
|
|
|
/s/
Michael J. Scheske
|
|
Vice President and Corporate Controller
|
|
Michael J. Scheske
|
|
(principal accounting officer)
|
|
|
|
|
|
/s/
Peter Stavros
|
|
Director
|
|
Peter Stavros
|
|
|
|
|
|
|
|
/s/
Brandon F. Brahm
|
|
Director
|
|
Brandon F. Brahm
|
|
|
|
|
|
|
|
/s/
William P. Donnelly
|
|
Director
|
|
William P. Donnelly
|
|
|
|
|
|
|
|
/s/
William E. Kassling
|
|
Director
|
|
William E. Kassling
|
|
|
|
|
|
|
|
/s/
Michael V. Marn
|
|
Director
|
|
Michael V. Marn
|
|
|
|
|
|
|
|
/s/
Nickolas Vande Steeg
|
|
Director
|
|
Nickolas Vande Steeg
|
|
|
|
|
|
|
|
/s/
Joshua T. Weisenbeck
|
|
Director
|
|
Joshua T. Weisenbeck
|
|
|
|
|
|
|
|
/s/
Elizabeth Centoni
|
|
Director
|
|
Elizabeth Centoni
|
|
|
|
/s/
Marc E. Jones
|
|
Director
|
|
Marc E. Jones
|
|
|
SCHEDULE 1 – GARDNER DENVER HOLDINGS, INC
(PARENT COMPANY ONLY)
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(Dollars in millions)
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Cost of sales
|
|
|
|
|||||||||
|
Gross Profit
|
(
|
)
|
|
|
||||||||
|
Operating costs
|
|
(
|
)
|
|
||||||||
|
Other operating (income) expense, net
|
(
|
)
|
(
|
)
|
|
|||||||
|
Operating Income (Loss)
|
|
|
(
|
)
|
||||||||
|
Interest income
|
|
|
|
|||||||||
|
Income (Loss) Before Income Taxes
|
|
|
(
|
)
|
||||||||
|
Income tax (benefit) provision
|
(
|
)
|
|
(
|
)
|
|||||||
|
Income (Loss) of Parent Company
|
|
|
(
|
)
|
||||||||
|
Equity in undistributed income of subsidiaries
|
|
|
|
|||||||||
|
Net Income
|
|
|
|
|||||||||
|
Other comprehensive (loss) income
|
(
|
)
|
(
|
)
|
|
|||||||
|
Comprehensive Income
|
$
|
|
$
|
|
$
|
|
||||||
SCHEDULE 1 – GARDNER DENVER HOLDINGS, INC
(PARENT COMPANY ONLY)
BALANCE SHEETS
(Dollars in millions)
|
|
As of December 31,
|
|||||||
|
2019
|
2018
|
|||||||
|
Assets
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Equity in net assets of subsidiaries
|
|
|
||||||
|
Intercompany receivables
|
|
|
||||||
|
Deferred tax assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
Liabilities and Stockholders' Equity
|
||||||||
|
Other liabilities
|
$
|
|
$
|
|
||||
|
Total liabilities
|
|
|
||||||
|
Stockholders' equity:
|
||||||||
|
Common stock, $
|
|
|
||||||
|
Capital in excess of par value
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock at cost;
|
||||||||
|
December 31, 2019 and 2018, respectively
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Total Gardner Denver Holdings, Inc. stockholders' equity
|
|
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
|
$
|
|
||||
SCHEDULE 1 – GARDNER DENVER HOLDINGS, INC
(PARENT COMPANY ONLY)
CONDENSED STATEMENTS OF CASH FLOWS
(Dollars in millions)
|
|
For the Years Ended December 31,
|
|||||||||||
|
2019
|
2018
|
2017
|
||||||||||
|
Cash Flows From Operating Activities:
|
||||||||||||
|
Net cash (used in) provided by operating activities
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||
|
Cash Flows From Investing Activities:
|
||||||||||||
|
Advances to subsidiaries
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Cash Flows From Financing Activities:
|
||||||||||||
|
Proceeds from stock option exercises
|
|
|
|
|||||||||
|
Purchases of treasury stock
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Proceeds from the issuance of common stock
|
|
|
|
|||||||||
|
Net cash provided by (used in) financing activities
|
|
(
|
)
|
|
||||||||
|
(Decrease) increase in cash and cash equivalents
|
(
|
)
|
|
(
|
)
|
|||||||
|
Cash and cash equivalents, beginning of year
|
|
|
|
|||||||||
|
Cash and cash equivalents, end of year
|
$
|
|
$
|
|
$
|
|
||||||
SCHEDULE I - GARDNER DENVER HOLDINGS, INC.
(PARENT COMPANY ONLY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
1. Overview and Basis of Presentation
On July 30, 2013, Gardner Denver, Inc. was acquired by an affiliate of Kohlberg Kravis Roberts & Co. L.P. (“KKR”). The acquisition (also referred to as the “Merger”) was effected by the merger of Renaissance Acquisition Corp. with and into Gardner Denver, Inc., with Gardner Denver, Inc. being the surviving corporation. As a result of the Merger, Gardner Denver, Inc. became a wholly-owned subsidiary of Gardner Denver Holdings, Inc. (formerly Renaissance Parent Corp.)
Gardner Denver Holdings, Inc. Parent Company only financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this report. The accounting policies for the registrant are the same as those described in Note 1 “Summary of Significant Accounting Policies” to our audited consolidated financial statements included elsewhere in this Form 10-K.
2. Subsidiary Transactions
Investment in Subsidiaries
Gardner Denver Holdings, Inc.’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries.
Dividends and Capital Distributions
There were
no
dividends received from subsidiaries during the years ended December 31, 2019, 2018 and 2017.
3. Debt
A discussion of long-term debt, including the
five-year
debt maturity schedule, can be found in Note 10 “Debt” to our audited consolidated financial statements included elsewhere in this Form 10-K. Gardner Denver Holdings, Inc. had
no
long-term debt obligations as of December 31, 2019 and 2018.
4. Contingencies
For a summary of contingencies, see Note 20 “Contingencies” to our audited consolidated financial statements included elsewhere in this Form 10-K.
112
TABLE OF CONTENTS
Part IItem 1. BusinessItem 1A. Risk FactorsItem 1B. Unresolved Staff CommentsItem 2. PropertiesItem 3. Legal ProceedingsItem 4. Mine Safety DisclosuresPart IIItem 5. Market For Registrant S Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity SecuritiesItem 6. Selected Financial DataItem 7. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 7A. Quantitative and Qualitative Disclosures About Market RiskItem 8. Financial Statements and Supplementary DataNote 1: Summary Of Significant Accounting PoliciesNote 2: New Accounting StandardsNote 3: Business CombinationsNote 4: RestructuringNote 5: Allowance For Doubtful AccountsNote 6: InventoriesNote 7: Property, Plant and EquipmentNote 8: Goodwill and Other Intangible AssetsNote 9: Accrued LiabilitiesNote 10: DebtNote 11: Benefit PlansNote 12: Stockholders EquityNote 13: Accumulated Other Comprehensive (loss) IncomeNote 14: Revenue From Contracts with CustomersNote 15: Income TaxesNote 16: LeasesNote 17: Stock-based Compensation PlansNote 18: Hedging Activities, Derivative Instruments and Credit RiskNote 19: Fair Value MeasurementsNote 20: ContingenciesNote 21: Other Operating ExpenseNote 22: Segment ReportingNote 23: Related PartyNote 24: Earnings Per ShareNote 25: Share Repurchase ProgramItem 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureItem 9A. Controls and ProceduresItem 9B. Other InformationPart IIIItem 10. Directors, Executive Officers and Corporate GovernanceItem 11. Executive CompensationItem 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder MattersItem 13. Certain Relationships and Related Transactions, and Director IndependenceItem 14. Principal Accounting Fees and ServicesPart IVItem 15. Exhibits, Financial Statement ScheduleItem 16. Form 10-k Summary